Bile salt hydrolase in Lactobacillus plantarum: functional analysis and delivery to the intestinal tract of the host by Lambert, J.M.
  
Bile salt hydrolase in Lactobacillus plantarum: 
functional analysis and delivery to the intestinal tract of the host. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                Jolanda Lambert 
Promotor: 
 
Prof. Dr. Willem M. de Vos 
 Hoogleraar Microbiologie 
 Wageningen Universiteit 
 
Co-promotor: 
 
Prof. Dr. Michiel Kleerebezem 
 Hoogleraar Bacterial Metagenomics 
 Wageningen Universiteit 
 
 
 
Promotiecommissie: 
 
Prof. Dr. Tjakko Abee 
 Wageningen Universiteit 
 
Prof. Dr. Jerry Wells 
 Wageningen Universiteit 
 
Prof. Dr. R. Paul Ross 
 Teagasc, Moorepark Food Research Centre, Ireland 
 
Dr. Aat Ledeboer 
 Unilever, Vlaardingen  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dit onderzoek is uitgevoerd binnen de onderzoeksschool VLAG. 
 
Bile salt hydrolase in Lactobacillus plantarum: 
functional analysis and delivery to the intestinal tract of the host. 
 
 
 
 
 
Jolanda Lambert 
 
 
 
 
 
 
 
 
 
 
 
 
Proefschrift 
 
ter verkrijging van de graad van doctor 
op gezag van de rector magnificus 
van Wageningen Universiteit  
Prof. dr. M.J. Kropff 
in het openbaar te verdedigen 
op vrijdag 18 april 2008 
des namiddags te vier uur in de Aula 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
J. M. Lambert. Bile salt hydrolase in Lactobacillus plantarum: functional 
analysis and delivery to the intestinal tract of the host. 
 
PhD thesis. Wageningen University, The Netherlands, 2008.  
With summary in Dutch. 
 
ISBN: 978-90-8504-893-0 
Abstract 
 
In the liver of mammals, bile salts are synthesised from cholesterol and 
conjugated to either taurine or glycine. Following release into the intestine, 
conjugated bile salts can be deconjugated by members of the endogenous 
microbiota that produce an enzyme called bile salt hydrolase (Bsh). Bsh appears 
to play an important role in both host intestinal physiology and bacterial survival 
and persistence in the intestinal tract; especially lactobacilli have been suggested 
to be of importance for in vivo bile salt hydrolysis in the small intestine.  
In this thesis, a functional analysis of Bsh in Gram-positive bacteria, and 
in particular, the model organism Lactobacillus plantarum WCFS1 was 
performed. In-depth investigation of the annotation of bsh genes in Gram-
positive bacteria using a combination of in silico methods led to the re-
annotation of eight conjugated bile acid hydrolase superfamily members in 
various lactobacilli. Furthermore, these analyses provided a robust methodology 
for accurate annotation of this enzyme superfamily. L. plantarum WCSF1 was 
previously predicted to contain four bsh genes (bsh1, bsh2, bsh3, and bsh4), but 
according to our in silico analyses, three of these genes appeared to be penicillin 
acylase-related.  
To unravel the functionality of each of the separate bsh genes, the 
generation of multiple isogenic bsh-deletion strains was required. Therefore, a 
Cre-lox-based toolbox for the construction of multiple deletions and selectable-
marker removal in Gram-positive organisms was designed and implemented in 
L. plantarum WCFS1. Using heterologous over-expression and multiple bsh-
deletion derivatives of L. plantarum WCFS1, Bsh1 was shown to be the major 
bile salt hydrolase in this strain, where it appeared to be involved in 
glycodeoxycholic acid tolerance. Although these experiments validated the 
prediction that bsh2, bsh3, and bsh4 do not encode true Bsh enzymes, the in vivo 
functionality of Bsh2, Bsh3, and Bsh4 was not entirely clarified. Bsh2, Bsh3, 
and Bsh4 appeared to encode enzymes with acylase activity possibly using 
penicillin-like chemicals as their preferred substrate.  
To investigate the influence of Bsh-producing probiotics on host 
physiology, two modes of Bsh delivery to the small intestine were investigated 
in this work; delivery of Bsh activity by viable L. plantarum was compared to 
delivery using Bsh-whey protein/gum arabic microencapsulates in an in vitro 
model. The microencapsulates provided excellent protection of the enzyme 
during transit through gastric conditions, however, under pancreatin pressure 
during intestinal conditions, the Bsh enzyme was subject to proteolytic 
degradation. In contrast, L. plantarum was able to withstand both gastric and 
intestinal conditions, however, enzyme delivery levels are limited when 
compared to the capacity of microencapsulates. Finally, the influence of delivery 
of bile salt hydrolase activity by viable bacteria and whey protein/gum arabic 
microencapsulates on the host was investigated in vivo using a rat model. 
However, no effect of delivery of Bsh on the intestinal bile salt composition or 
mucin excretion was detected. These results may indicate that the physiological 
relevance and magnitude of bile salt hydrolase activity of probiotics in the small 
intestine is limited. 
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Introduction 
1. Introduction and outline of this thesis 
 
INTRODUCTION 
 
Intestinal microbiota. The microbiota of the intestine of humans and 
other mammals encompasses a myriad of microbes, and is dominated by low 
G+C Gram-positive bacteria. Between 103 to 108 bacteria per gram of intestinal 
content are present in the small intestinal tract, and this number rises to 
approximately 1011 bacteria per gram in the colon (Figure 1). Thereby, the total 
number of bacteria in the human intestine surpasses the total number of cells of 
the human body itself. To assess the activities and composition of the intestinal 
microbiota, culturing techniques have been employed extensively. However, 
many intestinal species appear to be unculturable to date. In addition, culturing 
techniques usually do not distinguish between injured, but physiologically 
active, and dead cells. It was shown that with flow cytometry using live/dead 
staining probes, viable, injured and dead cells can be distinguished, yielding 
relevant information on the physiological status of groups of intestinal bacteria 
(5, 14). Furthermore, a wide range of biochemical assays for common bacterial 
enzyme activities has been used for analysis of the activities of the microbiota 
(for review, see (109)). In addition, comparative genomics approaches can be 
used to predict the metabolic potential of the microbiota, e.g., using completely 
sequenced microbial genomes or libraries of large genomic DNA fragments 
from bacterial communities, often called metagenomic libraries (126). In 
addition, the in vivo expression of genes in bacteria has been studied. Examples 
include the use of microarrays from human in vivo samples of L. plantarum 
(34), or a resolvase-based IVET method that was used to identify promoters 
induced in L. plantarum during its passage through the gastro-intestinal tract of 
mice (21). In addition, various molecular typing methods have been used for 
analysis of the phylogeny of bacterial species present in the gastro-intestinal 
tract, such as protein electrophoresis and random amplification of polymorphic 
DNA (109). Many molecular typing methods for determination of the diversity 
of the microbiota are based on 16S rRNA sequences, such as sequencing and 
denaturing gradient gel electrophoresis (DGGE) of 16S rRNA gene amplicons, 
16S rRNA gene fingerprinting, fluorescent in situ hybridisation (FISH), 
quantitative PCR, and 16S rRNA phylogenetic microarrays (e.g., the Human 
Intestinal Tract Chip (HitChip); (19, 35, 92, 109, 125, 126). 
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Figure 1. Interactions of intestinal bacteria with the human intestinal tract. The length of the 
various parts of the human intestine and its estimated bacterial content is indicated. 
 
Host-microbe interactions. The intestinal microbiota has a profound 
influence on the host, which is exemplified by the marked differences found 
between germ-free animals and their conventional counterparts. For example, 
organ weights, cardiac output, intestinal wall thickness and motility, epithelial 
cell turnover and several immunological parameters are reduced or atrophic in 
germ-free animals when compared to the conventional situation (39, 50, 109).  
Several modes of interaction between the host and intestinal microbes can 
be distinguished (Figure 1), such as direct attachment to mucosa or the mucin 
layer of the intestinal tract, molecular recognition of bacterial compounds by 
host receptors, and microbial conversion of host or diet-derived luminal factors. 
However, in many cases, the interactions occurring in situ will depend on more 
than a single molecular mechanism, and may also include additional 
mechanisms not encompassed by the modes of interaction presented here. 
Furthermore, our knowledge of the molecular basis of the interactions between 
the host and the microbiota is limited, although several studies have aimed to 
address this issue, such as experiments performed in germ-free animals (for 
review, see (39)), and among others, studies of the interaction between the host 
and specific bacteria, such as L. plantarum and Akkermansia muciniphila (20, 
36, 78, 79). Therefore, the model of the modes of interaction between host and 
intestinal microbes presented here can only been seen as exemplary. 
Attachment of bacteria to intestinal epithelial cells by direct adhesion 
most likely plays a key role in the capacity of microbial cells to colonize the 
intestine. The capacity to adhere to intestinal epithelial cells has been described 
for both intestinal pathogens as well as intestinal commensals. For example, 
several pathogens, such as Escherichia coli spp. (72, 124), Salmonella (6), and 
Vibrio (16) were shown to attach to epithelial cells through mannose-specific 
Introduction 
adhesion. In addition, a mannose-specific adhesin was found in the non-
pathogenic bacterium Lactobacillus plantarum, which is one of the 
Lactobacillus species frequently encountered in the human intestine (3, 85). 
Protection against intestinal infections by pathogenic bacteria through the 
activity of the resident microbiota may also depend on interactions between 
bacteria. For example, the microbiota protects the host from invasion by 
pathogens by filling all available ecological niches in the intestine, preventing 
growth of exogenous (pathogenic) organisms, which is a process often termed 
competitive exclusion, or by the secretion of specific antimicrobial substances, 
such as bacteriocins. Notably, bacteriocin production by Lactobacillus salivarius 
was found to be important in the protection of mice against Listeria 
monocytogenes infection (29). These experiments are examples of research on 
the molecular basis of host-microbe interactions. This type of research is 
indispensable for improving our understanding of the population dynamics and 
interactions taking place in the gastro-intestinal tract.  
In a second mode of interaction, the host is influenced by binding of 
microbiota-derived molecules to host receptors, leading to receptor-mediated 
molecular host responses (Figure 1) (for review, see (120)). For example, 
immature dentritic cells, anchored between intestinal epithelial cells, recognize 
microbes by conserved pattern recognition receptors (PRRs), including Toll-like 
receptors (TLRs), that recognize specific components of bacteria, such as 
lipopolysaccharide, lipoprotein or bacterial DNA (114, 116), and C-type lectins, 
such as DC-SIGN, that recognize carbohydrate structures on the cell surface of 
bacteria (122). The microbiota is thought to have a large impact on the immune 
system, which is clearly illustrated by the observation that the aspects of the 
immune system that are underdeveloped in germ-free animals are at least 
partially restored upon introduction of a microbiota (25, 59, 118). However, 
disbalance in the microbiota or disruption of the normal immunological response 
to the microbiota may lead to the development of inflammatory bowel diseases 
such as Crohn’s disease and ulcerative colitis, where an abnormal inflammatory 
reaction against the natural microbiota is observed (98). 
Possibly, the most prominent influence of the microbiota on host 
physiology is exerted through the capacity of intestinal microbes to convert 
dietary or host-derived components (Figure 1). For example, the microbiota 
contributes to the metabolism of the host in several ways, including the 
fermentation of non-digestible carbohydrates and mucus, the production of 
vitamin such as vitamin K, B12, biotin, folic acid, and pantothenate, and the 
synthesis of amino acids from ammonia or urea (59). Accumulation of mucus in 
germ-fee animals leads to a significant enlargement of the cecum (52), that can 
be reversed by the introduction of glycoside-hydrolysing bacteria, such as 
Peptostreptococcus (24). Furthermore, the microbiota does not only complement 
the metabolism of the host by fermentation of non-digestible polysaccharides 
(e.g., from plant material) to short chain fatty acids (SCFAs); colonization also 
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appears to modulate host genes that affect energy deposition in adipocytes (7). 
The contribution of the microbiota to host metabolism is clearly illustrated by 
the observation that germ-free mice are resistant to diet-induced obesity (8). Not 
all microbial activities contribute to host metabolism in a positive manner. For 
example, the bacterial putrefaction of proteins leads to the formation of 
potentially toxic and carcinogenic substances, such as ammonia, amines, 
phenols, thiols, and indols (50, 101). Another example of potentially harmful 
bacterial activities in the intestinal tract is the biotransformation of bile salts. To 
understand the influence of microbial bile salt biotransformations on host 
physiology, it is important to improve our knowledge of the differential 
responses of the intestinal mucosa to the natively produced bile salts compared 
to their derivatives that are generated through the activities of the intestinal 
microbiota. 
Bile and bile salts. Since long, it has been recognized that the bile salts 
present in bile play an important role in the absorption and digestion of fats and 
lipid-soluble vitamins in vertebrates. Bile acids improve the solubility of dietary 
lipophilic substances in the watery environment of the small intestine, and 
enable digestion of triacylglycerols by lipases, liberating free fatty acids (1). 
Bile is produced in the liver by hepatocytes, followed by secretion into bile 
canaliculi, draining into the hepatic ducts. In many mammals, a proportion of 
the bile is stored into the gallbladder, where it is concentrated. Following food 
intake, the gallbladder is stimulated by the hormone cholecystokinin to secrete 
the bile into the duodenum (94). However, the gallbladder appears to be non-
essential for proper functioning of bile, since some mammals, such as rat (but 
not all rodents), horse, most deer and most birds, do not possess a gallbladder. In 
these animals, a constant flow of relatively dilute bile is secreted directly into 
the small intestine (65). 
Typically, mammalian bile contains bile salts (12 %) and phospholipids (4 
%) (1), and a small amount of cholesterol and substances that cannot be 
eliminated via the urine, such as the protein-bound bilirubin, or drugs such as 
certain antibiotics and morphine. Bile salts and phospholipids form mixed 
micelles above their critical micellar concentration, which solubilise cholesterol. 
In addition, small amounts of the immunoglobulin IgA, mucus and tocopherol 
are present in bile, preventing bacterial growth and oxidative damage to the 
epithelium (56). 
 Bile salts are synthesized from cholesterol, and therefore can be seen as 
not only having a function in the digestion of fats, but also in the elimination of 
cholesterol. Most vertebrates synthesize C24 bile salts. However, in reptiles and 
some ancient mammals, such as elephant and sea cow, bile alcohols with more 
than 24 carbon atoms are formed (117). Biosynthesis of C24 bile salts occurs via 
the classical and the alternate biosynthetic pathway (1, 97). The classical 
pathway is operated entirely in the liver, whereas in the alternate pathway, the 
first steps of cholesterol conversion are carried out in other tissues, using 
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oxysterols as intermediate molecules; the last steps of bile salt synthesis, 
however, are always carried out in the liver. The alternate pathway for synthesis 
of bile salts may play an important role in the elimination of excess cholesterol 
from tissues such as the brain; an impairment in brain cholesterol homeostasis is 
thought to be involved in several neurodegenerative diseases (17). The classical 
pathway, which is quantitatively the most important, involves the epimerisation 
of the 3β-hydroxyl group of cholesterol, the elimination of the side chain, and 
saturation and hydroxylation of the steroid nucleus (1) (Figure 2).  
 
 
 
Figure 2. Biosynthesis of bile salts from cholesterol via the classical pathway. As an example, 
the structure of glycocholic acid (GC) is shown. The bond that is hydrolysed by Bsh-activity 
is indicated by an arrow. The OH-group that is absent in glycodeoxycholic acid (GDC) when 
compared to glycocholic acid is indicated with *. Likewise, the OH-group that is absent in 
glycochenodeoxycholic acid (GCDC) is marked with **; in lithocholic acid (LC), the two 
OH-groups marked with * and **, respectively, are absent. G, glycine; T, taurine.  
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Commonly, one or two hydroxyl groups are added to the bile salts, with 
the site of hydroxylation varying between species. Hydroxylation occurs on one 
side of the steroid nucleus, resulting in an amphiphatic molecule with detergent 
properties. In human, hydroxylation results in the formation of the bile salts 
cholic acid (C) and chenodeoxycholic acid (CDC) (Figure 2). Finally, the 
amphiphatic nature of the bile salts is further enhanced by the addition of 
glycine or taurine (Figure 2). The type of amino acid that is conjugated to the 
bile salts depends on animal species and can be influenced by the diet. Since 
taurine is abundantly available in meat, but not in plants, carnivores usually 
produce mainly taurine-conjugated bile salts, whereas herbivores usually 
produce mainly glycine-conjugated bile salts. Omnivores synthesize both 
glycine- and taurine-conjugated bile salts (1). In rats, the source of 
carbohydrates in the diet has been shown to have a major influence on the ratio 
of glycine and taurine conjugation of bile salts. However, evidence on the 
precise mechanism is conflicting and needs further investigation (43, 61-64). 
Enterohepatic cycling of bile salts. Following excretion into the small 
intestine, conjugated bile salts are efficiently (~ 95 %) re-absorbed by epithelial 
cells of the terminal ileum (Figure 3). Putative transporters involved in the 
transport of bile salts have been described; for review, see (4, 73, 84, 115).  
At physiological pH, conjugated bile salts, and especially taurine-
conjugated bile salts, are membrane-impermeable anions. Therefore, conjugated 
bile salts are mainly recovered from the terminal ileum by active transport 
through the apical sodium dependent bile acid transporter (ASBT) (44, 53) and 
sodium independent organic anion transporting peptides (OATPs) (121). The 
transcellular transport of bile acids is mediated by the cytosolic ileal bile acid 
binding protein (IBABP) (76). Following transport from the epithelial cells into 
the portal blood via organic solute transporters (OSTs) (30), the bile salts are 
actively taken up into hepatocytes by the sodium taurocholate co-transporting 
peptide (NTCP) and OATPs (83). Subsequently, the bile salts are transported 
through the hepatic cells by binding proteins and resecreted by an ATP-
dependent bile salt excretory pump (BSEP) (106) and multi drug resistance 
proteins (MRPs) (115). This process of secretion and re-absorption is called 
enterohepatic cycling (Figure 3). The rate of enterohepatic cycling greatly 
exceeds the rate of synthesis from cholesterol, providing an efficient way of 
both excreting lipophilic molecules from the liver and the digestion and uptake 
of fats and lipid-soluble vitamins in the small intestinal tract. 
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Figure 3. Schematical overview of the enterohepatic cycle of bile salts in human. The primary 
bile salts cholic acid (C) and chenodeoxycholic acid (CDC) are synthesized from cholesterol 
and conjugated to glycine (G) or taurine (T) in the liver. Subsequently, the bile salts are 
secreted into the small intestine. At the distal part of the small intestine, the majority of 
glycine- or taurine-conjugated C and CDC is actively reabsorbed into the portal blood and 
resecreted via the liver. A part of the primary, conjugated, bile salts C and CDC is 
deconjugated by the microbiota in the intestinal tract into free C and CDC by bile salt 
hydrolase (Bsh) activity, and subsequently, may be dehydroxylated into deoxycholic acid 
(DC) and lithocholic acid (LC), respectively. These bile salts are passively absorbed along the 
intestinal tract, reconjugated with glycine or taurine in the liver, and re-secreted into the small 
intestine. LC, however, is poorly soluble, and is partly excreted in faeces. The fraction of LC 
that is reabsorbed is sulphonated in the liver to a poorly reabsorbed form, re-secreted into the 
small intestine, and finally excreted in faeces. 
 
 Bile salt biotransformations. Some of the bile salts synthesized by the 
host, referred to as primary bile salts, are metabolized by the microbiota 
encountered in the intestinal tract. The first and obligatory step (10) in the 
majority of bile salt transformations is the deconjugation of the amino acid 
moiety of the bile salts by a bacterial enzyme called bile salt hydrolase (Bsh, or 
conjugated bile acid hydrolase [CBAH]). Subsequently, the quantitatively most 
important bile salt biotransformation is 7α-dehydroxylation of the steroid 
nucleus, leading to the formation of bile salts referred to as secondary bile salts. 
This type of bile salt biotransformation has been attributed mainly to colonic 
activity of clostridia (95). In human, the dehydroxylation of the primary bile 
salts C and CDC results in the secondary bile salts deoxycholic acid (DC) and 
lithocholic acid (LC) (Figure 2). Another type of bile salt biotransformation that 
occurs to a much lower extent is oxidation and epimerization of the bile salt 
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hydroxyl groups, carried out by hydroxysteroid dehydrogenases that are found 
for example in Clostridium, Bacteroides, Egerthella lenta, Escherichia coli, 
Peptostreptococcus productus, and Eubacterium aerofaciens (95). 
In contrast to conjugated bile salts, deconjugated bile salts are not charged 
at physiological pH and can be passively absorbed along the entire intestine 
(Figure 2). The rate of cell entrance is dependent on bile salt hydrophobicity. 
Thus, deconjugated primary and secondary bile salts enter the enterohepatic 
circulation as well, with the exception of LC, which is usually sulphated in the 
liver to a poorly re-absorbed bile salt and excreted in faeces. In some animals, 
such as rodents and prairie dogs (88), but not humans (15), it was found that the 
liver is able to convert secondary bile acids back into primary bile salts. 
Impact of the bile salt-converting activity of the microbiota on the 
host. The generation of secondary bile salts by intestinal bacteria, which occurs 
after the deconjugation of primary bile salts, was shown to have a large impact 
on host physiology. Especially, elevated levels of the secondary bile salts DC 
and LC have been correlated with the development of colorectal cancer (for 
review, see (82)). Furthermore, the more hydrophobic (i.e., deconjugated and 
secondary) bile salts have been found to increase mucin excretion from 
gallbladder ex vivo tissues and cell lines and intestinal epithelial cell lines (55, 
69-71, 99), which is thought to promote the nucleation of cholesterol gallstones. 
Since mucin is the major component of the protective mucous layer lining the 
intestine, an increase in mucin excretion can be seen as a response to the 
cytotoxicity of hydrophobic bile salts. Furthermore, increased mucin excretion 
could influence the nutritional environment encountered by the intestinal 
microbiota, and decrease intestinal transit time (100), eventually even resulting 
in diarrhoea. However, prolonged exposure of colonic cell lines to relatively low 
concentrations of hydrophobic bile salts was found to reduce mucin excretion 
(99). Mucin is the main constituent of the mucous layer lining the intestine. The 
mucous layer appears to prevent direct adhesion of gut bacteria to the epithelial 
surface (80), therefore, a reduction in mucin excretion could impair the barrier 
function of the mucous layer against irritants and pathogens.  
Notably, the intake of several probiotic strains (i.e., bacterial strains 
conferring a specific health benefit to the host) has been linked to lowering of 
serum cholesterol levels (32, 87, 90, 91, 112). Several drugs are available to 
treat hypercholesterolemia, such as bile acid sequestrants, which are synthetic 
polymeric resins binding bile salts, draining the bile salt pool and increasing the 
demand for bile acid synthesis from cholesterol, and statins, which inhibit the 
enzyme HMG-CoA reductase that is involved in cholesterol synthesis. However, 
these agents often have side effects such as gastro-intestinal complaints and 
muscle cramps. Thus, the ingestion of probiotics may provide an attractive 
alternative. A partial explanation for the cholesterol-lowering effect of some 
bacterial strains may lie in their bile salt-hydrolyzing activity. Deconjugated bile 
salts are less soluble and therefore, are more prone to be extracted from the 
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enterohepatic cycle by precipitation and excretion in the faeces than the more 
soluble conjugated bile salts. Thereby, the demand for de novo bile salt synthesis 
from cholesterol would increase, leading to cholesterol lowering. In addition, 
deconjugated bile salts are not as efficient in solubilising lipids such as 
cholesterol, possibly lowering blood cholesterol levels by an impaired uptake of 
cholesterol from the diet. However, this also implicates that bile salt hydrolase 
activity might compromise normal lipid digestion. Indeed, in chicken, an 
increase in growth by antimicrobial supplementation was found to be related to a 
decrease in total microbial Bsh activity (and in particular, Lactobacillus) (40, 41, 
51). However, this relation was not found in mice (9), indicating that intestinal 
Bsh activity does not always correlate to growth defects in the host. 
Bacterial Bsh activity. Since bile salt deconjugation by intestinal bacteria 
is thought to have a large impact on host physiology (see above), it deserves 
special attention. The enzyme responsible for bile salt deconjugation, bile salt 
hydrolase (EC3.5.1.24), is expressed by a wide variety of Gram-positive 
bacteria, such as Enterococcus faecium (123), Bifidobacterium species (67, 
108), Clostridium (28), Lactobacillus species (27, 38, 74, 75) and Listeria 
monocytogenes (37). Experimentally verified Pva-family proteins can be found 
for Bacillus species (89, 93) and Listeria monocytogenes (13) (for review, see 
(12)). Among Gram-negative bacteria, only Bacteroides was found to express 
bile salt hydrolase activity (66, 105). Bsh amino acid sequences resemble those 
of penicillin V acylases (Pva, EC3.5.1.11) and belong to the enzyme 
superfamily of linear amide C-N hydrolases (Pfam CBAH, PF02275). Some 
bacteria have been predicted to possess more than one Bsh-homologue, such as 
L. plantarum (68), L. johnsonii (38), L. acidophilus (81) and L. brevis (77). The 
precise role of these homologues should be investigated by the construction of 
targeted multiple isogenic bsh-mutant strains and bsh overexpression strains. 
Bsh activity appears to be typical for inhabitants of the gastro-intestinal 
tract. A strong correlation has been found between the habitat of a specific 
bacterial species or strain and Bsh activity (107). This finding suggests a 
particular advantage of the capability to deconjugate bile salts for survival or 
persistence of bacteria under gastro-intestinal conditions. For this reason, the 
capability to hydrolyse bile salts has often been included as a prerequisite in the 
selection of probiotic bacteria. However, the precise advantage that a bacterium 
would gain from the expression of Bsh activity is unclear. For example, it has 
been suggested that Bsh activity plays a role in the detoxification of bile. E.g., in 
Lactobacillus amylovorus, L. plantarum and L. monocytogenes, the level of Bsh 
activity was found to correlate to sensitivity to bile salts (11, 31, 33, 37, 49). 
This correlation may be confirmed by the fact that Bsh activity is rare amongst 
Gram-negative bacteria, which are believed to be inherently more resistant to 
bile salts, although little is known about the exact mechanism. In fact, 
enrichment media for Gram-negative bacteria commonly contain bile salts. 
However, other groups reported that bile salt tolerance in Lactobacillus spp. is 
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not related to the level (2) or presence (86) of bile salt hydrolase activity. Since 
most Bsh enzymes show a preference for glycine-conjugated bile salts as 
compared to taurine-conjugated bile salts (e.g., in Clostridium, Bifidobacterium, 
and Lactobacillus (28, 67, 108, 113)), the lack of correlation found in the latter 
reports may be due to the use of taurine-conjugated bile salts to detect Bsh 
activity. Furthermore, the contribution of Bsh activity to bile tolerance can 
possibly only be assessed properly when comparing isogenic bsh-mutant strains, 
since membrane characteristics greatly influence bile tolerance (for review, see 
(11)). For example, damage to cell membrane lipopolysaccharides by freezing of 
Escherichia coli was shown to increase susceptibility to bile salts (26). 
Furthermore, L.  plantarum was shown to regulate membrane synthesis in 
response to bile salt stress (22). The wide-spread preference of Bshs for glycine-
conjugated bile salts may reinforce the hypothesis that bile salt hydrolase 
activity serves to detoxify bile salts, since glycine-conjugated bile salts are very 
toxic to bacterial cells, whereas taurine-conjugated bile salts appear to be less 
toxic. Finally, deconjugated bile salts precipitate more readily, leading to their 
removal from the environment and excretion in faeces.   
 Another commonly encountered hypothesis for the role of Bsh activity in 
bacteria is that the glycine and taurine liberated by deconjugation of bile salts 
may be used as carbon, nitrogen and energy source, thus conferring an 
advantage for bile salt-hydrolyzing strains in the competitive environment of the 
intestine (e.g., in Clostridium and Bifidobacterium (60, 108, 119)). However, 
experiments in lactobacilli showed that none of the strains tested were able to 
utilize either the amino acid or steroid moiety of the bile salts (45, 110). 
Importance of lactobacilli. Especially lactobacilli were found to be of 
importance for in vivo bile salt deconjugation in the small intestine (18, 110, 
111). For example, in mice that harboured a complex intestinal microbiota, but 
not lactobacilli, bile salt hydrolase activity in ileal contents was found to be 
reduced 90 % as compared to Lactobacillus-reconstituted mice (110). Using the 
same mouse model, the bile salt hydrolase activity produced by the lactobacilli 
was shown to be relevant in vivo for bile salt deconjugation levels in the small 
intestine (i.e., 70 % and 20 % of bile salts deconjugated for lactobacillus-
reconstituted and Lactobacillus-free animals, respectively). 
In addition, there is an increasing interest in the use of lactobacilli as a 
probiotic to positively influence host physiology and health status. The key 
notion in the use of probiotics is that any harmful effects of some of the resident 
bacteria can be, at least temporarily, balanced by shifting of composition of the 
gut microbiota towards more beneficial organisms. Especially lactobacilli and 
bifidobacteria have been considered to provide specific health benefits to the 
host, such as lowering of gas production, immunostimulation, antitumor activity, 
and the production of short chain fatty acids (for review, see (50)). Indeed, 
specific Lactobacillus strains have been used as probiotics (58). Especially in 
infantile, antibiotic, and travellers’ diarrhoea, Lactobacillus spp. were found to 
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reduce the incidence or duration of diarrhoea (for review, see (42). Furthermore, 
Lactobacillus spp. were found to improve Clostridium difficile colitis, and 
increased resistance to food-borne pathogens (42). In addition, a probiotic 
mixture of four strains of lactobacilli, three strains of bifidobacteria, and one 
strain of Streptococcus called VSL#3 was found to improve inflammatory bowel 
diseases such as pouchitis (46, 47), and Crohn’s disease (23). 
The administration of large amounts of bile salt-hydrolysing probiotic 
bacteria could potentially result in a shift in intestinal bile salt composition that 
might be associated with an undesirable impact on intestinal physiology. 
Therefore, the influence of the delivery of bile salt hydrolase activity to the 
intestine on host response deserves attention. Considering their apparent 
importance in relation to host response, lactobacilli are excellent candidate 
organisms to study the functionality of Bsh in bacteria, the impact of Bsh 
activity of the microbiota, and of probiotics on host physiology.  
Delivery of enzymes in the gastro-intestinal tract. The use of 
lactobacilli to influence host response does not need to be limited to the 
implementation of wild-type strains. For example, derivatives of L. lactis and L. 
plantarum have been used to deliver cytokines such as IL-10 and vaccines (e.g., 
tetanus toxin) to the intestinal tract of mice (21, 48, 57, 96, 102-104). The use of 
recombinant lactic acid bacteria appears to have a wide applicability, ranging 
from use in prevention of infectious diseases, allergies, inflammatory bowel 
diseases, and delivery of therapeutic proteins (54). Clearly, delivery of bile salt 
hydrolase by wild-type and genetically modified lactobacilli could prove to be 
an important tool in elucidating the influence of Bsh on host response. Indeed, 
the implementation of viable bacteria as a delivery vehicle is attractive, 
especially for use in the food industry, now that the use of fermented food 
products has become wide-spread among consumers. However, containment of 
genetically modified organisms used as probiotics remains subject to debate. For 
this purpose, self-containment strategies have been devised (104). 
 
OUTLINE OF THIS THESIS 
 
In this thesis, the functionality of bile salt hydrolases in Gram-positive 
bacteria, with a focus on Lactobacillus plantarum WCFS1, and the impact of 
delivery of bile salt hydrolase to the small intestine on the host were 
investigated.  
Since bacterial bile salt hydrolase activity appears to play as significant 
role in both host intestinal physiology and bacterial survival and persistence in 
the intestinal tract, correct annotation of bsh genes in a particular bacterial 
species is of importance. Therefore, the annotation of bsh genes in Gram-
positive bacteria was investigated in depth, leading to an improved annotation of 
eight conjugated bile acid (CBAH) superfamily members in various lactobacilli 
Introduction 
and providing robust methodology for accurate annotation of this enzyme 
superfamily (Chapter 2).  
In several intestinal lactobacilli, multiple genes coding for Bsh-family 
members have been predicted to be present in one organism. As a model 
organism, L. plantarum WCFS1 (68) was used, that was previously predicted to 
contain four bsh-like genes. The unravelling of the functionality of each of the 
separate genes requires the generation of multiple isogenic bsh-deletion strains. 
Therefore, a Cre-lox-based toolbox for the construction of multiple deletions and 
selectable-marker removal in Gram-positive organisms was designed and 
implemented in L. plantarum WCFS1 (Chapter 3). 
Using the Cre-lox mutagenesis and existing overexpression tools, the 
functionality of the four Bsh-family members Bsh1, Bsh2, Bsh3, and Bsh4 of L. 
plantarum WCFS1 was investigated in Chapter 4. By a combination of 
heterologous over-expression and multiple bsh-deletion derivatives of L. 
plantarum WCFS1, Bsh1 was shown to be the major bile salt hydrolase in this 
strain, where it appeared to be involved in glycodeoxycholic acid tolerance. 
Although these experiments validated the prediction that bsh2, bsh3, and bsh4 
do not encode true Bsh enzymes (Chapter 2), they could also not entirely clarify 
the in vivo functionality of Bsh2, Bsh3, and Bsh4, which appear to encode 
enzymes with acylase activity possibly using penicillin-like chemicals as their 
preferred substrate.   
In Chapter 5, the delivery of bile salt hydrolase activity to the small 
intestine using viable bacteria, with L. plantarum WCFS1 as a model organism, 
was compared to delivery using Bsh-whey protein/gum arabic 
microencapsulates in an in vitro model. 
Finally, the influence of delivery of bile salt hydrolase activity by viable 
bacteria and whey protein/gum arabic microencapsulates on host response was 
investigated in vivo using a rat model (Chapter 6). However, no effect of 
delivery of Bsh on the intestinal bile salt composition or mucin excretion was 
detected. These results could indicate that the physiological relevance and 
magnitude of bile salt hydrolase activity of the natural microbiota and probiotics 
in the small intestine is of low significance. 
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2. Improved annotation of conjugated bile acid hydrolase 
superfamily members in Gram-positive bacteria 
 
  Most Gram-positive bacteria inhabiting the gastro-intestinal tract are 
capable of hydrolyzing bile salts. Bile salt hydrolysis is supposed to play an 
important role in various biological processes in the host. Therefore, correct 
annotation in public databases of bile salt hydrolases (Bsh; EC3.5.1.24) in 
bacteria is of importance, especially for lactobacilli, which are considered to 
play a major role in bile salt hydrolysis in vivo. In the present study, all enzymes 
in public databases belonging to the bile salt hydrolase family and closely 
related penicillin V acylase (Pva; 3.5.1.11) family were compared, with the 
sequences annotated as Bsh in Lactobacillus plantarum WCFS1 as an example. 
In Gram-positive bacteria, a clear distinction could be made between the two 
families using sequence alignment, phylogenetic clustering, and protein 
homology modelling. Biochemical and structural data on experimentally 
verified Bsh and Pva enzymes were used for validation of function prediction. 
Hidden-Markov models were constructed from the sequence alignments that 
enable a more accurate prediction of Bsh-encoding genes and their distinction 
from the Pva family. Many Pva-related sequences appeared to be annotated 
incorrectly as Bsh in public databases. This refinement in the annotation of Bsh 
family-members especially influences the prediction of the function of bsh-like 
genes in species of the genus Lactobacillus, which is discussed in detail. 
 
INTRODUCTION 
 
Bile salts play an important role in lipid digestion in mammals. In the 
liver, bile salts are synthesized from cholesterol and conjugated with the amino 
acids glycine or taurine. Following excretion into the intestinal lumen, the amino 
acid part of the bile salts can be hydrolysed by bile salt hydrolases (Bshs; 
EC3.5.1.24), also designated choloylglycine hydrolase or conjugated bile acid 
hydrolase, produced by the intestinal microbiota.  
Bacterial Bsh activity has received much attention based on its postulated role in 
various biological processes in the host. For example, bile salt hydrolysis may 
be involved in serum cholesterol lowering (21). Bile salt deconjugation is the 
gate-keeping reaction in further oxidation and dehydroxylation steps of bile salts 
by intestinal bacteria, which includes the production of secondary bile salts that 
have been linked to various intestinal diseases such as the formation of 
gallstones and colon cancer (24). Moreover, in vitro studies have suggested that 
bile salt deconjugation plays a role in the mucin production and excretion in the 
intestinal lumen (14), which could affect the nutritional environment 
encountered by the intestinal microbiota and intestinal transit time (26). 
Based on the biological implications of Bsh activity, it is important to 
provide a correct annotation of bsh genes in bacterial DNA sequences. Notably, 
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Bsh amino acid sequences resemble those of penicillin V acylases (Pva, 
EC3.5.1.11) and belong to the same enzyme superfamily of linear amide C-N 
hydrolases (Pfam CBAH, PF02275). Although both Bsh and Pva are capable of 
hydrolysing the same type of chemical bond, the overall chemical nature of their 
substrates is quite different (bile salts and penicillins, respectively; Figure 1). 
Especially, the steroid moiety of bile salts is significantly more voluminous 
when compared to the corresponding moiety of penicillin V. Penicillin acylase-
encoding genes may at times be incorrectly annotated as bile salt hydrolase, as 
was found for example in Listeria monocytogenes (3), leading to unreliable 
prediction of Bsh activity presence in a particular bacterial strain. 
 
 
Figure 1. Chemical structure of bile salts and penicillins. As an example, the bile salt 
glycodeoxycholic acid (panel A) and penicillin V (panel B) are shown. The bond that is 
hydrolysed by either Bsh or Pva is indicated by an arrow. 
 
To confidently draw conclusions from in silico analysis of CBAH 
superfamily members, information on experimentally established enzyme 
activity and/or structure of Bsh and Pva enzymes is indispensable (Table 1). For 
example, experimentally verified Bsh enzymes can be found for Enterococcus 
faecium (33), Bifidobacterium species (11, 29), Clostridium (12), Lactobacillus 
species (5, 10, 16, 17) and Listeria monocytogenes (9). Experimentally verified 
Pva-family proteins can be found for Bacillus species (19, 23) and Listeria 
monocytogenes (3).  
Among bacterial species that are capable of bile salt hydrolysis, especially 
lactobacilli have been reported to play a major role in bile salt deconjugation in 
vivo (4, 7, 22, 31). In Lactobacillus-free mice, the Bsh activity in the ileal 
content was found to be reduced by almost 90 % when compared to 
Lactobacillus-reconstituted mice (30). Moreover, one of the commonly used 
criteria in selection of candidate probiotic strains is their ability to hydrolyse bile 
salts (2). There is a growing interest in the use of bile salt-hydrolysing 
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Lactobacillus strains in fermented milk products for lowering of serum 
cholesterol concentrations (21). Consequently, the accuracy of annotation of bsh 
genes in lactobacilli deserves special attention.  
 In this study, a combination of in silico methods was employed to 
distinguish accurately between the Bsh and Pva family members. All protein 
sequences of CBAH superfamily members from public databases were 
compared and their functionality was predicted using phylogenetic profiling, 
sequence alignment and 3D-modeling techniques, incorporating experimentally 
verified Bsh and Pva proteins. In addition, hidden Markov models were 
constructed that enabled the distinction between Bsh and Pva proteins. Previous 
annotation of Bsh-family members in several Lactobacillus species was based 
mainly on sequence homology, and was found to be mostly incorrect, as 
exemplified for the four CBAH superfamily paralogs found in the model 
organism Lactobacillus plantarum WCFS1 (13, 16). In this work, we propose a 
refined annotation of Bsh and Pva family members in lactobacilli.  
 
Table 1. Experimentally verified Bsh and Pva family proteins. 
Sequence ID nr1 Bacterial strain Reference Remarks 
Bsh family    
  Q6R974 B. bifidum ATCC11863 (11)  
  Q9KK62 B. longum SBT2928  (29) Crystallised (15) 
  P54965 C. perfringens 13 (6) Crystallised (25) 
  Q83YZ2 E.  faecium FAIRE-E 345 (33)  
  Q9F660 L. johnsonii 100-100 (10) α subunit  
  P97038 
   
L. johnsonii 100-100  (10) β subunit 
  Q8Y5J3 L. monocytogenes EGDe (9)  
  S51638 (GB) L. plantarum LP80 (5)  
  Q06115 L. plantarum WCFS1 (16) Bsh1 
Pva family    
   P12256 B. sphaericus  ATCC14577 (19) Crystallised (27) 
  Q2HPP6 B. subtilis  NCIMB (23) Crystallised 
  Q8Y9S7 L. monocytogenes EGDe (3)  
 1Sequence ID as used in the SwissProt database.  
GB; Genbank database 
 
MATERIALS AND METHODS 
 
Sequence alignment, phylogenetic profiling and construction of 
hidden Markov models. For phylogenetic profiling of Bsh- and Pva-family 
members, the sequences of putative CBAH superfamily members were retrieved 
from the ERGO database (20) using BLASTP (1) and as seed the sequence of 
the experimentally verified bile salt hydrolase (Bsh1, lp_3536) of L. plantarum 
WCFS1 (13, 16). Multiple sequence alignments were created with MUSCLE 
(Edgar, 2004). Clustal X (Thompson, 1997) was used to display multiple 
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sequence alignments and to create phylogenetic trees, and these trees were then 
displayed with LOFT (32). Hidden Markov models (HMMs) were constructed 
from the multiple sequence alignments using HMMER 2.3.2 (8). 
3D-structure homology modelling. The 3-D structures used as templates 
for homology modelling were bile salt hydrolase (Bsh) from Bifidobacterium 
longum (2hez.pdb), Bsh from Clostridium perfringens in complex with reaction 
products taurine and deoxycholate (2bjf.pdb), and penicillin V acylase (Pva) in 
complex with diethane diol from Bacillus sphaericus (2pva.pdb). Homology 
modelling was performed with the ‘The Whatif/Yasara Twinset’ software 
(www.yasara.com). 
 
RESULTS 
 
Phylogenetic profiling. The sequences of the CBAH superfamily 
members (retrieved using the sequence of the experimentally verified Bsh1 of L. 
plantarum WCFS1 (16) as seed) were analyzed together with sequences of 
experimentally studied Bsh and Pva enzymes that were not present in the ERGO 
database (20) (Table 1). The superfamily tree shows that sequences derived from 
gram-negative and Gram-positive organisms were clearly divided in two 
separate groups.  
Focusing on the group of sequences derived from Gram-positives, two 
clusters could be identified (Figure 2). The first cluster, hereafter called the Bsh-
cluster, consisted of sequences that appeared phylogenetically closely related, 
and contained all biochemically verified Bsh proteins, including Bsh1 of L. 
plantarum WCFS1. The Bsh-cluster contained twenty-five sequences, of which 
twenty-three were annotated in the public NCBI database 
(http://ncbi.nlm.nih.gov) as Bsh and one was annotated as penicillin acylase 
(Table 2). For one sequence, no function was annotated; however, this protein 
was experimentally shown to be a Bsh (9). Furthermore, this cluster contained 
ten sequences derived from lactobacilli, of which nine sequences were annotated 
as Bsh, and one sequence was annotated as Pva. The second cluster, hereafter 
called the Pva-cluster, consisted of sequences that generally appeared to be less 
tightly related phylogenetically as compared to those in the Bsh-cluster. All 
experimentally verified Pva proteins were encompassed within the Pva cluster. 
This cluster contained forty-nine sequences, of which eleven were annotated as 
penicillin acylase, thirty were annotated as bile salt hydrolase, one was 
annotated as an ABC transporter, and seven sequences lacked a functional 
annotation (Table 2). Furthermore, eight sequences of lactobacilli were grouped 
in the Pva-cluster, of which seven were annotated as Bsh and one was annotated 
as Pva. The three paralogous proteins previously annotated as Bsh (Bsh2, Bsh3 
and Bsh4; (13)) that are predicted to be present in addition to the experimentally 
verified Bsh1 (16) in L. plantarum WCFS1 were grouped phylogenetically in 
the Pva-cluster, with Bsh2 and Bsh3 being more closely related than Bsh4. 
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 Importantly, all experimentally verified Bsh and Pva enzymes were 
grouped correctly during in silico analysis, strongly suggesting that Bsh- and 
Pva-proteins can be distinguished properly using the phylogenetic profiling 
technique. 
 
 
Figure 2. Family tree of Bsh- and Pva-family members in Gram-positive bacteria. For clarity, 
one representative sequence is shown when sequences of different strains of the same 
organism are identical or nearly identical. Sequences shown in italics were experimentally 
verified, and sequences with known 3D-structures were marked with arrows. 
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Table 2. Annotation of Gram-positive CBAH superfamily members in the phylogenetic tree.  
Sequence ID 
number1 
Species Exp. 
verified 
Current annotation  
Bsh-cluster    
  Q8KUA7 Enterococcus faecalis V583  bile salt hydrolase 
  Q83YZ2 Enterococcus faecium FAIR-E345 + bile salt hydrolase 
  Q8Y5J3 Listeria monocytogenes EGD-e + hypothetical protein 
  Q71XU7 Listeria monocytogenes 4b F2365  bile salt hydrolase 
  Q3Y203 Enterococcus faecium DO  bile salt hydrolase 
  Q2NGA0 Methanosphaera stadtmanae DSM3091  bile salt hydrolase 
  Q1WR93 Lactobacillus salivarius UCC118  bile salt hydrolase 
  Q5FK51 Lactobacillus acidophilus NCFM  bile salt hydrolase 
  Q1U7R7 Lactobacillus reuteri 100-23  bile salt hydrolase2 
  Q9F660 Lactobacillus johnsonii 100-100 + bile salt hydrolase 
  P97038  Lactobacillus johnsonii 100-100 + bile salt hydrolase 
  Q74IV4 Lactobacillus johnsonii NCC 533  bile salt hydrolase 
  Q047A3 Lactobacillus gasseri ATCC 33323  bile salt hydrolase 
  Q74LX7 Lactobacillus johnsonii NCC 533  bile salt hydrolase 
  Q5FKM3 Lactobacillus acidophilus NCFM  bile salt hydrolase 
  Q043M7 Lactobacillus gasseri ATCC 33323  penicillin acylase 
  Q74JG0 Lactobacillus johnsonii NCC 533  bile salt hydrolase 
  S51638 (GB) Lactobacillus plantarum LP80 + bile salt hydrolase 
  Q06115 Lactobacillus plantarum WCFS1 (Bsh1) + bile salt hydrolase 
  Q6R974 Bifidobacterium bifido ATCC11863 + bile salt hydrolase 
  A1A1Q4 Bifidobacterium adolescentis ATCC 15703  bile salt hydrolase 
  Q9KK62 Bifidobacterium longum SBT2928 + bile salt hydrolase 
  Q8G653 Bifidobacterium longum NCC2705  bile salt hydrolase 
  Q0TT83 Clostridium perfringens ATCC 13124  bile salt hydrolase 
  P54965 Clostridium perfringens 13 + bile salt hydrolase 
Pva-cluster    
  Q03PK6 Lactobacillus brevis ATCC 367  penicillin acylase 
  Q1WUK8 Lactobacillus salivarius UCC118  bile salt hydrolase 
  A2RL39 Lactococcus lactis MG1363  penicillin acylase 
  Q04G99 Oenococcus oeni PSU-1  penicillin acylase 
  Q03NN7 Lactobacillus brevis ATCC 367  bile salt hydrolase 
  Q38Z70 Lactobacillus sakei 23K  bile salt hydrolase 
  Q03P51 Lactobacillus brevis ATCC 367  bile salt hydrolase 
  Q890F5 Lactobacillus plantarum WCFS1 (Bsh2)  bile salt hydrolase 
  Q88SP0 Lactobacillus plantarum WCFS1 (Bsh3)  bile salt hydrolase 
  Q88UC9 Lactobacillus plantarum WCFS1 (Bsh4)  bile salt hydrolase 
  Q1Y4P3 Staphylococcus aureus JH9  bile salt hydrolase2 
  Q2YV99 Staphylococcus aureus RF122  bile salt hydrolase 
  Q8NYG2 Staphylococcus aureus MW2  hypothetical protein 
  Q2FJZ5 Staphylococcus aureus USA300  bile salt hydrolase 
  Q5HJA0 Staphylococcus aureus COL  bile salt hydrolase 
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Table 2 continued 
Sequence ID 
number1 
Species Exp. 
verified 
Current annotation  
  Q99WVI Staphylococcus aureus Mu50  penicillin acylase 
  Q6GK36 Staphylococcus aureus aureus MRSA252  bile salt hydrolase 
  Q2G198 Staphylococcus aureus NCTC 8325  hypothetical protein 
  Q7A7T1 Staphylococcus aureus N315  hypothetical protein 
  Q6GCJ7 Staphylococcus aureus aureus MSSA476  bile salt hydrolase 
  Q4L9R9 Staphylococcus haemolyticus JCSC1435  hypothetical protein 
  Q4A0U7 Staphylococcus saprophyticus ATCC15305  bile salt hydrolase 
  Q8CQ66 Staphylococcus epidermidis ATCC 12228  penicillin acylase 
  Q5HRG6 Staphylococcus epidermidis RP62A  penicillin acylase 
  Q18WR1 Desulfitobacterium hafniense DCB-2  bile salt hydrolase2 
  Q24RH3 Desulfitobacterium hafniense Y51  hypothetical protein 
  Q2WKK9 Clostridium beijerincki NCIMB-8052  bile salt hydrolase2 
  Q9CEK2 Lactococcus lactis IL1403  penicillin acylase 
  Q9CGG1 Lactococcus lactis IL1403  penicillin acylase 
  Q04F26 Oenococcus oeni PSU-1  bile salt hydrolase 
  Q04G99 Oenococcus oeni PSU-1  penicillin acylase 
  P12256 Bacillus sphaericus ATCC14577 + penicillin acylase 
  Q8Y9S7 Listeria monocytogenes EGD-e + hypothetical protein 
  Q65D34 Bacillus licheniformis ATCC 14580 XX  bile salt hydrolase 
  Q2HHP6 Bacillus subtilis 168 + penicillin acylase 
  Q81H11 Bacillus cereus ATCC14579  bile salt hydrolase 
  A0RHD9 Bacillus thuringiensis Al Hakam  bile salt hydrolase 
  Q2AKF7 Bacillus-weihenstephaniensis KBAB4  bile salt hydrolase2 
  Q6HF48 Bacillus thuringiensis konkukian  ABC transporter, 
permease 
  Q732V9 Bacillus cereus ATCC 10987  bile salt hydrolase 
  Q81WS0* Bacillus anthracis A2012  bile salt hydrolase2 
  Q81WS0 Bacillus anthracis Ames 0581  bile salt hydrolase 
  Q81WS0 Bacillus anthracis Sterne  bile salt hydrolase 
  Q81WS0 Bacillus anthracis Ames  bile salt hydrolase 
  Q81WS0 Bacillus anthracis KrugerB  bile salt hydrolase2 
  Q81WS0 Bacillus anthracis A1055  hypothetical protein 
  Q81WS0 Bacillus anthracis CNEVA 9066  bile salt hydrolase2 
  Q81WS0 Bacillus anthracis Australia 94  bile salt hydrolase2 
  Q81WS0 Bacillus anthracis Vollum  bile salt hydrolase2 
1Sequence ID as derived from the SwissProt database; 2When no annotation was provided in 
the NCBI public database (http://ncbi.nlm.nih.gov), the annotation (when provided) from the 
ERGO database (http://wit.integratedgenomics.com) was used; ID, identification; Exp., 
experimentally; GB, GenBank database. Annotations that were predicted to be incorrect are 
shown in bold italics. 
* All B. anthracis amino acid sequences are identical, and not distinguished by SwissProt. 
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3D protein homology modelling and sequence alignment. The 3D-
structures of the crystallized Bsh of Bifidobacterium longum (15)(2HEZ.pdb), 
Bsh of Clostridium perfringens (25)(2bjf.pdb), and Pva of Bacillus sphaericus 
(27) (2PVA.pdb) were superimposed, and the catalytic residues and binding 
pockets were compared (Figure 3A and 3B). Based on multiple sequence 
alignment, the catalytic and binding pocket residues of all Bsh and Pva family 
members were defined. The residues present in the substrate binding pocket 
appeared to be more conserved in the Bsh-cluster compared to the Pva-cluster. 
Catalytic and putative substrate binding residues of the Bsh- and Pva-cluster, 
and of the four L. plantarum enzymes are compared in Table 3.  
 
 
Table 3. Catalytic and binding pocket residues in Bsh-family members. (A) Bsh-cluster 
members; (B) Pva-cluster members. For active site residues, the first number designates the 
residue number in the template 3D structure used in homology modelling (B. longum Bsh and 
B. sphaericus Pva) (Figure 3), whereas the number between brackets designates the residue 
number as used in Clustal X multiple sequence alignment. 
 
A.  
Residue B. 
longum 
C. 
perfringens 
Bsh1 L. 
plantarum 
In family Remarks 
Catalytic      
2 C C C C Conserved 
18 R R R R Conserved 
21 D D D D Conserved 
82 N N N N L. gasseri: S 
177 N N N N Conserved 
229 R R R R Conserved 
Binding pocket     
Loop 1      
20  L M F L, F All very hydrophobic 
22 W I Y Y, L, W All hydrophobic 
24 F Y I I, F Mostly hydrophobic, but variable 
26 Y F Y Y, F All hydrophobic 
Loop 2      
58 G G T G, A, S Neutral to hydrophobic 
59 V T A A, V, I All hydrophobic 
61 M F V M, V Mostly hydrophobic, but variable 
66 M T L L Mostly hydrophobic 
68 F A Y F, Y All hydrophobic  
103 F Y F F, Y All hydrophobic 
Loop 3      
133 deletion I F F, I All hydrophobic 
137 Q I L L All hydrophobic 
140 S T S S, A Neutral to hydrophobic 
142  L L L L Conserved; very hydrophobic 
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B. 
Residue B. 
sphaeric
us 
Bsh2 Lp1 Bsh3 Lp1 Bsh4 Lp1 In family Remarks 
Catalytic       
1 C C C C C Conserved 
17 R R R R R Conserved 
20 D D D D D Conserved 
82 Y Y Y Y Y Occasionally T 
175 N N N N N Except D. hafniense (Q) 
228 R R R R R Conserved 
Binding pocket     
Loop 1       
19 M M M M M Conserved; very hydrophobic 
21 F F F F F, W All hydrophobic 
23 M V F T F, Y Mostly hydrophobic, but variable 
25 P F L T L, F, M Mostly hydrophobic, but variable 
Loop 2       
58 G G G G G Conserved 
59 S R R R R Very variable 
61 D L L H L, M Very variable 
66 V I I L I, L, D Variable 
68 Y T V A A, F, G Neutral to hydrophobic 
Loop 3       
135  I L L D L, D, T, I Variable 
136 L I L T L, I, T Mostly hydrophobic, but variable 
140 P P V Y P, A, T Variable 
142 L L L F L All very hydrophobic 
1Lp: Lactobacillus plantarum 
 
 
In Figure 3A, the substrate binding pocket of Bifidobacterium longum Bsh 
is shown, with a deoxycholate molecule (as an example of the steroid moiety of 
bile salts) modeled in an orientation as in the C. perfringens 3D structure 
(2bjf.pdb). The side chains lining this pocket are shown to come mainly from 
three surface loops, and are predominantly hydrophobic. The substrate binding 
pocket is also hydrophobic in other sequences from the Bsh-cluster (Table 3), 
which is in agreement with the hydrophobic nature of the steroid moiety of bile 
salts. As expected, the predicted catalytic and substrate binding residues of the 
experimentally verified Bsh1 enzyme of L. plantarum WCFS1 are most similar 
to those of the B. longum and C. perfringens bile salt hydrolases, as shown in 
Table 3 and Figure 3C. 
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Figure 3. Three-dimensional structure comparison of Bsh and Pva proteins. (A) Substrate 
binding pocket of Bsh of B. longum (2hez.pdb), showing only side chains of three loops (light 
grey) presumed to be relevant in binding substrates such as deoxycholate, which is modelled 
in an orientation as found in the 3D structure of C. perfringens (2bjf.pdb). (B) Main chain 
backbone superposition of the three loops of the substrate binding pockets of Bsh of B. 
longum (light grey), C. perfringens (medium grey) and Pva of B. sphaericus (dark grey). (C) 
Substrate binding pocket of Bsh1 of L. plantarum WCFS1 as predicted by sequence 
alignment, using the 3D structure of the binding pocket of Bsh of B. longum as a template. 
(D) Substrate binding pocket of Bsh2 of L. plantarum WCFS1 as predicted by sequence 
alignment, using the 3D structure of the binding pocket of Pva of B. sphaericus as a template. 
 
 Clear differences were found in the 3D-structure of the substrate binding 
pockets of proteins of the Bsh- and Pva-clusters. Firstly, loop 3 differs in length 
and orientation, as illustrated in Figure 3B. In Pva of B. sphaericus loop 3 is 
folded inward, severely reducing the size of the binding pocket. Secondly, the 
side chains of loops 2 and 3 lining the binding pocket are far more variable in 
size and hydrophilicity/hydrophobicity in the Pva group (Table 3). The catalytic 
residues, however, appeared to be highly conserved in both respective groups. 
Five out of the six catalytic residues appeared to be identical in both the Bsh- 
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and Pva-cluster, whereas the catalytic residue at position 82 in the 3D-model 
usually was asparagine in the Bsh-cluster, and tyrosine or occasionally threonine 
(four out of twenty-seven) in the Pva-cluster. Predicted binding pocket residues 
of Bsh2 and Bsh3 of L. plantarum WCFS1 appeared to resemble those of the 
3D-structure of Pva as illustrated in Table 3 and Figure 3D, whereas the residues 
of Bsh4 appeared to fit less well to that of either Bsh of B. longum or Pva of C. 
perfringens. Thus, using 3D-modeling, the separation of Bsh-family members in 
either the Bsh- or Pva-cluster as found by phylogenetic profiling was confirmed 
based on 3D models of the substrate binding pocket and consequently, the 
ability to accommodate bile salt molecules.  
 
 
Hidden Markov models for distinction between Bsh and Pva family 
members. From the Clustal X alignments, separate and distinctive hidden 
Markov models (HMMs) were constructed for the proteins of the Bsh- and Pva-
clusters. Using the Bsh-HMM to annotate the CBAH superfamily members, 
only proteins of the Bsh-cluster were found as best hit. Likewise, only proteins 
of the Pva-cluster were found as best hit using the Pva-HMM. Subsequently, the 
two HMMs were used for searching all publicly available sequenced genomes. 
Using the Bsh-HMM, all best hits found in the sequenced genomes were already 
present in the Bsh-cluster of the phylogenetic tree (Figure 2), and no additional 
hits were found (E-value score better than 1.80 .10-179). Furthermore, with the 
Bsh-HMM, a clear separation was found in the E-value score of the members of 
the Bsh-cluster (E score better than 1.80 .10-179) and subsequent hits (E-value 
worse than 2.00.10-108), which were members of the Pva-cluster. Likewise, using 
the Pva-HMM, all best hits (E-value score better than 6.60.10-132) found in the 
sequenced genomes consisted of members of the Pva-cluster. Again, a clear 
separation was found in the E-value score of the Pva sequences (E-value better 
than 6.60.10-132) and subsequent hits (E-value worse than 8.20.10-97), which 
were either members of the Bsh-cluster or gram-negative sequences not present 
in our phylogenetic tree. These findings strongly suggest that the HMMs 
presented here enable an accurate prediction of the functionality of any CBAH 
superfamily member, classifying them either as Bsh enzymes (EC3.5.1.24) or 
Pva-related enzymes (EC3.5.1.11). 
 
DISCUSSION 
 
In this study, we strived to improve the annotation of CBAH superfamily 
members by employing both phylogenetic clustering and 3D-modeling 
techniques in addition to the more conventional method of sequence alignment. 
The in silico analyses employed here consistently distinguished between the 
Bshs and the homologous penicillin V acylase enzymes. The Bsh enzymes are 
considered especially relevant for microbes that reside in the mammalian 
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intestinal system, where the lactobacilli are considered to be among the most 
important participants in bile salt deconjugation in vivo (30).  
The construction of a phylogenetic tree is an excellent way of visualising 
the relatedness of sequences that is more informative than the study of sequence 
homology alone. In our study, phylogenetic clustering clearly separated Gram-
positive CBAH superfamily members into two groups: a Bsh-cluster, that is 
predicted to contain Bshs, and a Pva-cluster, where its members are predicted to 
be penicillin-acylase-related proteins. Interestingly, it appeared that all strains 
that were represented only in the Bsh-cluster are typical gut-related bacteria (i.e. 
Bifidobacteria, Enterococcus faecalis and faecium, and Lactobacillus 
acidophilus species), while strains represented only in the Pva-cluster were not. 
This finding is in good agreement with the previously reported correlation 
between the presence of Bsh activity in lactic acid bacteria and isolation from 
the intestine or feces (28). The prediction of the functionality of the CBAH 
superfamily members by phylogenetic profiling was reinforced by the fact that 
the functionality of all experimentally verified Bsh and Pva proteins matched the 
in silico clustering. 
Our results indicate that the sequences annotated as Bsh in the Pva-cluster 
are likely to be incorrectly annotated in the public NCBI and KEGG databases 
(http://ncbi.nlm.nih.gov, http://www.genome.jp/kegg), and probably are Pva or 
Pva-related enzymes. Particularly for Lactobacillus species, the refinement of 
the annotation of functionality of this family of enzymes could have an 
important impact on their anticipated influence on gastrointestinal bile salt 
metabolism and its cognate physiological consequences in the host. According 
to our current analysis, the present Pva annotation of one the L. gasseri ATCC 
33323 CBAH superfamily sequences (SwissProt ID Q047A3) should be 
corrected to Bsh, while the sequences in the Pva-cluster currently annotated as 
Bsh in L. salivarius UCC118 (SwissProt ID Q1WUK8), L. brevis ATCC 367 
(SwissProt ID Q03NN7 and Q03P51), L. sakei 23K (SwissProt ID Q38Z70), 
and L. plantarum WCFS1 (SwissProt ID Q890F5 [Bsh2]; Q88SP0 [Bsh3], and 
Q88UC9 [Bsh4]) should be corrected to Pva-related (Table 2).  
Furthermore, the members of the Pva- and Bsh-clusters were not only 
found to be phylogenetically, but also structurally different. 3D-modeling and 
sequence alignment showed clear differences in the 3D-structure of the substrate 
binding pockets of Bsh- and Pva-enzymes, as illustrated in Figure 3. Especially, 
one loop of the substrate binding pocket (loop 3) in Pva is folded inwards as 
compared to the Bsh enzymes. As a consequence, it is unlikely that bile salts can 
be accommodated in the substrate binding pocket of Pva (Figure 1). The 
members of the Pva-cluster were found to be less related than members of the 
Bsh-cluster during phylogenetic analysis. This finding was reflected in a higher 
variability in the residues of the binding pocket of members of the Pva-cluster as 
compared to members of the Bsh-cluster, suggesting considerable variation in 
putative penicillin derivatives or similar molecules that could be bound. As 
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expected, the predicted substrate binding pocket of the experimentally verified 
bile salt hydrolase Bsh1 of L. plantarum (16) structurally resembled the Bsh 
enzymes of B. longum (15) and C. perfringens (25). In addition, the paralogs 
Bsh2, Bsh3, and Bsh4 were clustered in the Pva-group during phylogenetic 
analysis, with Bsh2 and Bsh3 being more related to each other than to Bsh4. 
This is in agreement with the finding that the predicted substrate binding pocket 
of Bsh2 and Bsh3 appeared to structurally resemble the Pva enzyme of B. 
sphaericus (27) considerably more than that of Bsh4. Possibly, Bsh4 encodes an 
enzyme related to Pva, capable of acylating a substrate other than penicillin V. 
Notably, one of the catalytic residues appeared to differ between the Bsh- 
and Pva-cluster. This finding facilitates accurate prediction of the functionality 
of the Bsh-family members as Bsh or Pva (-related) from their amino acid 
sequences. Novel and discriminative HMMs were constructed to distinguish 
between Bsh and Pva-family members. Thereby, our analyses defined the 
discriminative characteristics of the Pva- and Bsh-enzyme families, which 
appeared not feasible using the available conserved motif databases. For 
example, the conserved domain search tool (18) provided by NCBI 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) aims at detection and 
prediction of conserved domains in proteins, and includes domains imported 
from SMART, Pfam or COG databases. However, this tool attributes ‘penicillin 
V acylase, also known as conjugated bile salt acid hydrolase’ to the best 
conserved domain found in all experimentally verified Bsh- and Pva-proteins 
used here (Table 1), and thereby fails to distinguish between Bsh- and penicillin 
acylase-like domains. Analogously, neither SMART, Pfam nor COG databases 
provide a correct discriminative domain description for all experimentally 
verified Bsh- and Pva-proteins (data not shown). 
 In conclusion, we have provided evidence that various Pva-related 
sequences are wrongly annotated as Bsh in various Gram-positive bacteria, 
including several lactobacilli. Especially for intestinal lactobacilli, the capacity 
to deconjugate bile acids has been suggested to be of importance for their 
survival capacity in the gastrointestinal tract of mammals and is proposed to 
strongly influence gut physiology. Therefore, appropriate annotation of the Bsh 
enzymes in Lactobacillus and other lactic acid bacteria genomes is important to 
predict their in situ functionality in the gastrointestinal tract. The methodology 
presented here provides the in silico tools to effectively distinguish the genes 
encoding the important Bsh enzymes from those encoding closely related Pva-
like activities. 
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3. A Cre-lox-based system for multiple gene deletions and 
selectable-marker removal in Lactobacillus plantarum  
 
The classic strategy to achieve gene deletion variants is based on double 
cross-over integration of non-replicating vectors into the genome. In addition, 
recombination systems such as Cre-lox have been used extensively mainly in 
eukaryotic organisms. This study presents the construction of a Cre-lox-based 
system for multiple gene deletions in Lactobacillus plantarum that could be 
adapted for use in Gram-positive bacteria. First, an effective mutagenesis vector 
(pNZ5319) was constructed that allows direct cloning of blunt-end PCR 
products representing homologous recombination target regions. Using this 
mutagenesis vector, double cross-over gene replacement mutants could be 
readily selected based on their antibiotic resistance phenotype. In the resulting 
mutants, the target gene is replaced by a lox66-P32-cat-lox71 cassette, where 
lox66 and lox71 are mutant variants of loxP and P32-cat is a chloramphenicol 
resistance cassette. The lox sites serve as recognition sites for the Cre enzyme, 
which is a protein that belongs to the integrase family of site-specific 
recombinases.  Thus, transient Cre recombinase expression in double-cross over 
mutants leads to recombination of the lox66-P32-cat-lox71 cassette into a double 
mutant loxP site, called lox72, which displays strongly reduced recognition by 
Cre. The effectiveness of the Cre-lox-based strategy for multiple gene deletions 
was demonstrated by construction of both single and double gene deletions at 
the melA and bsh1 loci on the chromosome of the Gram-positive model 
organism Lactobacillus plantarum WCFS1. Furthermore, the efficiency of the 
Cre-lox-based system in multiple gene replacements was determined by 
successive mutagenesis of the genetically closely linked loci melA and lacS2 in 
L. plantarum WCFS1. The fact that 99.4 % of the clones that were analysed had 
undergone correct Cre-lox resolution emphasizes the suitability of the system 
described here for multiple gene replacement and deletion strategies in a single 
genetic background. 
 
INTRODUCTION 
 
 The development of tools for genetic engineering in Gram-positive 
bacteria is highly valuable for research applications. The classic strategy to 
obtain gene deletion variants is based on homologous recombination, using 
double cross-over integration of heterologous non-replicating vectors such as 
pUC (34, 36, 37, 42) , pACYC184 (6, 48, 50), or their derivatives in the genome 
. Several convenient systems that derive from this strategy use conditionally 
replicating vectors, such as the thermo-sensitive pG+host system (40), and the 
RepA dependent lactococcal pORI system (originating from pWV01) (12, 33, 
51) and its broad host range derivative (42, 51). 
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 In addition to systems that derive from the classic strategy, various site-
specific recombination systems such as Flp-FRT (52), Gateway (Invitrogen), 
ParA-res (31), TnpR-res (13) and Cre-lox are used in mutational strategies. 
However, these systems have until now not been available for construction of an 
unlimited number of mutations in the same genetic background in Gram-positive 
bacteria. For this purpose, the versatile Cre-lox system is a promising candidate. 
The Cre recombinase is a 38 kD protein that belongs to the integrase family of 
site-specific recombinases. It catalyses co-factor independent recombination 
between two of its recognition sites, called loxP. The 34 bp consensus for loxP 
sites consists of an asymmetrical core spacer of 8 bp, defining the orientation of 
the loxP site, and two 13 bp palindromic flanking sequences (1, 23). A DNA 
sequence that is flanked by loxP sites is excised when the loxP sites are 
convergently oriented, whereas the sequence is inverted when the loxP sites are 
divergently oriented. Cre recombinase is able to act on both inter- and 
intramolecular loxP sites, although recombination of intramolecular lox sites is 
kinetically favorable (32). 
 The versatile properties of Cre recombinase make it ideal for use in many 
genetic manipulation strategies. Therefore, the Cre-lox system has been used in 
a wide variety of eukaryotic such as plants (20), yeast (54), mice (45, 55), feline 
cell lines (30), human cell lines (26, 43), and chicken cell lines (5). For example, 
recombination of intermolecular loxP sites has been used for site-specific 
integration of transfected DNA into the chromosome (4, 29, 30). Many 
strategies use recombination of loxP sites to excise the intermediate DNA 
sequence. This includes work on conditional gene deletions (5) and 
recombinatorial activation of gene expression (55). In particular, an important 
application of the Cre-lox system is selectable marker excision in gene 
replacements. Commonly used gene replacement strategies result in the 
introduction of a selectable marker into the genome, facilitating selection of 
gene mutations that might cause growth retardation. However, the expression of 
the marker may result in polar effects on expression of up- and downstream 
located genes. Selectable-marker removal from the genome by Cre-lox 
recombination is an elegant and efficient way of circumventing this issue and 
has therefore been used frequently in for example plants (20), mouse cell lines 
(2), and yeast (22).  
Notably, use of native loxP sites for consecutive rounds of gene replacement and 
subsequent selectable-marker removal would lead to the integration of multiple 
loxP sites in the genome that can still be recognized by Cre. To minimize 
genetic instability, lox sites containing mutations within the inverted repeats 
(lox66 and lox71; Figure 1) have been used in plants (4) and chicken cell lines 
(5). Recombination of lox66 and lox71 results in a lox72 site that shows strongly 
reduced binding affinity for Cre, allowing for repeated gene deletion in a single 
genetic background.  
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Figure 1. Schematic representation of mutant lox66 and lox71 sites, which after Cre 
recombination result in a double mutant lox72 site. Sequences in bold type are mutated 
compared to the native loxP site (shown as reference). 
 
In contrast to the many eukaryote examples, the Cre-lox system has been 
used much less frequently in prokaryotic organisms. For example, in 
Escherichia coli, mechanistic studies on Cre recombination were performed (3, 
44). In Lactobacillus plantarum, the Cre-lox system was used for conditional 
gene deletions in the murine GI-tract (10). In addition, Cre-lox mediated 
selectable-marker removal in gene replacements has been used in the Gram-
negative bacteria Methylobacterium extorquens, Burkholderia fungorum, 
Escherichia coli, and Pseudomonas aeruginosa (41, 46, 49). However, these 
experiments implemented native loxP sites for multiple gene replacements. 
Previously, it was shown in Lactococcus lactis,  Corynebacterium glutamicum 
and Salmonella typhimurium that Cre readily excises or inverts large fragments 
of DNA flanked by loxP sites in prokaryotes (14, 15, 57, 62), thereby leading to 
genomic instability. 
Here we describe the construction of a Cre-lox-based toolbox for multiple 
gene deletions in a single genetic background in Gram-positive bacteria, which 
combines the advantages of selectable gene replacement and a marker-free, in-
frame gene deletion in the final strain. For this purpose, a mutagenesis vector 
was constructed and used for classic double cross-over replacement of target 
genes by the selectable marker cassette lox66-P32-cat-lox71, which can be 
recombined from the chromosome into a double-mutant lox72 site by transient 
Cre recombinase expression from a second plasmid.  
To validate the effectiveness of the system described here, the mutagenesis 
targets melA, bsh1, and lacS2 were selected in the model organism L. plantarum 
WCFS1, of which the genome was sequenced (28). The melA and bsh1 genes 
are genetically unlinked loci, whereas the melA and lacS2 loci are genetically 
closely linked. Although only experimentally tested in this bacterium, the 
simple, functional implementation of the same basic characteristics involved in 
this host to other bacterial hosts will be discussed. 
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MATERIALS AND METHODS 
 
 Bacterial strains, plasmids and primers. The bacterial strains, plasmids 
and primers used in this study and their relevant features are listed in Table 1 
and 2.  
As a model strain for Gram-positive bacteria, L. plantarum WCFS1 (28) was 
used. L. plantarum was grown at 37°C in MRS broth (Difco, West Molesey, 
United Kingdom) without aeration. Escherichia coli strains DH5α (63) and 
MC1061 (16, 61) were used as an intermediate cloning host and were grown at 
37°C on TY broth (27) with aeration (53). When appropriate, antibiotics were 
added to the media. For L. plantarum, 10 μg/ml chloramphenicol and 10 μg/ml 
or (for replica-plating) 30 μg/ml erythromycin was used. For E. coli, 10 μg/ml 
chloramphenicol and 250 μg/ml erythromycin were used. 
 
Table 1. Strains and plasmids used in this study 
Strains Relevant featuresa References 
  L. plantarum   
    WCFS1 Single colony isolate of L. plantarum NCIMB8826 (28) 
    NZ5304 Derivative of WCFS1 containing a lox66-P32-cat-lox71 
replacement of bsh1 (bsh1:: lox66-P32-cat-lox71) 
This work 
    NZ5305 Derivative of NZ5304 containing a lox72 replacement of 
bsh1 (Δbsh1) 
This work 
    NZ5334 Derivative of WCFS1 containing a lox66-P32-cat-lox71 
replacement of melA (melA:: lox66-P32-cat-lox71) 
This work 
    NZ5335 Derivative of NZ5334 containing a lox72 replacement of 
melA (ΔmelA) 
This work 
    NZ5337 Derivative of NZ5335 containing a lox72 replacement of 
melA and bsh1 (ΔmelA, Δbsh1) 
This work 
 
    NZ5338 Derivative of NZ5335 containing a lox66-P32-cat-lox71 
replacement of part of lacS2 (ΔmelA, lacS2::lox66-P32-
cat-lox71) 
This work 
    NZ5339 Derivative of NZ5338 containing a lox72 replacement of 
melA and part of lacS2 (ΔmelA, ΔlacS2) 
This work 
  E. coli   
    DH5α Cloning host ; F´,Φ80dlacZΔM15, endA1, recA1, 
hsdR17 (rk-,mk+), supE44, thi-1, gyrA96, relA1, 
Δ(lacZYA-argF)U169, deoR, λ- 
(63) 
    MC1061 Cloning host ; F- araD139 Δ(ara-leu)7696 galE15 
galK16 Δ(lac)X74 rpsL (Strr) hsdR2 (rk-mk+) mcrA 
mcrB1 
(16, 61) 
 
  L. lactis   
    MG1363 Plasmid-free derivative of NCDO 712 (19) 
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Table 1 continued 
 
 
Plasmids Relevant featuresa References 
  pCR®-Blunt Kanr ; cloning vector for blunt-end PCR products Invitrogen 
  pGID023 Emr; pJDC9 derivative containing the pE194 replication 
functions; unstable in lactobacilli 
(24) 
  pGIZ850 Cmr, Emr, Apr; pUC18 derivative containing a P32-cat 
cassette that is selectable at single copy level 
(21) 
  pNZ273 Cmr ; pNZ124 carrying the promoterless gusA gene 
from E. coli 
(47) 
  pNZ5315 Cmr, Emr; pNZ7101 derivative containing a lox66 site This work 
  pNZ5317 Cmr, Emr ; pNZ5315 derivative containing a lox71 site This work 
  pNZ5318 Cmr, Emr ; pNZ5317 derivative for multiple gene 
replacements containing las and pepN terminators  
This work 
  pNZ5319 Cmr, Emr ; pNZ5318 derivative for multiple gene 
replacements in Gram-positive bacteria 
This work 
  pNZ5340 Cmr, Emr ; pNZ5319 derivative containing homologous 
regions up- and downstream of WCFS1 melA 
This work 
  pNZ5325 Cmr, Emr ; pNZ5319 derivative containing homologous 
regions up- and downstream of WCFS1 bsh1 
This work 
  pNZ5344 Cmr, Emr ; pNZ5319 derivative containing homologous 
regions up- and downstream of lacS2 in melA::lox72 
strain NZ5335 
This work 
  pNZ5346 Cmr; pNZ273 derivative containing the promoter region 
and ribosome binding site of lp_1144 of WCFS1 
This work 
  pNZ5347 Cmr; pNZ7110 derivative containing the promoter 
region and RBS of lp_1144, driving expression of cre 
This work 
  pNZ5348 Emr; pGID023 derivative containing cre under control 
of the lp_1144 promoter 
This work 
  pNZ7101 Cmr, Emr ; pACYC184 derivative for gene replacements (8) 
  pNZ7110 Apr; pUC18 derivative containing the cre gene (9) 
  pNZ84 Cmr; pACYC184 derivative (59) 
 
a Kanr, kanamycin resistant; Cmr, chloramphenicol resistant ; Emr, erythromycin resistant; 
Apr, ampicillin resistant. 
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Table 2. Primers used in this study 
Primers 5’ to 3’ sequence 
  Bsh1fr1F gattaagtttgcaggacatggag 
  Bsh1R gccagccattggaacttactctg 
  Cat96F tcaaatacagcttttagaactgg 
  Cat97R accatcaaaaattgtataaagtggc 
  creF ctaactcgagtgatcaccaattc 
  creR ggctatcaatcaaagcaacacg 
  EryintF cgataccgtttacgaaattgg 
  EryintR cttgctcataagtaacggtac 
  Lastermi_F acgtccgcggggacaatatggggtaagcg 
  Lastermi_R aagaagatctctaaagctgacggggtaaac 
  MellacF accgttaagatgcgtgggactgg 
  MellacR catagtaaaatcttcccttcgcta 
  pNZ84F cgggatcccaacagtactgcgatgag 
  pNZ84R ggggtaccatccagtgatttttttctcc 
  80 cgtttaaacaatttaaatctaccgttcgtataatgtatgctatacgaagttatgaca 
  81 ttgtcataacttcgtatagcatacattatacgaacggtagatttaaattgtttaaacgtgct 
  82 gacccataacttcgtataatgtatgctatacgaacggtacagcccgggcatgagctccgat 
  83 cggagctcatgcccgggctgtaccgttcgtatagcatacattatacgaagttatgg 
  85 gtttttttctagtccaagctcaca 
  87 gccgactgtactttcggatcct 
  90 catagtaaaatcttcccttcgc 
  91 gtcgtaaagtgttcttcttagc 
  92 gctaaggactaagctcagcc 
  93 gagtttaggactacagggggc 
  95 aatatgtgtacaggctgagcttagtccttagcc 
  101 gattgcgattgatatcgatggc 
  102 tatggcagtacacataactagtaatcctcc 
  103 tactatgcagttaactaaaagcc 
  104 cttaccaatcatgcgtcccg 
  106a gttcgataaagaatgaggatggc 
  107a ttatcgcaagtatctcaaattgcg 
  108 tattggccttcccaccattagc 
  109 cacgttatttacggcgacggg 
  111 cgtgttgctttgattgatagcc 
  113 gctcgagcgcgttatcggtcctttaattgg 
  124 gcgcctcgagccgcaatcgctttgatttctgcc 
  125 tccgattgcatggcgagtcgg 
  126 taccgttaagatgcgtggg 
  127 ggcgggatccttatacggtgacagcagacgg 
  128 cattaaaccaacggatggtcgcg 
  130 cgtggttggatggcatttggg 
  137 cttctacccattattacagca 
  1144F ggatccgtcgaccgcgatttttgtatgagatg 
  1144R ggatccgctgttcgccaccctttcta 
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DNA manipulations. Plasmid DNA was isolated from E. coli on a small 
scale using the alkaline-lysis method (7). Large-scale plasmid DNA isolations 
were performed using Jetstar columns as recommended by the manufacturer 
(Genomed GmbH, Bad Oberhausen, Germany). For DNA manipulations in E. 
coli, standard procedures were used (53). 
DNA isolation and transformation of L. plantarum was performed as described 
previously (25), with slight modifications. For DNA isolation, an overnight 
culture of L. plantarum WCFS1 was diluted 20 times in 50 ml of fresh MRS 
medium and cells were grown to an optical density at 600 nm (OD600) of 1. Cells 
were pelleted by centrifugation for 10 minutes at 4500 rpm (Megafuge 1.0R, 
Heraeus, Hanau, Germany), resuspended in 2.5 ml of THMS buffer (30 mM 
Tris-HCl pH 8, 3 mM MgCl2, 0.73 M sucrose) containing 50 mg/ml lysozyme 
and incubated for 2 hours at 37°C. Cells were pelleted by centrifugation and 
resuspended in 2.5 ml TE containing RNase. Subsequently, 125 μl of 10% SDS 
was added and cells were incubated for 15 minutes at 37°C. Then, 25 μl of 20 
mg/ml proteinase K was added and the solution was subjected three times to 
phenol/chloroform extraction. The total DNA was precipitated with isopropanol, 
washed with 70% ethanol, dried and taken up in water. For transformation of L. 
plantarum WCFS1, a preculture in MRS broth was diluted in MRS broth 
containing 1% glycine and cells were grown to an OD600 of 1. Cells were kept 
on ice for 10 minutes and pelleted by centrifugation for 10 minutes at 4000 rpm 
(Megafuge 1.0R, Heraeus, Hanau, Germany). Cells were then resuspended in ice 
cold 30% PEG-1450 and kept on ice for 10 minutes. Finally, cells were pelleted 
by centrifugation for 10 minutes at 4000 rpm and concentrated 100-fold into ice 
cold 30% PEG-1450. Subsequently, 40 μl of cell suspension and up to 5 μl of 
plasmid DNA solution was electroporated using a GenePulser Xcell 
electroporator (Biorad, Veenendaal, The Netherlands) in cuvettes with a 2 mm 
electroporation gap at 1,5 kV, 25 μF capacitance and 400 Ω parallel resistance.   
Restriction endonucleases, Taq, Pfx and Pwo DNA polymerases, T4 DNA 
ligase, and Klenow enzyme were used as specified by the manufacturers 
(Promega, Leiden, The Netherlands, and Boehringer, Mannheim, Germany). 
Primers were obtained from Genset Oligos (Paris, France). 
 Mutagenesis vector construction. To facilitate construction of 
chromosomal gene replacements, the universal mutagenesis vector pNZ5319 
was constructed (Figure 2A).  
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Figure 2. Panel A. Schematic representation of the construction of mutagenesis vector 
pNZ5319. 80 and 81 linkers were annealed (Table 2) and cloned into pNZ7101 digested with 
Bsp1286I and Tth111I, yielding pNZ5315 (Table 1). Subsequently, 82 and 83 linkers (Table 
2) were annealed and cloned into pNZ5315 digested with PpuMI and PvuI, yielding pNZ5317 
(Table 1). Subsequently, the las terminator (38, 39) and pepN terminator (58) were amplified 
by PCR from L. lactis MG1363 (19) using primers LasTermi_F and LasTermi_R, 111 and 
113, respectively (Table 2). The PCR fragment containing the las terminator and BglII 
restriction site was digested with Ecl136II and cloned in pNZ5317 digested with AflIII and 
treated with Klenow enzyme. Subsequently, the PCR fragment containing the pepN 
terminator and XhoI restriction site was cloned into the PvuII site of the targeting vector, 
yielding pNZ5318 (Table 1). Finally, non-functional DNA sequences were removed by BbsI 
and SalI digestion, treatment with Klenow enzyme and self-ligation, resulting in pNZ5319 
(Table1). Panel B. Schematic representation of mutagenesis vector pNZ5319. Indicated are 
the pACYC184-derived origin of replication (ori), the erythromycin (ery) resistance gene, the 
chloramphenicol resistance gene under control of the P32 promoter (P32-cat), flanked by lox66 
and lox71 sites, and the lactococcal Tlas and TpepN terminators. The presence of rare-cutting 
blunt-end restriction sites SwaI, PmeI, SrfI and Ecl136II allow direct cloning of blunt-end 
PCR products of the flanking regions of the target locus. As an example, the regions used for 
PCR amplification and cloning into pNZ5319 for construction of a L. plantarum melA mutant 
are indicated. In addition, the sticky-end restriction sites XhoI and BglII can be used in 
combination with the blunt-end restriction sites. The presence of two selectable marker gene 
cassettes (P32-cat and ery) on the mutagenesis vector allows direct selection of double cross-
over integrants based on their antibiotics resistance (Cmr) and sensitivity (Ems) phenotype. 
Primers used in this study are indicated as black arrowheads. Panel C. Schematic 
representation of the in-frame insertion that is left in the genome after lox72-replacement of 
the target gene. Depending on the restriction sites used for cloning of the homologous DNA 
fragments (as indicated in the figure) that encompass a whole number of codons of the target 
gene, the number of foreign nucleotides left in the genome is 45 (cloning using SwaI and SrfI 
restriction sites), 54 (PmeI/SrfI or SwaI/Ecl136II), or 63 (PmeI/Ecl136II), thereby creating an 
in-frame deletion of the target gene. 
For this, the pACYC184-derived origin of replication was amplified by PCR 
(using Pfx polymerase, pNZ84F and pNZ84R primers and pNZ84 (59) as 
template DNA) and cloned into the NaeI restriction site of pGIZ850 (21), 
resulting in pNZ7101 (8). To introduce lox66 and blunt-end restriction sites 
SwaI and PmeI, 80 and 81 linkers (Table 2), which were annealed and cloned 
into the Bsp1286I and Tth111I restriction sites upstream of the P32-cat cassette 
of pNZ7101 (8), yielding pNZ5315 (Table 1). Subsequently,  82 and 83 linkers 
(Table 2), which contained lox71 and blunt-end restriction sites Ecl136II and 
SrfI, were annealed and cloned into the PpuMI and PvuI restriction sites 
downstream of the P32-cat cassette of pNZ5315, yielding pNZ5317 (Table 1). 
Furthermore, both the las-operon and pepN terminator regions (38, 39) were 
amplified by PCR from L. lactis MG1363 (19) using primers LasTermi_F and 
LasTermi_R, 111 and 113, respectively (Table 2). The PCR fragment containing 
C 
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the las terminator and BglII restriction site was digested with Ecl136II (to avoid 
introduction of an extra Ecl136II restriction site into the mutagenesis vector) and 
cloned in pNZ5317 that was digested with AflIII and treated with Klenow 
enzyme to generate blunt ends. Subsequently, the PCR fragment containing the 
pepN terminator and XhoI restriction site was cloned into the PvuII restriction 
site of the targeting vector, yielding pNZ5318 (Table 1). Removal of residual 
and non-functional DNA sequences from the pNZ5318 mutagenesis vector was 
achieved by BbsI and SalI digestion, treatment with Klenow enzyme to generate 
blunt ends, and self-ligation, yielding pNZ5319 (Table 1). 
Construction of gene-specific mutagenesis vectors.  For construction of 
gene-specific mutagenesis vectors, a standard cloning procedure was used 
(Figure 2B). Typically, a fragment of 1kb of the up- and of the downstream 
sequence of the target locus was amplified by PCR using a proofreading 
polymerase and cloned in blunt-end restriction sites SwaI or PmeI and Ecl136II 
or SrfI of pNZ5319, respectively. When desired, sticky-end restriction sites 
XhoI or BglII can be used in combination with the blunt-end restriction sites. To 
ultimately obtain in-frame gene deletions (following Cre recombination, see 
below and Figure 2C), primers were designed in such a way that the 5'- and 3'-
flanking regions of the target gene encompassed the first and last five codons of 
that gene, respectively. Cloning efficiency of the PCR amplification products of 
the 5’- and 3’-flanking regions of the target gene into the mutagenesis vector 
was enhanced by removal of self-ligation vector in the ligation mixture by 
digestion with SwaI, PmeI, Ecl136II, or SrfI, depending on the restriction site 
used for cloning. Colonies harboring the anticipated insert in the desired 
orientation could be identified effectively by colony PCR using a vector-specific 
primer (annealing to the P32-cat region: for cloning of 5' sequences in SwaI or 
PmeI, reverse primer 85; for cloning of 3' sequences in Ecl136II or SrfI, forward 
primer 87), combined with an insert-specific primer (see also below) (Table 2). 
Following the strategy described above, the melA mutagenesis vector pNZ5340 
was constructed by successive cloning of the 5' and 3'-flanking regions of melA 
(lp_3485) (28) (Figure 2B) into the SwaI and Ecl136II restriction sites of 
pNZ5319, (amplified by PCR using Pfx, L. plantarum WCFS1 genomic DNA as 
a template, and primer sets 91 and 90, 92 and 93, respectively (Table 2)). Clones 
that harbored the anticipated inserts were identified by PCR using primer sets 91 
and 85, 87 and 93, respectively (Table 2 and Figure 2B). 
Likewise, the bsh1 replacement vector pNZ5325 was constructed by the 
successive cloning of PCR products of the 5' and 3'-flanking regions of WCFS1 
bsh1 (lp_3536) (28) (amplified using Pfx polymerase, WCFS1 genomic DNA as 
a template, and primer sets 101 and 102, 103 and 104, respectively (Table 2)) 
into pNZ5319 digested with SwaI and Ecl136II, respectively. Clones that 
harbored the correct inserts were identified by PCR using primer sets 101 and 
85, 87 and 104, respectively (Table 2). 
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The third locus lacS2 (lp_3486) (28) was targeted for mutagenesis in a L. 
plantarum WCFS1 ΔmelA background (NZ5335; Table 1). For construction of 
the corresponding mutagenesis vector pNZ5344, PCR products of 5' and 3' 
regions of lacS2 (amplified using Pfx polymerase, ΔmelA (NZ5335) template 
DNA, and primer sets 124 and 125, 126 and 127, respectively (Table 2)) were 
digested with XhoI and BamHI, respectively and sequentially cloned in XhoI, 
SwaI and BglII, Ecl136II digested pNZ5319. Clones harboring the correct insert 
were identified using primer sets 124 and 85, 87 and 127, respectively (Table 2). 
 Mutant construction. In order to engineer lox66-P32-cat-lox71 gene 
replacements, 4 μg of the appropriate mutagenesis vector was transformed into 
L. plantarum WCFS1 by electroporation, as described previously (25). 
Chloramphenicol-resistant (Cmr) transformants were selected and replica-plated 
to check for an erythromycin-sensitive (Ems) phenotype. Candidate double 
cross-over clones (Cmr, Ems) were analyzed by PCR amplification of the cat and 
ery gene, using cat96F/cat97R and eryintF/eryintR primers, respectively (Table 
2). Correct integration of the lox66-P32-cat-lox71 cassette into the genome (for 
melA replacement, see Figure 3A) was confirmed by PCR amplification of the 
flanking regions of the integrated lox66-P32-cat-lox71 cassette, using primers 
annealing uniquely to genomic sequences (for melA, primer 108 for 
amplification of the 5'-region and primer 109 for amplification of the 3'-region) 
combined with the mutagenesis vector-specific primers 85 and 87 that annealed 
to the P32-cat region, respectively (Table 2 and Figure 3A). Likewise, for 
analysis of the flanking regions of the lox66-P32-cat-lox71 replacement of bsh1, 
primers 106a and 85, 87 and 107a were used; for lacS2 replacement, primers 
130 and 85, 87 and 109 were used (Table 2 and Figure 3A)). 
 Transient Cre expression vector. For expression of Cre, a 100 bp region 
upstream of the L. plantarum WCFS1 gene lp_1144 (28), containing the 
functional promoter P1144 (11), was amplified by proofreading PCR using 1144F 
and 1144R primers and cloned into pCR®-Blunt (Invitrogen, Breda, the 
Netherlands) (Table 1 and 2). To assess the promoter activity of the P1144 
fragment, it was digested from the pCR®-Blunt vector with BamHI and cloned 
upstream of the gusA gene into BglII digested pNZ273 (47), resulting in 
pNZ5346. Quantitative β-glucuronidase activity measurements were performed 
as described previously (17). To obtain cre expression, the promoter-fragment 
was digested from pNZ5346 with SalI and BamHI and cloned upstream of cre 
into SalI, BamHI digested pNZ7110 (9), yielding pNZ5347. Finally, the P1144 
promoter-cre cassette was digested from pNZ5347 using KpnI and HindIII and 
cloned into correspondingly digested pGID023, yielding pNZ5348, which is 
unstable in lactobacilli (24). 
The stability of the pGID023 replicon in L. plantarum was determined in 
duplicate by culturing for 10 generations without selection pressure. 
Subsequently, cells were plated with and without selection pressure and the 
amount of colony forming units (CFU)/ml was determined. The presence of 
A Cre-lox-based system for multiple gene deletions and selectable-marker removal 
pGID023 in L. plantarum was verified by colony PCR, using eryintF and 
eryintR primers (Table 2). 
 
Figure 3. Panel A. Strategy for construction of double cross-over mutants and subsequent 
Cre-lox-mediated selectable-marker removal (melA and subsequent lacS2 mutagenesis are 
shown as an example). Subsequent to transformation of the gene-specific mutagenesis vector, 
the target gene (melA) is replaced by a lox66-P32-cat-lox71 cassette by homologous 
recombination. After selection of the double cross-over mutant, the lox66-P32-cat-lox71 
cassette is resolved to a single double-mutant lox72 site by transient Cre expression from a 
curable plasmid. Subsequently, the next round of gene replacement (lacS2) can be performed. 
Primers that were used for amplification of the homologous DNA fragments used for 
targeting cloning in the mutagenesis vector pNZ5319 (91 and 90; 92 and 93 for melA 
targeting; 124 and 125; 126 and 127 for lacS2 targeting), confirmation of correct integration 
of the mutagenesis vector into the genome (108 and 85; 87 and 109 for melA targeting; 130 
and 85; 87 and 109 for lacS2 targeting) and confirmation of Cre resolution of the lox66-P32-
cat-lox71 cassette (108 and 109 for melA targeting) are indicated by black arrowheads. Panel 
B. Possible products of Cre recombination during multiple gene replacement in a single 
genetic background, as exemplified by recombination of the lox66-P32-cat-lox72 at the lacS2 
locus in a ΔmelA background. Primers that were used for distinction of the four possible 
products of lacS2::lox66-P32-cat-lox72 recombination in a ΔmelA background by PCR are 
indicated by black arrowheads (128, 137 and 95 in one reaction mixture). The corresponding 
PCR product sizes are indicated on the right. (1). No recombination occurred; (2). Correct 
recombination occurred, removing the P32-cat selectable marker cassette. (3). Incorrect 
recombination between lox66 and lox72 occurred, resulting in deletion of the intermediate 
region. (4). Incorrect recombination between lox71 and lox72 occurred, resulting in deletion 
of the intermediate region. 
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 Cre-mediated mutant locus resolution. To excise the P32-cat selectable 
marker cassette from the chromosome, 4 μg of the transient erythromycin-
selectable cre expression plasmid pNZ5348 was transformed into lox66-P32-cat-
lox71 gene replacement mutants. After 48 to 72 hours of growth, Emr colonies 
were checked by PCR for the presence of cells that had undergone Cre-mediated 
recombination, using primers spanning the recombination locus (specifically, 
using the following primers: for melA, 108 and 109 (Figure 3A); for bsh1, 
bsh1fr1F and bsh1R; for lacS2, 128, 137 and 95 in one PCR reaction (Figure 
3B);(Table 2)). The pNZ5348 vector was cured from appropriate colonies of L. 
plantarum mutants by growing without erythromycin selection pressure for 10 
generations. To obtain clonal strains, single colony isolates were selected in 
which curing of the Cre expression vector was confirmed by absence of PCR 
amplification of ery (using primers eryintF and eryintR) and cre (using primers 
creF and creR) (Table 2) and Cre-mediated recombination was confirmed by 
PCR amplification as stated above. Additionally, the presence of a correctly 
resolved lox72 (Figure 2C) site in these PCR products was confirmed by 
sequencing (Baseclear, Leiden, the Netherlands) using primers 95, bsh1fr1F, 
and 95 for melA, bsh1, and lacS2 replacement, respectively. 
 Southern blot analysis. To confirm the genotype of WCFS1 mutant 
derivatives melA::lox66-P32-cat-lox71 (NZ5334), ΔmelA (NZ5335), ΔmelA, 
lacS2::lox66-P32-cat-lox71 (NZ5338), and ΔmelAΔlacS2 (NZ5339) (Table 1), 
Southern blot analysis was performed as described earlier (53) using AvaI and 
DraI digests of total DNA. As a probe, a PCR amplification product of the 
intergenic region of melA and lacS2 (amplified with Taq polymerase, WCFS1 
total DNA and primers mellacF and mellacR, respectively) was used. 
HPLC assay of bile salt hydrolase activity. To determine bile salt 
hydrolase activity of L. plantarum, an overnight culture was inoculated 1:10 in 
fresh MRS medium and cells were grown to an OD600 of 5. Cells were pelleted 
by centrifugation for 10 minutes at 4500 rpm (Megafuge 1.0R, Heraeus, Hanau, 
Germany) and resuspended in MRS medium to an OD600 of 100. For 
determination of bile salt hydrolase activity, wild type L. plantarum cells were 
diluted in MRS to an OD600 of 10, whereas cells of bsh1 deletion strains were 
used undiluted. Conversion of the bile salt glycocholic acid (Sigma, 
Zwijndrecht, the Netherlands) was determined by HPLC as described previously 
(18). Separations were carried out with a reversed-phase resin-based column 
(PLRP-S, 5 μm, 300 Å, 250 x 4.6 mm I. D., Polymer laboratories, Shropshire, 
UK) and matching pre-column. Bile salts were detected using a pulsed 
amperometric detector (EG&G Princeton applied research, Princeton, NJ), 
equipped with a gold working electrode and a reference electrode (Ag/AgCl).  
Nucleotide sequence accession number. The sequence of the 
mutagenesis vector pNZ5319 is available in the GenBank database under 
accession number DQ104847.  
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The sequence of the P1144-cre cassette of the cre expression plasmid pNZ5348 is 
available in the GenBank database under accession number DQ340306. 
 
RESULTS 
 
 Strategy of gene replacement and selectable-marker removal. For 
generation of gene deletions, the mutagenesis vector pNZ5319 (Figure 2B) was 
constructed and implemented in the Gram-positive model organism 
Lactobacillus plantarum WCFS1 (28). This medium copy E. coli cloning vector 
contains a PACYC184 origin of replication, which is suitable for 'suicide' 
mutagenesis in lactic acid bacteria, as described earlier (17, 59).  
Cloning of PCR-amplified homologous DNA fragments up- and downstream of 
the mutagenesis locus (necessary for targeting of the mutagenesis vector to the 
genomic locus) in pNZ5319 is facilitated by the presence of rare-cutting blunt-
end restriction sites PmeI, SwaI, SrfI and Ecl136II in the vector, flanked by the 
lactococcal las (38, 39) and pepN (58) terminators (Figure 2B).  
Furthermore, the mutagenesis vector pNZ5319 contains both a chloramphenicol 
(lox66-P32-cat-lox71) and erythromycin (ery) resistance cassette that can be 
selected at single copy chromosomal level. Following transformation of the 
mutagenesis vector to the target organism, the antibiotic resistance cassettes 
allow for direct selection of double cross-over mutants on basis of their 
antibiotic resistance and sensitivity phenotype. In the resulting double cross-over 
mutant strains, the target gene is replaced by a lox66-P32-cat-lox71 cassette. The 
presence of the lox sites renders the P32-cat cassette excisable from the genome 
of the double-cross over mutant strain by Cre recombinase. Using native loxP 
sites, multiple gene deletions would lead to the integration of multiple loxP sites 
into the genome that can cause genomic instability in the presence of Cre (14, 
15, 57). Therefore, loxP sites containing mutations within the inverted repeats 
(lox66 and lox71) (4) were used (Figure 1) that after Cre recombination result in 
a double-mutant loxP site (lox72), which shows strongly lowered affinity for 
Cre.  
Transient Cre expression was driven by P1144 (upstream of gene lp_1144) from 
the vector pNZ5348, which contains a replicon that is unstable in lactobacilli 
(24). Although this plasmid can be introduced in L. plantarum when selective 
(Emr) conditions are maintained, its intrinsic instability in this host resulted in 
rapid curing of the plasmid when selective pressure was relieved. In our 
experiments, an approximate 1000-fold reduction in plasmid retention was 
obtained by culturing for 10 generations in absence of selection pressure, as 
determined by antibiotic resistance profiling and PCR (data not shown). Finally, 
the P1144 promoter is predicted to drive constitutive, moderate levels of 
transcription of the downstream gene (pcrA), encoding a DNA helicase. 
Previous experiments in our laboratory using gusA (which encodes ß-
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glucuronidase) as a promoter probe confirmed the prediction of the 
characteristics of the P1144 promoter (data not shown).  
Notably, in our design, the PCR-amplified homologous DNA fragments used for 
locus targeting include a whole number of codons of the 5’ and 3’ ends of the 
gene targeted for mutagenesis. Thus, depending on the restriction sites in 
pNZ5319 that were used for cloning of the 5’ and 3’ homologous regions, the 
total number of foreign nucleotides left in the genome after Cre-mediated 
excision of the selectable marker cassette is 45 (using SrfI and SwaI), 54 (using 
SrfI and PmeI or Ecl136II and SwaI) or 63 (using Ecl136II and PmeI), thereby 
generating an in frame deletion (Figure 2C).   
 Single locus mutagenesis. To validate the gene deletion system, the melA 
gene (lp_3485) and bsh1 gene (lp_3536) of L. plantarum WCFS1 (28) were 
chosen as target genes for single locus mutagenesis. The melA gene encodes an 
alpha-galactosidase (EC3.2.1.22), which is predicted to be involved in 
hydrolysis of the sugar melibiose into galactose and glucose. In L. plantarum, 
the melA gene is induced by melibiose and repressed by glucose (56). The melA 
gene is a convenient target for mutagenesis, since it is predicted to encode a 
non-redundant function in L. plantarum WCFS1 and its phenotype is likely to be 
measurable both quantitatively (hydrolysis of a chromogenic substrate) and 
qualitatively (absence of growth on melibiose as a sole carbon source). The bsh1 
gene of L. plantarum WCFS1 is predicted to encode a bile salt hydrolase (Bsh; 
EC3.5.1.24). Bile salt hydrolases catalyze cleavage of the amino acid moiety 
from the steroid nucleus of conjugated bile salts. The DNA sequence of bsh1 of 
L. plantarum WCFS1 is 99% identical to the sequence of the bsh gene of L. 
plantarum LP80, of which a previously constructed bsh mutant derivative was 
shown to be deficient in bile salt hydrolase activity (35). However, the L. 
plantarum WCFS1 genome appears to be four-fold redundant for this function, 
containing genes annotated as bsh1 to bsh4 (28). The L. plantarum bsh1 gene 
was selected as a target for mutagenesis to investigate whether it is the sole bile 
salt hydrolase-encoding gene in this strain. 
 For construction of melA and bsh1 mutant strains, gene-specific 
mutagenesis vectors pNZ5340 and pNZ5325 were constructed by direct cloning 
of PCR-amplified homologous DNA fragments up- and downstream of melA or 
bsh1, respectively, and transformed to L. plantarum WCFS1. The genetic events 
involved are schematically illustrated for the melA locus in Figure 3A. During 
primary selection of melA double cross-over mutants, a number of 34 Cmr 
colonies was found, of which 9 appeared to display the Ems phenotype 
correlated to the melA::lox66-P32-cat-lox71 genotype. A single colony isolate 
was selected and designated NZ5334 (Table 1). For bsh1 mutagenesis, a slightly 
lower number of 12 Cmr colonies was found during primary selection of double 
cross-over mutants, of which the relative amount of colonies displaying an Ems 
phenotype (3; correlating to a bsh1::lox66-P32-cat-lox71 genotype) appeared to 
be similar to that observed for the melA locus. A single colony isolate was 
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selected and designated NZ5304 (Table 1). Correct integration of the lox66-P32-
cat-lox71 cassette into the genome was confirmed by PCR and by Southern blot 
analysis (Figure 4).  
 
 
 
 
Figure 4. Southern blot analysis of WCFS1 and melA::lox66-P32-cat-lox71 (NZ5334), ΔmelA, 
lacS2::lox66-P32-cat-lox71 (NZ5338), ΔmelA, ΔlacS2 (NZ5339), and ΔmelA (NZ5335) 
derivatives. The restriction enzymes (DraI and AvaI, respectively) used for restriction of 
genomic DNA of the strains were chosen in such a way that all strains could be distinguished 
based on the predicted size of the hybridizing bands (indicated at the bottom of the figure in 
bp). The size of the hybridizing bands of the various strains was as expected, as can be 
determined by the size of the bands of the DNA ladder (indicated at the right of the figure in 
bp). DraI; DraI digestion of total DNA; AvaI; AvaI digestion of total DNA. 
 
To resolve the lox66-P32-cat-lox71 cassette at the mutation locus to a 
single in-frame lox72 site, the erythromycin-selectable Cre expression plasmid 
pNZ5348 was transformed to the NZ5334 and NZ5304 double cross-over 
mutant strains. After 48 hours of incubation, a number of 22 Ems colonies was 
analysed, of which 9 (for the melA-mutagenised stain) and 15 (for the bsh1-
mutagenised strain) colonies were found to contain cells that had undergone Cre 
recombination, as determined by PCR. Subsequently, the Cre expression vector 
was allowed to be lost from the cells by culturing without selective pressure. 
Single colony isolates (designated NZ5335 (ΔmelA), and NZ5305 (Δbsh1) 
(Table 1)) were selected and analysed for loss of the Cre expression vector and 
correct Cre-mediated recombination of the target loci, as determined by Ems 
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phenotype, PCR (Figure 3A), DNA sequencing of the mutated locus and 
Southern blot analysis (Figure 4).  
To further confirm the genotypes of these mutants, the anticipated 
physiologic consequences were analysed. As expected, growth on MRS plates of 
the L. plantarum WCFS1 melA deletion mutant NZ5335 in the presence of 
glucose as a carbon and energy source was unaffected as compared to the wild 
type. However, in the presence of melibiose as a sole carbon and energy source, 
growth on MRS plates of the L. plantarum WCFS1 melA deletion mutant 
NZ5335 was completely abolished, whereas growth of the wild type strain was 
normal (data not shown). This confirms the lack of functional redundancy for 
this gene in the L. plantarum WCFS1 genome and indicates that melA is 
essential for growth on melibiose. In analogy, quantitative determination of bile 
salt hydrolase activity of the bsh1-deletion mutant NZ5305 revealed that bsh1-
deficiency leads to a 90 % reduction of bile salt hydrolase activity in L. 
plantarum WCFS1 (Figure 5). 
 
 
 
Figure 5. Bsh activity of Δbsh1 (NZ5303), ΔmelA (NZ5335), and ΔmelA, Δbsh1 (NZ5337) 
strains relative to WCFS1. Deletion of bsh1 in WCFS1 or NZ5335 results in a 90 % reduction 
of Bsh activity. 
 
 Mutagenesis of genetically unlinked loci in a single genetic 
background. To establish that the mutagenesis system constructed was indeed 
suitable for efficient construction of successive selectable marker-free gene 
deletions, the bsh1 gene was mutated in the ΔmelA derivative (NZ5335) of L. 
plantarum WCFS1.  
After transformation of the bsh1 mutagenesis vector pNZ5325 into NZ5335 
(Table 1), a number of 38 Cmr colonies was found during primary selection of 
double cross-over integrants, of which 4 colonies displayed an Ems phenotype 
correlating to a bsh1::lox66-P32-cat-lox71 genotype (as confirmed by PCR). 
Subsequently, the lox66-P32-cat-lox71 cassette in the ΔmelA, bsh1::lox66-P32-
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cat-lox71 strain was efficiently resolved to a single in-frame lox72 site by 
transient Cre expression from the erythromycin-selectable vector pNZ5348. 
After 72 hours of incubation, all of 15 Emr colonies that were analysed 
contained cells that had undergone Cre-mediated recombination as confirmed by 
PCR. Following removal of the Cre expression vector by culturing without 
selection pressure, single colony isolates were taken and designated NZ5337 (L. 
plantarum ΔmelA, Δbsh1). Loss of the Cre expression vector and correct 
recombination of the target locus was confirmed by PCR and DNA sequencing 
of the mutated locus. Furthermore, the anticipated double mutant (ΔmelA, 
Δbsh1) phenotype could be confirmed, i.e. lack of growth on melibiose as a sole 
carbon and energy source and strongly reduced Bsh activity (Figure 5). 
 Mutagenesis of genetically linked loci in a single genetic background. 
The approaches described above showed that mutagenesis of two genetically 
unlinked loci (melA and bsh1) could be performed effectively. However, 
secondary gene replacement at a locus that is closely linked to the initially 
mutated locus leads to close proximity of the lox66-P32-cat-lox71 cassette and 
the lox72 site of the primarily targeted locus (Figure 3), which could lead to 
incorrect resolution by the Cre enzyme. Provided that Cre recognizes all 
available lox sites with a certain affinity, four different modes of resolution of 
the locus could occur that involve lox66 and lox71 sites alone, or that involve 
lox66 and/or lox71 sites in combination with the lox72 site. These modes of 
resolution can be distinguished by PCR analysis of resulting individual clones 
(Figure 3B). To evaluate the frequency of these potential artifact resolutions, a 
small part of the WCFS1 lacS2 gene (lp_3486) (28), which is located directly 
upstream of melA (lp_3485) and is orientated in the same orientation as melA, 
was chosen as a secondary target for mutagenesis in the WCFS1 ΔmelA strain 
NZ5335. In presence of glucose as a carbon and energy source, mutation of 
lacS2 was not expected to affect growth. The lacS2-specific mutagenesis vector 
pNZ5344 was constructed by cloning of PCR-amplified homologous DNA 
fragments into the mutagenesis vector pNZ5319. Following transformation of 
pNZ5344 into the ΔmelA strain, double cross-over integrants were selected 
based on their Cmr and Ems phenotype. Out of 22 Cmr transformants, 12 clones 
displayed an Ems phenotype and the corresponding ΔmelA, lacS2::lox66-P32-cat-
lox71 genotype, as could be confirmed by PCR and Southern blot analysis 
(Figure 4). After Cre mediated resolution, recombination patterns could be 
distinguished by PCR using primers 128, 137 and 95 in a single PCR reaction 
(Table 2; Figure 3B). Of the 192 colonies that were analysed, 179 gave a PCR 
product, of which the vast majority (126 colonies; 70.4 %) appeared to have 
undergone correct Cre recombination (ΔmelA, ΔlacS2), while almost all of the 
residual colonies (52 colonies; 29.1 %) appeared to contain a mixed population 
of correctly resolved (ΔmelA, ΔlacS2) and unresolved cells (ΔmelA, 
lacS2::lox66-P32-cat-lox71). Only a single colony (0.6 %) was detected that had 
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undergone incorrect recombination between the lox66 site at the lacS2 locus and 
the lox72 site at the melA locus, while no colonies were detected that had 
undergone incorrect recombination between the lox71 site at the lacS2 locus and 
the lox72 site at the melA locus. To further establish correct Cre-mediated 
resolution, the genotype of a single ΔmelA, ΔlacS2 colony (designated NZ5339) 
was confirmed by DNA sequencing of the mutated locus and Southern blot 
analysis (Figure 4). Taken together these experiments support the robustness and 
selectivity of Cre-mediated resolution of the mutant loxP sites introduced in the 
genome, and exemplify the suitability of the mutagenesis system presented here 
for the construction of multi-locus mutants in a single genetic background.  
 
DISCUSSION 
 
 Here we describe the construction of an effective Cre-lox-based toolbox 
for multiple gene replacements in a single genetic background. The procedure 
consists of three steps. In the first step, a gene-specific mutagenesis vector is 
constructed using standard cloning procedures. In the second step, the target 
gene is replaced by a lox66-P32-cat-lox71 cassette by double cross-over 
recombination. In the third step, the lox66-P32-cat-lox71 cassette introduced at 
the target locus is resolved by transient Cre expression, resulting in an in-frame 
lox72 site in the genome (Figure 1 and 2C).  
 The mutagenesis vector presented facilitates efficient direct cloning of 
blunt-end PCR amplification products that represent homologous 5'- and 3'-
flanking regions of any desired target locus in rare-cutting blunt-end restriction 
sites in the medium-copy E. coli cloning vector. The presence of two (single 
copy) selectable marker gene cassettes on the mutagenesis vector enables direct 
selection of double cross-over integrants. Direct selection of mutants provides a 
major advantage in procedures aiming to generate gene mutations that might 
result in growth retardation, where mutants may not be obtained when a method 
that implements a single selectable marker on the mutagenesis vector (i.e., 
pUC18 or pG+host) is used (12, 64). 
However, the presence of a selectable marker in the chromosome hampers 
multiple gene replacements and may influence the expression of surrounding 
genes. As opposed to most mutagenesis systems that enable direct selection of 
double cross-over mutants by implementation of two selectable markers on the 
mutagenesis vector (such as pUC18ery) (60), the method described here adds 
the option of selectable-marker removal from the genome by transient Cre 
expression in the gene replacement background using an unstable and easily 
curable Cre-expressing vector that ensures removal of Cre activity before 
introduction of additional mutations. Thus, our system provides an important 
advantage over mutagenesis systems for Gram-positive bacteria that have been 
described to date.  
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 Targeting of the melA and bsh1 locus of the Gram-positive model 
organism L. plantarum WCFS1 (28) showed the effectiveness of our system for 
construction of single locus double cross-over mutants and subsequent marker 
removal. The melA gene was shown to be essential for growth of L. plantarum 
WCFS1 on melibiose as a sole carbon and energy source. Although predicted to 
be four-fold redundant, the bsh1 gene appeared to be the major bile salt 
hydrolase-encoding gene in L. plantarum WCFS1. This is in good agreement 
with the finding that bsh1 of L. plantarum WCFS1 is almost identical to the bsh 
gene of L. plantarum LP80, of which a previously constructed mutant was 
shown to be bile-salt hydrolase deficient (35). However, to determine whether 
the bsh2, bsh3, and/or bsh4 play a role in the remaining Bsh activity in the 
Δbsh1 derivative of strain WCFS1, further investigation is required. 
 Furthermore, an essential characteristic for the successful generation of 
multiple gene deletions by Cre-lox recombination depends on correct resolution 
events even in presence of previously integrated lox72 sites. In the work 
presented here, the efficiency of Cre-lox-based removal of the P32-cat selectable 
marker cassette in multiple gene replacements was determined by successive 
mutagenesis of genetically unlinked and closely linked chromosomal loci. Thus, 
bsh1was effectively deleted in an L. plantarum WCFS1 ΔmelA strain, resulting 
in a ΔmelA, Δbsh1 double mutant strain, which displayed the anticipated 
combination of the single-locus mutant phenotypes. During successive 
mutagenesis of the genetically closely linked loci melA and lacS2 in L. 
plantarum WCFS1 (Figure 3), Cre-mediated resolution of lox66 and lox71 in 
close proximity of a lox72 site was shown to occur correctly in 99.4 % of the 
colonies that were successfully analysed. Moreover, no colonies were found to 
have undergone incorrect resolution of lox71 and lox72. However, the latter type 
of recombination (lox71 and lox72) results in a lox71 site, which in its turn can 
recombine with the still remaining lox66 site, thereby generating a single lox72 
site (Figure 3B). This situation is indistinguishable from direct recombination of 
lox66 and lox72, which was found to occur in only a single colony tested (0.6 
%). The fact that correct Cre resolution of lox66 and lox71 occurs almost 
exclusively even in the close proximity of a lox72 site emphasizes the selectivity 
of the Cre enzyme and underlines the advantage of this system relative to 
mutagenesis systems that employ native loxP sites, as have been used in some 
Gram-negative bacteria (41, 46, 49). Especially in prokaryotes, where only one 
chromosome is present, the use of loxP sites to resolve the selectable marker 
cassette in multiple gene deletions is highly undesirable, as it can lead to (large) 
genomic inversions and/or rearrangements (14, 15, 57). 
Although the Cre-lox system as described here was used in L. plantarum 
WCFS1, it can easily be adapted to other Gram-positive bacteria, including 
other lactic acid bacteria such as Lactococcus lactis and Streptococcus 
thermophilus. The only prerequisite to use this system is the availability of a 
method to establish transient Cre expression. For example, a temperature-
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sensitive vector such as pG+host (40) can be used for this purpose by sub-
cloning of the P1144-Cre expression cassette present in pNZ5348. Applicability 
of this approach in L. lactis has already been established in our laboratory (R. 
Brooijmans, personal communication). More advanced alternative possibilities 
could also be employed, including for example strictly controlled Cre expression 
from a permanently present plasmid or from a chromosomal locus, or expression 
of Cre from a plasmid in which Cre or the origin of replication are flanked by 
lox sites to ensure cessation of Cre activity before construction of additional 
mutations in the same genetic background. Analogously, the mutagenesis vector 
pNZ5319 could be modified by replacement of the pACYC184 replicon by a 
temperature-sensitive replicon (pG+host-derived) to facilitate mutagenesis in 
bacterial species that display a low transformation frequency that eliminates the 
suicide mutagenesis strategy employed here. These relatively simple 
modifications allow functional implementation of the Cre-lox-based 
mutagenesis system in a range of other Gram-positive or Gram-negative 
bacteria, and exemplify the broad applicability of the system presented here. 
In conclusion, the multiple gene deletion system for Gram-positive 
bacteria presented here allows effective, standardized double cross-over mutant 
constructions that can be introduced in a single genetic background by a simple 
repetitive procedure. The use of mutant lox sites for Cre-mediated selectable-
marker removal enables stable multi-locus mutants that are suitable for 
subsequent rounds of mutagenesis.  
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4. Functional analysis of conjugated bile acid hydrolase family 
members in Lactobacillus plantarum WCFS1 
Bile salts play an important role in the digestion of lipids in vertebrates, 
and are synthesized and conjugated to either glycine or taurine in the liver. 
Following secretion into the small intestine, intestinal microbes are capable of 
deconjugating the glycine or taurine from the bile salts using an enzyme called 
bile salt hydrolase (Bsh). Intestinal lactobacilli are regarded as major 
contributors to bile salt hydrolysis in vivo. Since the bile salt-hydrolyzing strain 
Lactobacillus plantarum WCFS1 was predicted to encode four bsh-genes (bsh1, 
bsh2, bsh3, and bsh4), the functionality of these bsh genes was explored using 
heterologous over-expression and multiple bsh-deletion strains. Thus, Bsh1 was 
shown to be responsible for the majority of Bsh activity in L. plantarum 
WCFS1. In addition, bsh1 of L. plantarum WCFS1 was shown to be involved in 
conferring tolerance to specific bile salts (i.e., glycocholic acid). Northern blot 
analysis established that bsh1, bsh2, bsh3, and bsh4 are all expressed in L. 
plantarum WCFS1 during the exponential growth phase. In biodiversity 
analysis, bsh1 appeared to be the only bsh homologue variable among L. 
plantarum strains; furthermore, presence of bsh1 correlated with presence of 
Bsh activity, suggesting that Bsh1 is commonly responsible for Bsh activity in 
L. plantarum strains. The fact that bsh2, bsh3, and bsh4 genes appeared to be 
conserved among L. plantarum strains suggests an important role of these genes 
in the physiology and life-style of the species L. plantarum. Analysis of these 
additional bsh-like genes in L. plantarum WCFS1 suggests that they might 
encode penicillin acylase rather than Bsh activity. This could indicate their 
implication in conversion of substrates other than bile acids or penicillin-like 
compounds in the natural habitat.  
INTRODUCTION 
 
Bile salts play an essential role in lipid digestion in vertebrates. They act 
as a detergent that emulsifies and solubilises dietary lipids and lipid-soluble 
vitamins. In the liver, bile acids are synthesized and conjugated as an N-acyl 
amidate with the amino acid taurine or glycine before being excreted via the bile 
duct into the small intestine (Figure 1). Usually, species of the intestinal 
microbiota, including a number of lactobacilli, produce bile salt hydrolases that 
are able to deconjugate the amino acid moiety from the bile salts in the intestine 
(Figure 1). A strong correlation has been found between the habitat of a specific 
bacterial species or strain and Bsh activity (47), suggesting a relation between 
the capability to deconjugate bile salts and survival or persistence of bacteria 
under gastro-intestinal conditions. Furthermore, intestinal bile salt deconjugation 
is believed to plays an important role in host physiology, as it is the gate-
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keeping reaction in further oxidation and dehydroxylation steps of primary bile 
salts (as synthesized by the host) into secondary bile salts by intestinal bacteria. 
Notably, the production of secondary bile acids has been linked to various 
intestinal diseases such as the formation of gallstones and colon cancer (44).  
 
 
 
 
 
Figure 1. General structure of bile salts. As an example, the structure of glycocholic acid is 
shown. The bond that is hydrolysed by Bsh-activity is indicated by an arrow. G, glycine; T, 
taurine, * OH-group absent in glycodeoxycholic acid; ** OH-group absent in 
glycochenodeoxycholic acid. 
 
According to the enzyme classification system, bile salt hydrolase (Bsh; 
EC3.5.1.24) belongs to the category of enzymes that act on carbon-nitrogen 
bonds in linear amides, other than peptide bonds. Among others, this enzyme 
category includes members of the β-lactam acylase family such as penicillin and 
cephalosporin acylases (EC3.5.1.11), and ceramidases (EC3.5.1.23). Although 
Bsh shares significant sequence homology with some of the enzymes in the 
EC3.5.1.- group and the type of bond that is cleaved is identical, the type of 
substrates that can be converted by the various enzymes is quite heterogeneous, 
and may very significantly in molecule size and hydrophobicity.  
Bsh activity has been found in a wide variety of mostly Gram-positive 
species (for review, see (3)), including Bifidobacterium (22, 25, 48), Clostridium 
(21, 26, 27, 33), Enterococcus (18),  Listeria (4), and Lactobacillus (2, 9-11, 17, 
23, 32, 34, 42), with the exception of the Gram-negative species Bacteroides 
(33, 46). The Lactobacillus plantarum WCFS1 genome (28) was predicted to 
contain four related genes annotated as bsh1 to bsh4 that are spread throughout 
the genome (28). However, functional analysis of a L. plantarum WCFS1 bsh1 
mutant suggested that bsh1 encodes for the majority of Bsh activity produced by 
this strain (32).  
Here, we present the functional analysis of bsh1, bsh2, bsh3, and bsh4 of 
L. plantarum WCFS1. To investigate the predicted function of these genes, each 
of the four bsh genes was overexpressed in the Bsh-deficient Lactococcus lactis. 
In addition, single, double, triple, and quadruple bsh knockout mutants of L. 
plantarum WCFS1 were constructed to evaluate the contribution of the 
individual bsh genes to hydrolysis of and/or tolerance to various substrates, 
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including bile salts, penicillin V, and acyl-homoserine lactones. Furthermore, 
the evolutionary conservation of bsh-homologs was investigated in several 
strains of the species L. plantarum using complete genome hybridisation (CGH) 
(37). These results indicated that bsh2, bsh3, and bsh4 appear to be conserved 
among L. plantarum strains, suggesting an important physiological role. In 
addition, bsh1 presence appeared to be correlated to Bsh activity of L. plantarum 
strains. 
 
MATERIALS AND METHODS 
 
Bacterial strains, plasmids and primers. The bacterial strains, plasmids and 
primers used in this study and their relevant features are listed in Table 1 and 2. 
L. plantarum WCFS1 (28) and bsh-mutant derivatives were grown at 37°C in 
MRS broth (Difco, West Molesey, United Kingdom) without aeration. The 
heterologous, nisin controlled expression (NICE) host L. lactis NZ9000 and its 
parental strain MG1363 that was used as an intermediate cloning host for NICE 
overexpression constructs (35) were grown at 30°C in M17 broth (Oxoid, 
Hampshire, United Kingdom) supplemented with 0.5 % glucose (w/v; G-M17), 
without aeration. Escherichia coli strains DH5α (54) and MC1061 (8, 53) were 
used as intermediate cloning host for L. plantarum mutagenesis constructs and 
pCR-Blunt constructs, respectively, and were grown at 37°C on TY broth (24), 
with aeration . When appropriate, antibiotics were added to the media. For L. 
plantarum, 10 μg/ml chloramphenicol and 10 μg/ml (in liquid medium) or 30 
μg/ml (on solid medium) erythromycin were used. For L. lactis, 10 μg/ml 
chloramphenicol was used. For E. coli, 10 μg/ml chloramphenicol and 250 
μg/ml erythromycin were used. 
DNA and protein manipulations. Plasmid DNA was isolated from E. 
coli on a small scale using the alkaline-lysis method (5). Large-scale plasmid 
DNA isolations were performed using Jetstar columns as recommended by the 
manufacturer (Genomed GmbH, Bad Oberhausen, Germany). Purification of 
DNA fragments from agarose gels was performed using the Wizard SV gel and 
PCR clean-up system (Promega, Leiden, The Netherlands). DNA isolation and 
transformation of L. plantarum and L. lactis was performed as described 
previously (14, 32). For DNA manipulations in E. coli, protein extraction, and 
sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE), 
standard procedures were employed (45). Restriction endonucleases, Taq, Pfx 
and Pwo DNA polymerases, T4 DNA ligase, and Klenow enzyme were used as 
prescribed by the manufacturers (Promega, Leiden, The Netherlands, and 
Boehringer, Mannheim, Germany). Primers were obtained from Genset Oligos 
(Paris, France). 
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Table 1. Strains and plasmids used in this study.  
Material Relevant feature(s)a Reference 
Strains   
  L. plantarum  
  WCFS1 Single colony isolate of NCIMB8826 (28) 
  NZ5305 bsh1 deletion derivative of WCFS1 (∆bsh1) (32) 
  NZ5307 bsh2 deletion derivative of WCFS1 (∆bsh2) This work 
  NZ5309 bsh3 deletion derivative of WCFS1 (∆bsh3) This work 
  NZ5311 bsh4 deletion derivative of WCFS1 (∆bsh4) This work 
  NZ5313 bsh1 deletion derivative of NZ5307 (∆bsh1, ∆bsh2 ) This work 
  NZ5315 bsh4 deletion derivative of NZ5309 (∆bsh3, ∆bsh4 ) This work 
  NZ5324 bsh3 deletion derivative of NZ5313 (∆bsh1, ∆bsh2, ∆bsh3) This work 
  NZ5326 bsh4 deletion derivative of NZ5313 (∆bsh1, ∆bsh2, ∆bsh4) This work 
  NZ5328 bsh1 deletion derivative of NZ5315 (∆bsh1, ∆bsh3, ∆bsh4) This work 
  NZ5330 bsh2 deletion derivative of NZ5315 (∆bsh2, ∆bsh3, ∆bsh4) This work 
  NZ5332 bsh3 deletion derivative of NZ5326 (∆bsh1, ∆bsh2, ∆bsh3, ∆bsh4) This work 
L. lactis   
  MG1363 Used as cloning host for NICE expression vectors; plasmid-free 
derivative of NCDO 712 
(20) 
  NZ9000 Used for heterologous expression using the NICE system; 
derivative of MG1363 with an insertion of the nisR, K genes into 
the pepN gene (pepN::nisRK) 
(30) 
Strains   
E. coli   
  DH5α Used as cloning host for L. plantarum mutagenesis vectors; F-, 
φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, recA1, endA1, 
hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1 
(54) 
    MC1061 Used as cloning host for pCR-Blunt vectors; F- araD139 Δ(ara-
leu)7696 galE15 galK16 Δ(lac)X74 rpsL (Strr) hsdR2 (rk-mk+) 
mcrA mcrB1 
(8, 53) 
Plasmids   
  pCR-Blunt KanR, commercial cloning vector for blunt-end PCR products Invitrogen 
  pNZ5306 CmR, pNZ8048 derivative; translational fusion of bsh1 to the nisin 
promotor 
This work 
  pNZ5307 CmR, pNZ8150 derivative; translational fusion of bsh2 to the nisin 
promotor 
This work 
  pNZ5308 CmR, pNZ8048 derivative; translational fusion of bsh3 to the nisin 
promotor 
This work 
  pNZ5309 CmR, pNZ8048 derivative; translational fusion of bsh4 to the nisin 
promotor 
This work 
  pNZ5319 CmR EmR, standard mutagenesis vector (32) 
  pNZ5325 CmR EmR, pNZ5319 derivative for bsh1 mutagenesis (32) 
  pNZ5329 CmR EmR, pNZ5319 derivative for bsh2 mutagenesis This work 
  pNZ5332 CmR EmR, pNZ5319 derivative for bsh3 mutagenesis This work 
  pNZ5336 CmR EmR, pNZ5319 derivative for bsh4 mutagenesis This work 
  pNZ5348 EmR, expression of cre from a plasmid that is unstable in 
lactobacilli 
(32) 
  pNZ8048 CmR, NcoI site used for translational fusions to the nisin promoter (30) 
  pNZ8150 CmR, ScaI site used for translational fusions to the nisin promoter (35) 
a KanR, kanamycin resistant; CmR; chloramphenicol resistant; EmR, erythromycin resistant. 
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Table 2. Primers used in this study. 
Primers 5’ to 3’ sequence 
  106a gttcgataaagaatgaggatggc 
  107a ttatcgcaagtatctcaaattgcg 
  85 gtttttttctagtccaagctcaca ggattactagacatgtgtactgcc 
  87 gccgactgtactttcggatcct ggattactagacatgtgtactgcc 
  Bsh1F ggattactagacatgtgtactgcc 
  Bsh1fr1F gattaagtttgcaggacatggag 
  Bsh1intF cgggattaaattttgcagg 
  Bsh1R gccagccattggaacttactctg 
  Bsh2contrR gagttactgcttttctgaaagtc 
  Bsh2F2 ccctttacatgtgcactagtctaac 
  Bsh2fr1intF catggaattgtcatatgatgtcg 
  Bsh2intF tcatgcaatttaccagcc 
  Bsh2ko-down cgatttgatcggcgggcagg 
  Bsh2ko-up ctgagcgcatatccaacttag 
  Bsh2kofr1F catggcaccaatataccccgcctc 
  Bsh2kofr1R tagactagtgcacatacaaatcgctcc 
  Bsh2kofr2F ttgccagcggcccattaagactttcag 
  Bsh2kofr2R gctatgcaaccggttgcattgaaactg 
  Bsh2R caagacgggtagccgtcactc 
  Bsh2seqR cgagcgaattaaccttagc 
  Bsh3F gtgaaacacatgtgtactagtttaac 
  Bsh3fr1intF gtaatccaaatgatgtggtcgat 
  Bsh3intF tatttctcgggacaagc 
  Bsh3ko-down cttgtcagttgcataagctcgc 
  Bsh3ko-up ggtcgctgattatcaaagtagc 
  Bsh3kofr1NheF aaaaccccgctagcgccgcagtcttggcgatgatggccg 
  Bsh3kofr1R taaactagtacacatgggtttcacatcc 
  Bsh3kofr2F ttccggttagcaaactaagttggaatata 
  Bsh3kofr2R gcaaataagtgaccaataaagtacgttacg 
  Bsh3R gaaagtgctattctgcctag 
  Bsh4F2 ccctttacatgtgtaccagcttaac 
  Bsh4fr1intF gctgttttgcacacgcagatcatc 
  Bsh4intF acgccgttgaatacg 
  Bsh4ko-down gagaagcagtttggtcgtcag 
  Bsh4ko-up ccttgacagttgccttaggatc 
  Bsh4kofr1F ccggaatccgcacacaagttgcc 
  Bsh4kofr1R taagctggtacacatggcgcggc 
  Bsh4kofr2F2 tttcctgccgattgaaactaaaaaatc 
  Bsh4kofr2SalR tctctcgtcgaccctaaaacgctgtgggaggtgctg 
  Bsh4R ggtccgaatgcagcgcaagctg 
 
RNA isolation and Northern blotting. For RNA isolation, an overnight 
culture of L. plantarum WCFS1 was diluted 50-fold in 50 ml of fresh MRS 
medium, with or without the addition of 0.05 % (w/v) porcine bile (Sigma, 
Zwijndrecht, the Netherlands), and grown to an OD600 of 1. Subsequently, 3 
volumes of quench buffer were added (60% methanol, 66.7 mM HEPES, pH6.5, 
-40 ºC) (43) . The cells were immediately pelleted by centrifugation at 4500 rpm 
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for 10 minutes (Megafuge 1.0R, Heraeus, Hanau, Germany), resuspended in 750 
µl of ice-cold TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.5), and 
mechanically disrupted (FastPrep FP120, Qbiogene, Illkirch, Cedex, France) in 
the presence of  0.8 g of zirconium beads (Biospec Products, Bartlesville, OK, 
USA), 0.18 g of Macaloid (Kronos Titan GmbH, Leverkusen, Germany), 50 µl 
of 10% SDS, and 500 µl of phenol. Subsequently, the RNA was purified from 
the upper, aqueous phase of the cell extract by phenol-chloroform extraction, 
precipitated with absolute ethanol, washed with 70% ethanol (45), and 
resuspended in 50 µl of MQ water. Northern blot analysis was performed as 
described earlier (45) using total RNA. As a probe for bsh1, bsh2, bsh3, and 
bsh4, a PCR amplification product of a large part of the gene (0.7 to 0.8 kb) was 
used, which was amplified with Taq polymerase, using L. plantarum WCFS1 
total DNA as a template in combination with the primer sets bsh1intF/bsh1R, 
bsh2intF/bsh2seqR, bsh3intF/bsh3R, and bsh4intF/bsh4R, respectively (Table 
2). Cross-hybridization of the individual probes with the other bsh sequences of 
L. plantarum WCFS1 was checked using dot-blots of 0, 0.2, 0.8, 3.0, 12,5, and 
50 ng of PCR amplification products encompassing bsh1, bsh2, bsh3, or bsh4, 
respectively (amplified using Taq polymerase, WCFS1 total DNA, and primer 
sets bsh1F/bshR, bsh2F/bsh2seqR, bsh3F/bsh3R, and bsh4F/bsh4R , 
respectively [Table 2]).  
Construction of bsh over-expression strains. For over-expression of 
bsh1, a DNA fragment containing the complete bsh1 gene was amplified by 
PCR, using Pfx polymerase with L. plantarum WCSF1 genomic DNA as a 
template and primers bsh1F and bsh1R. The resulting amplicon was cloned into 
pCR-Blunt (Invitrogen, Breda, the Netherlands). Subsequently, the bsh1 gene 
was recovered from the resulting plasmid as a 1.1 kb AflII-HindIII fragment and 
cloned downstream of and translationally fused to the nisA promoter in NcoI-
HindIII digested pNZ8048 (35). The resulting nisin-controlled bsh1 expression 
plasmid was designated pNZ5306.  
A DNA fragment containing bsh2 was amplified by PCR using Pfx polymerase 
with L. plantarum genomic DNA as a template and primers bsh2F2 and bsh2R. 
The amplicon obtained was digested with HindIII, and the resulting 1.1 kb 
fragment was cloned downstream of and translationally fused to the nisA 
promoter in pNZ8150 (35), digested with ScaI and HindIII, resulting in the 
bsh2-overexpression vector pNZ5307.  
The over-expression plasmid for bsh3 was constructed analogous to the bsh1 
plasmid pNZ5306. A bsh3-containing PCR amplicon (using Pfx polymerase, L. 
plantarum WCFS1 genomic DNA as a template, and primers bsh3F and bsh3R) 
was initially cloned in pCR-blunt (Invitrogen, Breda, the Netherlands), and a 1.1 
kb fragment containing bsh3 was sub cloned in pNZ8048 following the same 
cloning strategy as employed with bsh1, yielding pNZ5308 that contains the 
bsh3 gene under control of the nisA transcription and translation signals.  
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Finally, a bsh4 containing DNA fragment was amplified by PCR using Pfx 
polymerase with L. plantarum WCFS1 genomic DNA as a template and primers 
bsh4F2 and bsh4R. The amplicon obtained was cloned into the pCR-Blunt 
vector. The bsh4 gene was recovered from the resulting plasmid by digestion 
with KpnI and ApaLI, followed by partial digestion with AflIII and cloning of 
the 1.1 kb, bsh4 containing fragment downstream of and translationally fused to 
the nisA promoter in NcoI-KpnI digested pNZ8048, yielding the bsh4 
overexpression construct pNZ5309. 
For over-expression studies of the bsh genes in L. lactis using the NICE system, 
pNZ5306, pNZ5307, pNZ5308, and pNZ5309 were transformed to L. lactis 
NZ9000. 
Construction of bsh deletion mutant strains. For the construction of 
deletion derivatives of L. plantarum WCFS1 that lack one or more of the bsh 
genes, the previously reported Cre-lox-based system for multiple gene deletions 
was used (32). The bsh1-deletion vector pNZ5325 and bsh1-deletion strain 
NZ5305 were constructed previously (32) (Table 1). The bsh2-mutagenesis 
vector pNZ5329 (Table 1) was constructed by successive cloning of the PCR-
amplified 1.0 kb 5’- and 3’-chromosomal flanking regions of bsh2 (lp_0067) 
(using Pfx polymerase, L. plantarum WCFS1 genomic DNA as a template, and 
the primer sets bsh2kofr1F / bsh2kofr1R and bsh2kofr2F / bsh2kofr2R, 
respectively [Table 2]) into the SwaI and Ecl136II restriction site of pNZ5319 
(Table 1), respectively (32). Analogously, the bsh3- mutagenesis vector 
pNZ5332 (Table 1) was constructed by successive cloning of the PCR-amplified 
1.0 kb 5’- and 3’-chromosomal flanking regions of bsh3 (lp_3362) (using Pfx 
polymerase, L. plantarum WCFS1 genomic DNA as a template, and primer sets 
bsh3kofr1NheF / bsh3kofr1R and bsh3kofr2F / bsh3kofr2R, respectively [Table 
2]) into the PmeI and Ecl136II restriction site of pNZ5319 (Table 1), 
respectively (32). Finally, the bsh4- mutagenesis vector pNZ5336 (Table 1) was 
constructed by successive cloning of the PCR-amplified 1.0 and 0.9 kb 5’- and 
3’-chromosomal flanking regions of bsh4 (lp_2572) (using Pfx polymerase, L. 
plantarum WCFS1 genomic DNA as a template, and primer sets bsh4kofr1F / 
bsh4kofr1R and bsh4kofr2F2 / bsh4kofr2SalR, respectively [Table 2]) into the 
SwaI and Ecl136II restriction site of pNZ5319 (Table 1), respectively (32). For 
all bsh-deletion constructs, the sequences of the cloned PCR-amplified regions 
were verified by double strand sequence analysis (BaseClear, Roosendaal, The 
Netherlands).  
The bsh-deletion strains NZ5305 (∆bsh1), NZ5307 (∆bsh2), NZ5309 (∆bsh3), 
NZ5311 (∆bsh4), NZ5313 (∆bsh1, ∆bsh2 ), NZ5315(∆bsh3, ∆bsh4 ), NZ5324 
(∆bsh1, ∆bsh2, ∆bsh3), NZ5326 (∆bsh1, ∆bsh2, ∆bsh4), NZ5328 (∆bsh1, 
∆bsh3, ∆bsh4), NZ5330 (∆bsh2, ∆bsh3, ∆bsh4), NZ5332 (∆bsh1, ∆bsh2, ∆bsh3, 
∆bsh4) were constructed as described previously (32) (Table 1 and Figure 2). 
Briefly, the desired bsh-deletion vector was transformed to L. plantarum 
WCFS1 or one of its mutant derivatives by electroporation (32) and double 
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cross-over gene replacement mutants, in which the target gene was replaced by a 
lox66-P32-cat-lox71 cassette, were selected based on their CmR, EmS phenotype. 
Correct integration of the lox66-P32-cat-lox71 cassette into the genome was 
confirmed by PCR amplification of the flanking regions of the integrated lox66-
P32-cat-lox71 cassette, using primers annealing uniquely to genomic sequences 
combined with the mutagenesis vector-specific primers 85 and 87 that annealed 
to the P32-cat region, respectively (i.e., primers 106a / 85 and 87 / 107a for bsh1 
replacement, bsh2ko-up / 85 and 87 / bsh2ko-down for bsh2 replacement, 
bsh3ko-up / 85 and 87 / bsh3ko-down for bsh3 replacement, and bsh4ko-up / 85 
and 87 / bsh4ko-down for bsh4 replacement [Table 2]). Subsequently, the lox66-
P32-cat-lox71 cassette was removed from the genome by transient expression of 
the Cre recombinase enzyme from a plasmid that is unstable in lactobacilli 
(pNZ5348), leading to a stable deletion of the bsh gene, as described earlier 
(32). The Cre-lox-based mutagenesis system has specifically been designed to 
allow subsequent rounds of mutagenesis within a single genetic background, by 
using single nucleotide mutant lox sites (lox66 and lox71) that after 
recombination lead to a double-mutant lox (lox72) recombination site that is not 
recognized by Cre in subsequent rounds of mutagenesis (32). The L. plantarum 
bsh-deletion mutant strains were checked by PCR, amplifying each of the four 
(mutated) bsh loci, using bsh1fr1F / bsh1R (yielding a 1.4 kb and 0.5 kb product 
for the wild type and mutated locus, respectively), bsh2fr1intF / bsh2contrR 
(yielding a 1.4 kb and 0.4 kb product for the wild type and mutated locus, 
respectively), bsh3fr1intF / bsh3R (yielding a 1.4 kb and 0.5 kb product for the 
wild type and mutated locus, respectively), bsh4fr1intF / bsh4R (yielding a 1.2 
kb and 0.3 kb product for the wild type and mutated locus, respectively) for 
bsh1, bsh2, bsh3, and bsh4, respectively (Figure 3). Using this system, L. 
plantarum WCFS1 derivatives were constructed that have stable deletion 
mutations in one, two, three or all four of the bsh genes (see above and Table 1). 
 
 
 
Figure 2. Schematical overview of phylogenetic relation of the L. plantarum bsh mutants that 
were constructed in this work. 
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Figure 3. Schematical overview of the bsh-mutants made in L. plantarum WCFS1 (shown as a 
reference) and correspondingly, PCR-analysis encompassing the bsh loci of the mutants. 
Sizes of the PCR-products are indicated. Δbsh1, 2, 3, 4: NZ5332; Δbsh1: NZ5305; Δbsh2: 
NZ5307; Δbsh3: NZ5309; Δbsh4: NZ5311; Δbsh2, 3, 4: NZ5330; Δbsh1, 3, 4: NZ5328; 
Δbsh1, 2, 4: NZ5326; Δbsh1, 2, 3: NZ5324. 
 
HPLC assay of Bsh activity. To determine Bsh activity of L. plantarum 
strains, an overnight culture was inoculated 1:10 in fresh MRS medium and cells 
were either grown to an OD600 of 3 or grown overnight. Cells were harvested by 
centrifugation for 10 minutes at 4500 rpm at room temperature (Megafuge 1.0R, 
Heraeus, Hanau, Germany) and resuspended in MRS medium to an OD600 of 
100.  
Overexpression of individual bsh genes in L. lactis using the nisin controlled 
expression system (NICE) was performed using established protocols (12). In 
short, overnight cultures of the L. lactis bsh over-expression strains were 
subcultured (1:50) in fresh G-M17 medium and grown to an OD600 of 0.5. 
Subsequently, 1 ng/ml nisin (Sigma, Zwijndrecht, the Netherlands) was added to 
these cultures and growth was continued for 2 h. Cells were harvested by 
centrifugation for 10 minutes at 4500 rpm at room temperature (Megafuge 1.0R, 
Heraeus, Hanau, Germany). Cell pellets were resuspended to a final  OD600 of 
200 in 55 mM sodium acetate buffer pH6.5 containing 1 mM DTT and 1 gram 
of zirconium beads (51) and mechanically disrupted (FastPrep FP120, 
Qbiogene, Illkirch, Cedex, France). Following centrifugation, cell-free extracts 
were used immediately. Protein concentration in cell extracts was determined as 
described previously (6). 
Conversion of 1 mmol/l of the bile salts glycocholic acid (GC), 
glycodeoxycholic acid (GDC), glycochenodeoxycholic acid (GCDC), 
taurocholic acid (TC), taurodeoxycholic acid (TDC), and 
taurochenodeoxycholic acid (TCDC) (Sigma, Zwijndrecht, the Netherlands) or 
Fischer rat bile (courtesy of Wageningen University, Wageningen, The 
Netherlands) by intact cells of L. plantarum or cell-free extract of L. lactis bsh 
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over-expression strains was determined at 37ºC by HPLC as described 
previously (15). Separations were carried out with a reversed-phase resin-based 
column (PLRP-S, 5 μm, 300 Å, 250 x 4.6 mm I. D., Polymer laboratories, 
Shropshire, UK) and matching pre-column. Bile salts were detected using a 
pulsed amperometric detector (EG&G Princeton applied research, Princeton, 
NJ), equipped with a gold working electrode and a reference electrode 
(Ag/AgCl). Chromatograms were analyzed and integrated using the Chromeleon 
program (Dionex, Sunnyvale, USA) and Bsh activity was determined based on 
the disappearance of the conjugated bile salts used as a substrate.  
Alternative acylase functionality. Cell-free extracts of bsh-
overexpressing L. lactis strains in physiological salt (following procedures as 
described above) were analyzed for alternative acylase activity (Table 3). To 
determine penicillin, ampicillin, cephalosporin, acyl-homoserine lactone, and 
phenylacetylglycine acylase activity, 5 volumes of the cell-free extract were 
mixed with 5 volumes of 100 mM sodium acetate buffer pH5 containing 1 mM 
DTT and 1 volume of 100 mM of penicillin V, penicillin G, ampicillin, 
cephalosporin C, ketocaproyl-homoserine lactone, oxooctanoyl-homoserine 
lactone, or phenylacetylglycine and incubated overnight at 37ºC. To stop the 
reaction, 35 volumes of 285 mM sodium acetate buffer pH4 were added. Free 
amino groups resulting from enzymatic conversion of the substrate were 
detected by the addition of 5 volumes of 10 mg/ml fluorescamine in acetone, 
centrifugation for 10 minutes at 4000 rpm at room temperature (TechnoSpin R, 
Sorval Instruments, Chandler Wilmington, USA), and measurement of 
fluorescence in the supernatant (excitation at 360 nm, emission at 465 nm; 
GENios F129004, Tecan Benelux, Giessen, the Netherlands). As a positive 
control, purified penicillin acylase and purified end-products of the acylase 
reactions (6-aminopenicillanic acid, 7-aminocephalosporanic acid, homoserine 
lactone, and glycine) were used (Sigma, Zwijndrecht, the Netherlands). 
Furthermore, acylase activity for 6-nitro-3-(phenylacetamido) benzoic acid 
(NIPAB; Sigma, Zwijndrecht, the Netherlands), which is a commonly used 
chromogenic substrate for assaying of penicillin G acylase activity, was 
determined as described earlier (1, 31). Briefly, 1 volume of cell-free extract 
was mixed with 9 volumes of 100 mM sodium acetate buffer containing 1 mM 
DTT and 2.5 mM NIPAB. Acylation of NIPAB at 25°C was determined by the 
increase of absorption at 405 nm, which was followed for 30 minutes and 
measured overnight. As a positive control, purified penicillin amidase of E. coli 
was used (Sigma, Zwijndrecht, The Netherlands). 
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Table 3. Overview of the substrates tested to investigate alternative functionality of the bsh 
genes of L. plantarum WCFS1.  
Substrate Comments 
Penicillin G Acylated by penicillin acylase 
Pencillin V Acylated by penicillin acylase 
Ketocaproyl-homoserine 
lactone 
Involved in quorum sensing 
Oxooctanoyl-homoserine 
lactone 
Involved in quorum sensing 
NIPAB Used for determination of penicillin acylase activity 
Phenylacetylglycine Phenylalanine metabolism, acylated by Pva* of E. coli 
Ampicillin β-lactam 
Cephalosporin C β-lactam 
*Pva: penicillin V acylase. 
 
Bile salt and penicillin V tolerance. To evaluate the tolerance of L. 
plantarum WCFS1 and its bsh-mutant derivatives to bile salts and penicillins, an 
overnight culture was inoculated 1:20 into fresh MRS medium containing 0 to 
30% ox gall (w/v), 0 to 0.4 % (w/v) GDC, 0 to 10% (w/v) TDC, and 0 to 14 
μg/ml penicillin V. Growth was followed for 16 hours by measurement of the 
OD600 at 37°C at intervals of 15 min. (Spectra Max Plus 384, Molecular 
Devices, Sunnyvale, USA). 
bsh diversity in L. plantarum strains. The genomic diversity of L. 
plantarum strains (299; 299v; CIP102359; CIP104440; CIP104441; CIP104448; 
CIP104450; CIP104451; CIP104452; LP85-2; NCIMB12120; SF2A35B) has 
previously been investigated using strain WCFS1 derived DNA micro arrays 
(37). This genomic genotyping database allowed the evaluation of the presence 
and/or absence of homologues of the four genes that have initially been 
annotated in the L. plantarum WCFS1 genome as bsh (bsh1, bsh2, bsh3, and 
bsh4). Following statistical analysis, a positive cut-off P-value of 1.e-5 was used 
for presence calling of bsh-homologs.  
Detection of Bsh activity in L. plantarum strains. The presence of Bsh 
activity in different L. plantarum strains (299; 299v; CIP102359; CIP104440; 
CIP104441; CIP104448; CIP104450; CIP104451; CIP104452; LP85-2; 
NCIMB12120, and SF2A35B) was detected using a bile salt plate-assay, as 
described earlier (11). Briefly, overnight cultures of L. plantarum strains were 
transferred to solid MRS medium with or without 0.5 % (w/v) of the bile salt 
taurodeoxycholic acid and incubated anaerobically for 48 hours at 37° C. Bsh-
active strains were recognized by the formation of opaque white colonies when 
grown in presence of taurodeoxycholic acid, which is due to the precipitation of 
deconjugated bile salt forms. 
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RESULTS 
 
Expression of bsh genes. L. plantarum WCFS1 contains four related bsh 
genes (28). The expression of these genes was studied by Northern blotting 
during exponential growth phase in the presence or absence of porcine bile 
(Figure 4A). The probes used for Northern blotting were specific for each of the 
individual bsh genes and did not show cross-hybridisation (Figure 4B). The 
Northern blot analysis established that bsh1, bsh2, bsh3, and bsh4 are all 
expressed in L. plantarum WCFS1 during the exponential growth phase. The 
estimated sizes of the transcripts corresponded with those predicted for 
monocistronic transcription of bsh1, bsh2, bsh3, and bsh4 (1.2 kb for bsh1, bsh2, 
and bsh3; 1.1 kb for bsh4). Incubation of L. plantarum WCFS1 grown in liquid 
medium with 0.5% (w/v) porcine bile did not induce significant expression of 
any of the bsh genes (Figure 4). 
 
Figure 4 (A) Northern blot analysis of bsh1, bsh2, bsh3, and bsh4 of L. plantarum WCFS1.  -, 
growth of L. plantarum WCFS1 without porcine bile; +, growth of L. plantarum WCFS1 with 
0.5% (w/v) porcine bile. (B) Determination of cross-hybrization of bsh-gene-specific probes. 
1, 2, 3, 4: Hybridizing DNA of bsh1, bsh2, bsh3, or bsh4, respectively; 0.0, 0.2, 0.8, 3.0, 12.5, 
50.0; amount of hybridizing DNA used for dotblotting (ng); bsh1, bsh2, bsh3, bsh4: bsh-gene-
specific probe used for dotblotting.  
Contribution to Bsh activity of individual Bsh proteins. Since all bsh 
genes of L. plantarum WCFS1 appeared to be expressed during exponential 
growth, the contribution of the individual bsh genes to the total Bsh activity was 
determined. For this purpose, heterologous bsh over-expression strains of L. 
lactis were established. Furthermore, a set of single and multiple bsh deletion 
derivatives of L. plantarum WCFS1 was constructed (Table 1).  
For heterologous over-expression using the NICE-system (35), vectors 
pNZ5306, pNZ5307, pNZ5308, or pNZ5309, containing bsh1, bsh2, bsh3, or 
bsh4 genes, respectively, translationally coupled to the nisin-inducible nisA 
promoter were constructed and transformed to the Bsh-deficient bacterium L. 
lactis NZ9000. Only following nisin induction, over-expression protein products 
could be detected by SDS-PAGE for Bsh2 and Bsh3 (Figure 5A) at their 
expected molecular mass of 38 and 36 kDa, respectively. In contrast, the bsh1 
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and bsh4-derived protein product could not be detected on protein gels, 
suggesting that these proteins are produced in much lower amounts in this 
heterologous host. HPLC-based Bsh-activity assays (15) using taurine- and 
glycine-conjugated bile salts of C, DC, and CDC as a substrate (Figure 1) 
revealed that Bsh1, Bsh3, and Bsh4 are capable of bile salt deconjugation 
(Figure 5A), confirming the functional expression of both Bsh1 and 4, despite 
the lack of detection of the corresponding protein product by SDS-PAGE. Bsh1 
and Bsh3 displayed a strong preference for glycine-conjugated bile salts as 
compared to taurine-conjugated bile salts, while Bsh4 appeared to exclusively 
convert glycine-conjugated bile salts. Moreover, consistent differential substrate 
specificity of Bsh1, Bsh3 and Bsh4 was observed, with a substrate preference 
diminishing from DC to CDC and to C-conjugated bile salts (Figure 5B).  
Contrary to the other Bsh proteins, no Bsh-activity could be detected for 
Bsh2 with any of the substrates tested. Notably, the suggestion that bsh1 
encodes the majority of Bsh activity in L. plantarum WCFS1 (32) was 
confirmed by these experiments, since the lactococcal strain expressing this 
gene displayed the highest level of Bsh activity, while no visible over-
expression protein product could be detected by SDS-PAGE. 
In parallel, a set of combinatorial bsh-mutant derivatives (Figure 3, Table 
1 and Figure 2) of L. plantarum WCFS1 was constructed using a Cre-lox-based 
mutation system that allows the effective deletion of multiple genes in a single 
genetic background (32). The bsh-mutant derivatives were checked by PCR, 
amplifying each of the four bsh loci (Figure 3). Growth appeared to be 
unaffected in these mutants as compared to the parental strain, indicating that 
the deleted genes were not necessary for growth under normal laboratory 
conditions (data not shown). Moreover, no difference in colony morphology was 
observed between wild-type and mutant strains on MRS growth medium.  
Bsh activity was analysed using the HPLC-based assay (15) with GDC as 
a substrate for the triple and quadruple bsh-mutant strains (NZ5324, NZ5326, 
NZ5328, NZ5330, and NZ5332, respectively); Figure 5C. These experiments 
revealed that cells harbouring an intact bsh1 gene-copy (NZ5330; Δbsh2, Δbsh3, 
Δbsh4) displayed Bsh activity levels that were comparable to the wild-type 
strain, confirming previous studies identifying this gene as the major Bsh-
encoding gene in L. plantarum (32). Moreover, Bsh1-dependent Bsh activity 
declined drastically (about 40 times) when comparing cells harvested during 
logarithmic growth phase with those that were obtained from the stationary 
phase of growth (Figure 5C), indicating growth phase-dependent expression of 
the bsh1 gene. Notably, in all triple-mutant and bsh1-deficient strains (NZ5324, 
NZ5326, NZ5328), a small but detectable amount of bile salt hydrolysis was 
found (Figure 5C) that appeared to be bsh2-, bsh3-, or bsh4-independent. This 
finding was further confirmed by the presence of background Bsh-activity in the 
quadruple bsh-mutant strain NZ5332 (Figure 5C).  
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Figure 5. (A) Protein gel and activity of heterologous overexpression products of bsh1, bsh2, 
h3, and bsh4 using the NICE system (35) in L. lactis. The predicted size of the Bsh1, Bsh2, 
Bsh3, and Bsh4 proteins was 37, 38, 36, and 36 kDa, respectively. For Bsh2 overexpression, 
no Bsh activity was detected. Bsh3 and Bsh4 were capable of marginal Bsh-activity; with no 
activity found for Bsh4 for taurine-conjugated substrates. In contrast, Bsh1 over-expression 
yielded major Bsh-activity. 0, no nisin induction; 1, induction with 1 ng/ml nisin; *, indication 
of protein band differentially expressed following  nisin induction. (B) Substrate preference of 
the Bsh proteins. For all heterologous Bsh-overexpression strains, substrate preference 
diminished from GDC to TC. (Continued on next page). 
A 
B 
C 
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As an example, the substrate preference of the Bsh1-overexpression strain is shown. (C) 
glycodeoxycholic acid deconjugation activity of L. plantarum WCFS1 and bsh-mutant 
derivatives at logarithmic and stationary growth phase. Grey bars represent the Bsh activity in 
logarithmic growth phase; black bars represent the Bsh activity in stationary phase. NZ5330: 
Δbsh2, Δbsh3, Δbsh4 phenotype; NZ5328: Δbsh1, Δbsh3, Δbsh4 phenotype; NZ5326: Δbsh1, 
Δbsh2, Δbsh4 phenotype; NZ5324: Δbsh1, Δbsh2, Δbsh3 phenotype; NZ5332: Δbsh1, Δbsh2, 
Δbsh3, Δbsh4 phenotype.  
 
Nevertheless, based on these experiments, differential substrate specificity 
for the bsh2, bsh3, and bsh4 gene products could not be excluded. To determine 
the contribution of the individual bsh genes to Bsh activity on complex bile, the 
Bsh activity of the triple and quadruple bsh-mutant derivatives (NZ5324, 
NZ5326, NZ5328, NZ5330, and NZ5332, respectively) of L. plantarum WCFS1 
on male Fischer rat bile was determined. Clearly, L. plantarum WCFS1 was 
capable of hydrolysing most of the bile salts present in rat bile (Figure 6). 
Consistent with the results obtained with the pure bile salt substrate GDC, Bsh1 
appeared to be responsible for the Bsh activity of L. plantarum WCFS1 on the 
complex rat bile substrate (Figure 6), while in bsh1 deficient strains a low but 
consistent level of background activity was found that appeared to be 
independent of bsh2, bsh3 or bsh4 functionality. 
 
 
Figure 6. Schematic representation of the HPLC-profiles of rat bile salts before and after 
incubation with L. plantarum WCFS1 and bsh-mutant strains. From bottom to top, the HPLC-
profiles are depicted of native Fischer rat bile, Fischer rat bile incubated with WCFS1, 
NZ5326 (Δbsh1, Δbsh2, Δbsh4) and NZ5332 (Δbsh1, Δbsh2, Δbsh3, Δbsh4 ). Clearly, most 
rat bile salts can be deconjugated by WCFS1, as can be seen by the shifting of the conjugated 
bile salt peaks in the chromatogram towards deconjugated bile salt peaks, whereas in strains 
lacking bsh1, no bsh2, bsh3, or bsh4-dependent bile salt deconjugation was found. 
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Alternative acylase activity. To determine alternative acylase activity of 
the Bsh proteins of L. plantarum WCFS1, a variety of alternative substrates was 
screened (Table 3). The Bsh proteins of L. plantarum WCFS1 share significant 
sequence homology with penicillin V acylase enzyme family-members. 
Furthermore, β-lactam acylases belong to the same category of proteins as 
penicillin V acylases, and are homologous to enzymes designated acyl-
homoserine lactone acylase, which hydrolyse a similar chemical bond as β-
lactam acylases and Bshs in acyl-homoserine lactones (Figure 7A). Therefore, 
the functionality of the different bsh gene-products of L. plantarum WCFS1 in 
the conversion of alternative substrates was screened by determination of the 
hydrolysis activity of over-expression products of the individual Bsh proteins 
using the NICE system (35) in L. lactis NZ9000 (using pNZ5306, pNZ5307, 
pNZ5308, and pNZ5309, respectively). Substrates tested were penicillin V, 
penicillin G, NIPAB (which is a commonly used substrate for 
spectrophotometric detection of penicillin acylase activity), the β-lactams 
ampicillin and cephalosporin C, ketocaproyl-homoserine lactone, oxooctanoyl-
homoserine lactone, and phenylacetylglycine, which is a molecule that is 
involved in phenylalanine metabolism and thereby readily available to L. 
plantarum, and is cleaved by penicillin acylase of E. coli (50) (Table 3; Figure 
7A). For NIPAB, ampicillin, cephalosporin C, and phenylacetylglycine, no 
activity could be detected in any of the Bsh-overexpression strains. However, 
bsh3 (and to a lower extent bsh2 and bsh4) over-expression resulted in an 
average of 4.3, 2.2  and 1.8 times increase in acylase activity of penicillin V, 
respectively, relative to the control strain NZ9000 in several independent 
experiments (Figure 7B). These findings clearly suggest a role as a penicillin 
acylase for bsh3, and possibly bsh2 and bsh4. In addition, bsh2, bsh3, and bsh4 
over-expression strains all showed an increase in activity (on average 1.9 times) 
towards penicillin G, ketocaproyl- and oxooctanoyl-homoserine lactone relative 
to NZ9000, suggesting a broad range of enzyme specificity. Notably, the bsh1 
over-expression strain showed no significant activity towards penicillin V, 
penicillin G, ketocaproyl- or oxooctanoyl-homoserine lactone when compared to 
NZ9000, confirming the role of bsh1 as a bonafide Bsh.  
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Figure 7. (A) Chemical structure of penicillin V (A), penicillin G (B), ketocaproyl-
homoserine lactone (C), and oxooctanoyl-homoserine lactone (D). The acylation site is 
indicated with an arrow. (B) Fold change of activity of heterologous over-expression products 
of bsh1, bsh2, bsh3, and bsh4 using the NICE system (35) in L. lactis NZ9000 relative to 
NZ9000 for penicillin V (penV), penicillin G (penG), ketocaproyl-homoserine lactone (KC-
HSL) and oxooctanoyl-homoserine lactone (OO-HSL). 
 
Bile salt and penicillin V tolerance. The contribution of the individual 
bsh genes to the tolerance of the bile salts TDC and GDC, ox-gall, and penicillin 
V (Figure 1 and Figure 7A) was determined using the triple and quadruple L. 
plantarum bsh-mutant strains (NZ5324, NZ5326, NZ5328, NZ5330, and 
NZ5332, respectively). To this end, growth in presence of a range of bile (salt) 
and penicillin concentrations was monitored spectrophotometrically.  
L. plantarum was able to grow in the presence of to up to 30% (w/v) of ox 
gall, while showing no significant differences in growth between the strains 
(data not shown). However, due to the high concentrations of ox gall used, 
measurements were severely hampered. In addition, L. plantarum was able to 
A 
B 
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grow in the presence of more than 14% (w/v) of TDC, where no significant 
differences were found for the strains used (data not shown). However, L. 
plantarum appeared to be remarkably more sensitive to GDC, with obvious 
differences between the strains (Figure 8). 
 
Figure 8. Representative result of GDC tolerance of L. plantarum WCFS1 wild type and bsh 
mutant derivatives, indicated by growth (OD600) of the strains at 37°C after 7 hours in the 
presence of 0.1% (w/v) of GDC. NZ5330 (Δbsh2, Δbsh3, Δbsh4), NZ5328 ( Δbsh1, Δbsh3, 
Δbsh4), NZ5326 (Δbsh1, Δbsh2, Δbsh4), NZ5324 (Δbsh1, Δbsh2, Δbsh3), NZ5332 (Δbsh1, 
Δbsh2, Δbsh3, Δbsh4).  
  
The results clearly established that presence of bsh1 in L. plantarum 
enhances GDC bile salt tolerance. Each of the bsh1-deficient derivatives 
displayed GDC-growth inhibition at a concentration as low as 0.1% (w/v) GDC. 
In contrast, strains containing an intact bsh1-gene were capable to sustain 
normal growth characteristics up to 0.5 to 0.7% (w/v) GDC. Analogous with the 
limited level of hydrolytic activity towards bile salts, bsh2, bsh3, and bsh4 did 
not appear to contribute significantly to tolerance of GDC.  
Furthermore, growth of L. plantarum was inhibited at the lowest concentration 
of penicillin V tested (0.3 µg/ml), with complete inhibition of growth in 
presence of 8 µg/ml penicillin V. However, no difference was found between 
WCFS1 and its bsh-mutant derivatives, indicating that none of the bsh genes 
appeared to influence penicillin V tolerance in L. plantarum under the 
conditions analyzed here. 
Divergence of Bsh in L. plantarum. In order to further explore the 
functionality of the bsh-genes of L. plantarum the presence of homologues of 
the four bsh genes of L. plantarum WCFS1 in other L. plantarum strains was 
determined by analysis of L. plantarum genomic DNA samples on L. plantarum 
WCFS1-specific micro-arrays, as described earlier (37), using a positive cut-off 
P-value of 1.e-5 for bsh gene presence calls. These presence and absence calls 
were correlated with the experimentally determined capability of these strains to 
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hydrolyse bile salts, using a previously described Bsh plate-assay (11). 
Remarkably, in all L. plantarum strains, bsh2, bsh3, and bsh4 generated very 
good probability scores for gene presence, suggesting that these genes are highly 
conserved among L. plantarum strains. In contrast, the presence of a gene 
homologous to bsh1 appeared to vary among the strains analyzed. The bsh1 
appeared to be absent in four of the thirteen strains analyzed, which appeared to 
correlate relatively well with the absence of Bsh activity in these four strains. 
The remaining nine strains appeared to contain a bsh1-homologue as concluded 
from CGH analysis. Seven of these nine strains also displayed clearly detectable 
Bsh activity in the plate assay employed, while the residual two strains were not 
displaying this activity in this assay (Figure 9). Therefore, it is likely that Bsh 
activity is related to the presence of a bsh1-homologue in the species L. 
plantarum.  
 
 
 
Figure 9. Diversity analysis of bsh genes in L. plantarum strains. Micro-array-based analysis 
of presence of bsh1 to bsh4 homologues in L. plantarum strains was correlated to the 
capability to hydrolyse the bile salt taurodeoxycholic acid. As a cut-off value for presence or 
absence calling of the bsh genes, a P-value of 1.e-5 was used. +, presence of Bsh activity; -, 
absence of Bsh activity. 
 
DISCUSSION 
  
Bile salt hydrolysis is a biologically important reaction in the intestinal 
tract, since it is the first step in bile salt biotransformations carried out by 
intestinal bacteria. The formation of secondary bile salts has a significant impact 
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on the physiology of the host, as exemplified by their implication in lowering of 
blood cholesterol levels (41), and various intestinal diseases such as the 
formation of gallstones and colon cancer (44). Furthermore, deconjugated bile 
salts were shown to induce mucin production by intestinal epithelial cells (29), 
possibly indicating irritation of the epithelial cells by the strong surface active 
properties of deconjugated bile salts. 
Remarkably, in several strains (e.g. L. johnsonii 100-100 and NCC533, L. 
acidophilus NCFM, and L. plantarum WCFS1), the presence of more than one 
gene encoding a Bsh homologue has been predicted. In L. plantarum WCFS1, 
the sequences of the bsh genes share a higher level of similarity with bsh genes 
from other strains or species than with each other. For example, bsh1 shares 
highest sequence similarity with the bsh genes of other L. plantarum strains and 
Enterococcus faecalis, whereas bsh2 and bsh4 share sequence similarity with 
the sequence annotated as bsh of L. brevis, and share no significant sequence 
similarity with any other organism of which the sequence is publicly available; 
in analogy, bsh3 shares significant sequence similarity only with the sequence 
annotated as bsh of L. sakei and L. brevis. The bsh genes of L. plantarum 
WCFS1 may have been acquired via horizontal gene transfer, as has been 
suggested earlier for L. johnsonii (17). However, the overall conservation among 
L. plantarum strains of the bsh2 to bsh4 genes would indicate that this 
acquisition has occurred very early in the evolution of this species. Moreover, 
this high level of conservation also supports an important role of these genes in 
the physiology and life-style of the species Lactobacillus plantarum.  
In line with the previous finding that bsh1 is the major Bsh in L. 
plantarum WCFS1 (32), bsh1 presence appeared to correlate with the capability 
to hydrolyse bile salts in eleven out of thirteen L. plantarum strains. For two 
strains, a Bsh1-homolog was concluded to be present, while the capability to 
hydrolyse taurodeoxycholic acid was not detected in these strains. This apparent 
inconsistency could have various reasons: 1. the presence of disruptive 
mutations in the bsh1-like gene detected by CGH analysis, 2. the gene detected 
encodes an intact Bsh enzyme but is not expressed under the conditions applied 
in the enzyme assay, 3. the enzyme encoded by the bsh1-homologue displays a 
more stringent substrate preference as compared to the Bsh1 of strain WCFS1 
and fails to convert TDCA.  
In L. plantarum WCFS1, the presence of bsh1 correlated with GDC 
tolerance, but not with TDC tolerance. The capacity to hydrolyse bile salts has 
been found to be linked to bile tolerance in L. plantarum (13)} and several other 
bacteria, including L. amylovorus (23), Listeria monocytogenes (4)}, and 
Bifidobacterium (39). Thus, the preference of L. plantarum WCFS1 for 
deconjugation of glycine- over taurine-conjugated bile salts appears to be 
reflected in the differential tolerance towards GDC and TDC. This could be 
related to the higher toxicity of glycine-conjugated bile salts as compared to 
taurine-conjugated bile salts, leading to evolution of a preference of Bsh for 
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glycine-conjugated bile salts. Indeed, most Bshs show a preference for glycine-
conjugated bile salts (3). Although the precise mechanism is unknown, bile salt 
hydrolysis could be of great importance for survival in vivo. Since deconjugated 
bile acids display reduced solubility as compared to their conjugated 
counterparts, especially at lower pH values, bile salt hydrolysis may lead to 
precipitation of the bile salts and thereby relieve stress levels caused by these 
surface active chemicals. Thereby, the capability to hydrolyse bile salts may 
contribute to the survival and persistence of bacterial strains in the intestinal 
tract, as has previously been shown in Listeria monocytogenes (16). 
Analogously, Bsh activity appears to be present in all lactobacilli isolated from 
the gastrointestinal environment (47). Notably, L. plantarum WCFS1 is capable 
of persisting in the mouse gastro-intestinal tract for 10 days (40) and has been 
shown to display relatively high survival and activity during transit of the human 
gastrointestinal tract (52). 
All four of the bsh genes of L. plantarum WCFS1 appeared to be 
expressed during the exponential phase of growth as monocistronic transcripts 
(Figure 4). The expression of the bsh-genes did not appear to be induced as a 
consequence of exposure to porcine bile during growth in liquid media. In 
contrast, previous whole genome transcriptome studies have suggested that 
expression of bsh1 was induced by porcine bile when cells are grown on solid 
media, while the expression of bsh3 appeared to be repressed under these 
conditions (Bron et al. 2006). In the same study, no regulation of bsh2 or bsh4 
by porcine bile was detected. Notably, these findings are in apparent agreement 
with the finding that bsh1, and to a lesser extent bsh3, are capable of bile salt 
hydrolysis. Nevertheless, the discrepancy in regulation of bsh expression may be 
due to the difference in growth conditions used (liquid vs. solid medium). To 
explain these different findings would require further investigation of regulation 
of expression of bsh as a function of culture conditions.  
Heterologous over-expression of the bsh genes using the NICE-system in 
the Bsh-deficient host L. lactis NZ9000 confirmed that Bsh1 encodes a 
functional and bonafide Bsh, as was described earlier (32). In addition, Bsh3 and 
Bsh4 displayed bile salt hydrolysis activity, although with lower enzymatic 
efficiency as compared with Bsh1, which suggests that these enzymes could 
contribute to the overall Bsh activity displayed by L. plantarum WCFS1. 
Analogous to what has been described for most of the Bsh enzymes studied to 
date (26, 36, 48, 49), the Bsh1, Bsh3, and Bsh4 enzymes displayed a clear 
preference for glyco-conjugated over tauro-conjugated bile salts. Furthermore, 
the substrate preference of bsh1, bsh3, and bsh4 decreased from deoxycholic to 
chenodeoxycholic and cholic acid as the steroid moiety of the conjugated bile 
salts (Figure 1 and Figure 5B), which has previously also been found for the Bsh 
activity of L. buchneri (38). This substrate preference is probably related to the 
positioning and presence or absence of hydroxyl-groups on the steroid moiety of 
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the bile salts (Figure 1), and concomitantly, the binding pocket properties of the 
enzyme.  
Mutation analysis in L. plantarum WCFS1 confirmed that Bsh1 encodes 
the major Bsh. However, no contribution of Bsh2, Bsh3, or Bsh4 to the overall 
Bsh activity of L. plantarum WCFS1 could be detected, using either purified 
bile salt components or complex rat-bile salts as the substrate. This finding was 
in good agreement with the observation that the reduced bile salt hydrolysis 
activity found in bsh1 single mutant derivative equals the level observed in a 
quadruple bsh-mutant derivative, which suggests that bsh2, bsh3, and bsh4 do 
not contribute significantly to this enzyme activity in L. plantarum. 
Nevertheless, differential activity under specific conditions or highly selective 
activity towards specific bile salts substrates cannot be excluded for Bsh2, Bsh3, 
and/or Bsh4.  
The CBAH family-members encoded by L. plantarum WCFS1 share 
significant sequence homology with penicillin V acylases, including the 
experimentally verified penicillin V acylase of Listeria monocytogenes EGDe 
(4). The sequence identity among these enzyme family members ranges from 30 
to 36 % at the amino acid level. Furthermore, β-lactam acylases are homologous 
to enzymes designated acyl-homoserine lactone acylase, which hydrolyse a 
similar chemical bond as hydrolysed by β-lactam and Bshs, although present in 
a different class of molecules called acyl-homoserine lactones (Figure 7A) that 
play a key-role in quorum sensing-dependent gene regulation in Gram-negative 
bacteria (7). Screening for involvement of the bsh genes of L. plantarum 
WCSF1 in the conversion of penicillins, acyl-homoserine lactones, NIPAB, 
ampicillin, cephalosporin C, and phenylacetylglycine showed that Bsh3, and to a 
lesser extent Bsh2 and Bsh4, were able to hydrolyse penicillin V. In addition, 
low-level acylase activity by Bsh2, Bsh3, and Bsh4 towards penicillin G, and 
both types of acyl-homoserine lactones tested was found, indicating broad 
substrate specificity of these enzymes. Acyl-homoserine lactones could have an 
important function in adhesion of bacteria to the epithelium of the intestinal 
tract. For example, the pathogen Pseudomonas  aeruginosa was found to up-
regulate PA-1 lectin/adhesin, an important virulence factor in this strain, in 
response to butanoyl-homoserine lactone in the environment (55). Therefore, 
bacteria that are capable of cleaving acyl-homoserine lactone could be of 
importance in preventing the adhesion of pathogens in the intestinal tract. 
Nevertheless, the low activity levels observed indicate that these substrates are 
not likely to represent the preferred substrate for bsh2, bsh3, or bsh4. Contrary 
to Bsh2, Bsh3, and Bsh4, Bsh1 displayed no detectable activity towards the 
alternative substrates tested, suggesting that Bsh1 displays a more narrow 
substrate specificity as compared to Bsh2, Bsh3, or Bsh4. Despite these results, 
no contribution of any of the bsh genes to penicillin V tolerance in L. plantarum 
could be detected in the bsh-deletion derivatives. 
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To date, the in vivo role of penicillin acylase remains unknown. Notably, 
the enzyme name appears to reflect primarily its industrial application rather 
than its natural substrate. Therefore, Bsh2, Bsh3 and Bsh4 may play a role in 
acylation of compounds other than the substrates tested here, such as additional 
phenylacetic acid derivates, as suggested by the capability of penicillin acylases 
to cleave these substrates in addition to penicillins (50). Notably, phenylacetic 
acid derivatives would be available to L. plantarum in vivo, since they are 
formed by microbial activity on plant constituents, where L. plantarum was 
found to occur naturally (19). However, these substrates are not commercially 
available. 
In conclusion, Bsh1 was found to be responsible for the majority of Bsh 
activity in L. plantarum WCFS1, and possibly in all L. plantarum strains. 
Computational analyses predicted three other Bsh-encoding genes to be present 
in L. plantarum WCFS1, while experimental evidence showed that the 
functionality of these genes is unclear, but possibly relates to acylase activity 
with penicillin-like chemicals as substrate. Notably, the conservation of bsh2, 
bsh3, and bsh4 suggests an important but so far unknown role of these genes in 
the physiology and life-style of the species L. plantarum.  
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5. In vitro analysis of Bsh enzyme protection against enteric 
conditions by whey protein-gum arabic microencapsulation 
 
The interest in efficient intestinal delivery of health-promoting substances 
is increasing. However, the delivery of vulnerable substances such as enzymes 
requires specific attention. The transit through the stomach, where the pH is very 
low, can be detrimental to the enzymatic activity of the protein to be delivered. 
Here we describe the microencapsulation of the model enzyme bile salt 
hydrolase (Bsh) using whey protein-gum arabic microencapsulates for food-
grade and targeted enzyme delivery in the proximal region of the small intestine. 
Furthermore, the efficacy of enteric coating-microencapsulates for site-specific 
enzyme delivery was compared in vitro with living Lactobacillus plantarum 
WCFS1 bacteria that endogenously produce the Bsh enzyme. Microencapsulates 
allowed highly effective protection of the enzyme under gastric conditions. 
Moreover, Bsh release under intestinal conditions appeared to be very efficient, 
although in the presence of pancreatin, the Bsh activity decreased in time due to 
proteolytic degradation. In comparison, L. plantarum appeared to be capable to 
withstand gastric conditions as well as pancreatin challenge. Delivery using 
encapsulates and live bacteria each have different (dis)advantages that are 
discussed. In conclusion, live bacteria and food-grade microencapsulates 
provide alternatives for dedicated enteric delivery of specific enzymes and the 
choice of enzyme to be delivered may determine which mode of delivery is most 
suitable. 
 
INTRODUCTION 
 
Microencapsulation technology can be used to protect substances from the 
environment by entrapment into another material. This technology has been 
used in the food and pharmaceutical industry for controlled release, 
enhancement of stability, and taste masking in applications such as drugs, 
vitamins and minerals (for review, see (7) and (8)). Nowadays, the food industry 
is increasingly focusing on the incorporation of components that provide a 
health benefit to the customer in food products. The most common and non-
invasive mode of administration of health-promoting substances is via the oral 
route. Therefore, the availability of systems for delivery of specific components 
into the intestinal tract is of importance. The intestinal delivery of enzymes 
deserves special attention, since only the slightest change in conformation of a 
protein can be detrimental to its enzymatic properties. However, the intestinal 
delivery of proteins or enzymes is severely hampered by denaturation and 
degradation of the protein in the highly acidic environment in the stomach.  
Whey protein-gum arabic microencapsulation of Bsh 
Several methods have been proposed to protect therapeutic proteins during 
passage of the stomach, such as delivery using viable bacteria (10), and alginate-
chitosan encapsulation (3, 20). However, not all encapsulation techniques can be 
used, as some require the use of high temperatures or organic solvents during the 
manufacturing process that in many cases prove to be detrimental to the enzyme. 
A promising system for enzyme encapsulation for intestinal delivery is the use 
of whey protein-gum arabic encapsulates using activated whey proteins (24), 
(6). Prior to the encapsulation procedure, activation of the whey proteins with a 
heat treatment leads to natural cross-linking via disulfide bridges. At the low pH 
conditions encountered during gastric transit, the activated whey proteins layer 
remains insoluble. Furthermore, the whey protein and gum arabic layers form an 
electrostatic complex below the iso-electric point of the protein (i.e. 5.2 for 
native whey proteins), leading to a tight network protecting the encapsulated 
enzyme at low pH. Subsequently, at the neutral pH of the duodenum, the 
coacervate network dissolves and the water-insoluble network of activated whey 
proteins slowly releases the encapsulated enzyme, with the release profile 
depending on the extent of cross-linking of the whey protein layer and on the 
presence of proteases in the environment. Furthermore, activated whey protein-
gum arabic encapsulates are label-friendly and food-grade, and are not 
associated with health and religion-derived dietary issues, which can not be 
claimed for the more commonly used gelatin-gum arabic coacervates (for 
examples, see (4, 9, 11, 17)). 
The delivery of enzymes protected by whey protein-gum arabic 
microencapsulates in the proximal small intestine was studied in vitro, using the 
model enzyme bile salt hydrolase (Bsh). Bsh is produced by the commensal 
bacterial inhabitants of the intestinal tract (2), and deconjugates the amino acid 
moiety of the bile salts that are produced in the liver and secreted into the 
proximal small intestine in vertebrates. Thereby, Bsh is an attractive model 
enzyme to study delivery in the proximal small intestinal tract, since its effective 
and active delivery would immediately affect the conjugation state of bile acids 
in this region of the small intestine. Moreover, the delivery efficacy of Bsh by 
these microencapsulates was compared with delivery by the living model 
bacterium L. plantarum WCFS1 (14), which is a natural Bsh-producing strain 
(16). 
 
MATERIALS AND METHODS 
  
Chemicals and enzymes. Bsh enzyme of Clostridium perfringens (see (1) 
and (13) for enzymatic properties), pepsin (43 U/mg solid), pancreatin (8x USP) 
were purchased from Sigma, St. Louis, USA. Whey protein isolate (Bipro) was 
purchased from Davisco, Eden Prairie, USA and gum arabic (IRX 40693) from 
Colloïdes Naturels International (Rouen, France). 
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Preparation of Bsh-whey protein-gum arabic encapsulates. Stomach-
resistant Bsh-encapsulates were prepared using a fluidized bed coater (FB-1, 
Glatt, Binzen, Germany) consisting of a core of inert 350 to 500 µm 
microcrystalline cellulose spheres (Cellets® 350, Syntapharm, Mülheim an der 
Ruhr, Germany) on which Bsh, whey protein and gum arabic were sprayed 
(Figure 1A). First, 60 g of a mixture of 7500 U (56 mg) powdered Bsh and 8% 
(w/v) heat denatured whey protein (pre-heated at 90°C at pH7 for 30 minutes) 
was coated onto 300 g of Cellets® at a product temperature of maximally 42°C. 
Subsequently, a coating of 30 g of 20% (w/v) gum arabic (pH 7) (Colloïdes 
Naturels International, Rouen, France) was added at a product temperature of 
maximally 42°C, resulting in the end-product (Figure 1B). 
 
 
 
Figure 1. (A) Schematical representation of the Bsh-whey protein-gum arabic encapsulate. 
(B) Stereoscopic image of the Bsh-whey protein-gum arabic encapsulate (40x magnification). 
 
Simulated gastro-intestinal conditions. Gastric conditions were 
simulated by the incubation of 0.5 g of microencapsulate, 1 U of free Bsh 
enzyme, or the Bsh-producing strain L. plantarum WCFS1 (14) (for preparation, 
see below) in 1 ml simulated gastric fluid (SGF) pH 4.5 (5 mM acetate buffer 
pH 4.5, ionic strength 70 mM) or SGF pH 2 (5mM phosphate buffer pH 2, ionic 
strength 70 mM) with or without 0.07 g/l pepsin (adapted from (15) and K. 
Venema, personal communication) for 15 minutes at 37°C. Subsequently, the 
samples were transferred to intestinal conditions by the addition of 1 ml of pre-
warmed simulated intestinal fluid (SIF; 50 mM phosphate buffer pH 7, ionic 
strength 111 mM (25)) with or without 1.25 g/l pancreatin at 37°C. When no 
gastric incubation was performed, intestinal conditions were simulated by 
incubation in a mixture of 1 ml of SGF pH 4.5 and 1 ml of SIF (which is a 
stronger buffer than SGF) with or without 1.25 g/l pancreatin at 37°C.  
 L. plantarum preparations. For L. plantarum WCFS1 Bsh activity 
assays, an overnight culture grown in MRS broth (Difco, West Molesey, United 
Kingdom) at 37°C without aeration was inoculated 1:20 in fresh MRS broth and 
grown to an OD600 of 3. Cells were harvested by centrifugation for 10 minutes at 
4500 rpm at room temperature (Megafuge 1.0R, Heraeus, Hanau, Germany) and 
resuspended in the appropriate SGF-buffer at a final OD600 of 50. Of this 
preparation, 1 ml was used for further assays. When no gastric incubation was 
performed, a mixture of equal amounts of SGF pH 4.5 and SIF was used for 
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resuspension of L. plantarum cells, and 2 ml of this preparation was used for 
further assays. 
 Bsh activity assays. To determine the BSH activity level of Bsh-
microencapsulates, 20 µl of 0.1 M of the bile salt glycocholic acid (GC) was 
added immediately after transfer to intestinal conditions. At regular time 
intervals, 40 µl of sample was transferred to 120 µl 70% (v/v) acetonitrile to 
stop the Bsh reaction and to precipitate proteins. HPLC analysis of GC 
deconjugation was carried out as described below. 
Influence of pancreatin on Bsh activity. The influence of pancreatin on 
the Bsh activity of microencapsulates, free enzyme and L. plantarum WCFS1 
was started either immediately or after regular time points after transfer to 
simulated intestinal conditions by addition of 20 µl of 0.1 M GC. After 30 
minutes of incubation with GC at 37°C, 40 µl of sample was transferred to 120 
µl 70% (v/v) acetonitrile to stop the Bsh reaction and to precipitate proteins. 
HPLC analysis of GC deconjugation was carried out as described below. 
Release properties of Bsh-encapsulate. The release of Bsh from the Bsh 
microencapsulates was studied by comparison of the input of enzymatic units of 
Bsh activity at encapsulate assay conditions and the output of activity during 
simulated intestinal conditions. For this, 0.5 g of Bsh encapsulate and 1U of free 
Bsh enzyme (which was used as a reference), respectively, were incubated in 2 
ml of pre-warmed SIF for 90 minutes at 37°C. Subsequently, 20 µl of 0.1 M GC 
was added. At several time points during incubation, 40 µl of sample was 
transferred to 120 µl 70% (v/v) acetonitrile to stop the Bsh activity and to 
precipitate proteins. HPLC analysis of GC deconjugation was carried out as 
described below. 
 HPLC analysis of GC deconjugation. Prior to HPLC analysis, samples 
obtained during GC deconjugation assays were cleared of proteins and 
encapsulates by repeated centrifugation at 13200 rpm for 5 minutes at room 
temperature (Eppendorf AG, Hamburg, Germany). Subsequently, the 
supernatant was diluted 3.5-fold in double distilled water. GC deconjugation 
was determined by HPLC as described previously (5). Separations were carried 
out with a reversed-phase resin-based column (PLRP-S, 5 µm, 300 Å, 250 x 4.6 
mm I. D., Polymer laboratories, Shropshire, UK) and matching pre-column, 
using an acetonitrile gradient. Bile salts were detected using a pulsed 
amperometric detector (EG&G Princeton applied research, Princeton, NJ), 
equipped with a gold working electrode and a reference electrode (Ag/AgCl). 
Chromatograms were analyzed and integrated using the Chromeleon program 
(Dionex, Sunnyvale, USA) and the Bsh activity level was calculated on basis of 
the disappearance of GC. 
 Microencapsulate imaging techniques. For stereoscopic imaging, Bsh 
microencapsulates were magnified 40 times using a Leica MZ16 stereoscope; 
images were captured using Leica IM imaging software (Leica, Rijswijk, the 
Netherlands). For microscopic imaging, microencapsulates were treated with 
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SGF with or without pepsin or left untreated. Subsequently, at regular time 
intervals after transfer to intestinal conditions, some microencapsulates were 
placed onto a glass slide, immersed in a small amount of SIF, and magnified 
312,5 times using a Leica Dialux 20 microscope; images were captured using a 
COHU High Performance CCD camera and Leica QFluoro imaging software 
(Leica, Rijswijk, the Netherlands). 
 
RESULTS AND DISCUSSION 
 
Bsh-microencapsulation. The Bsh enzyme was chosen as a model 
enzyme to study the enteric delivery properties of whey protein-gum arabic 
microencapsulates, using in vitro conditions mimicking physicochemical 
conditions encountered during gastric transit and upon proximal small intestinal 
entry. This food-grade delivery concept aims to protect the enzyme during 
gastric conditions, while allowing dedicated release into the lumen of the 
proximal small intestine. Bsh-microencapsulates were manufactured using the 
fluidized bed coating technique, applying a coat of a mixture of Bsh enzyme and 
heat denatured whey protein onto microcrystalline cellulose cellets. The heat-
treatment caused the whey proteins to form a coating linked by disulfide bonds, 
lowering the total porosity of the whey protein layer and providing lowered 
solubility of the coating in water (6), (21). Subsequently, a coat of gum arabic 
was added (Figure 1), enabling the reversible formation of a protein-gum arabic 
coacervate (24) at low pH.  
 Microencapsulate protection against gastric conditions. The influence 
of various gastro-intestinal treatments on the physical appearance of the Bsh 
microencapsulates was monitored by microscopical analysis (Figure 2A). The 
physical appearance of the microencapsulates did not appear to be altered under 
gastric conditions (SGF) either in the presence or absence of gastric pepsin 
(Figure 2A). Gastric conditions were applied by incubation of the Bsh-
encapsulates in SGF at pH 2 or pH 4.5, respectively, representing either the 
fasting or the fed state in humans (12, 15). In agreement with the physical 
appearance of the microencapsulates, the bile salt hydrolase activity of the 
microencapsulates under simulated intestinal conditions in absence of pancreatin 
appeared to be independent of the type of gastric incubation condition used (i.e., 
incubation at pH 2 or pH 4.5 and in presence or absence of pepsin, or no gastric 
incubation), with Bsh activity ranging from 10 to 12 nmol/min (Figure 3). These 
findings indicate a strong protective effect of the whey protein-gum arabic 
coacervate against stomach conditions.  
 
Whey protein-gum arabic microencapsulation of Bsh 
 
 
Figure 2. Microscopic images (312.5 x magnification) of the Bsh-whey protein-gum arabic 
coat of the Bsh-encapsulates. When appropriate, Bsh-encapsulates were pre-treated in SGF 
with or without pepsin, and images were made at the start of the SIF-incubation (T=0) and 
after 40 minutes of SIF incubation (T=40). The Bsh-whey protein-gum arabic coating on the 
cellets was visible as a transparent layer. Shown is the intestinal incubation of the 
microencapsulates in the absence (panel A) and presence (panel B) of pancreatin. Independent 
of the gastric pre-treatment condition, the encapsulate coat was dissolved only in the presence 
of pancreatin during the SIF-treatment. SGFpepsin, SGF containing pepsin; SIFpancreatin, 
SIF containing pancreatin; X, no pre-treatment. 
 
Intestinal Bsh activity from microencapsulates. In the absence of 
pancreatin during intestinal conditions, the amount of GC deconjugated 
increased linearly in time (Figure 3), indicating a constant rate of GC 
deconjugation. No lag-phase in bile salt hydrolase activity was observed; thus, it 
can be concluded that bile salt hydrolase activity from the microencapsulates 
was available immediately following transfer to intestinal conditions, as desired. 
Notably, these findings were not reflected macroscopically (Figure 2A). In the 
absence of pancreatin, the encapsulate coating was not dissolved during 
intestinal conditions. Upon entrance of the encapsulates into the intestine, the 
increase in pH led to the de-complexation of the gum arabic and whey protein 
layer complex. In addition, at the pH of the intestine, the activated whey protein 
provided a less tight network than at gastric pH, enabling the bile salt substrate 
to permeate into the microencapsulate layer, without total release of the 
relatively large Bsh enzyme from the microencapsulate being necessary. 
Apparently, intestinal delivery of Bsh activity from microencapsulates is highly 
efficient, regardless of physical release from the microencapsulate.  
Furthermore, Bsh-activity from the encapsulates under intestinal conditions in 
absence of pancreatin was approximately 10 % of the theoretical input. Since 
intestinal delivery of Bsh from the microencapsulates was highly efficient, the 
loss of activity was very likely due to processing conditions during the fluid bed 
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coating procedure. The relative instability of the Bsh enzyme in solution (data 
not shown) may be of importance here, and activity retainment could probably 
be improved by reduction of processing time. In addition, the process 
temperature could be decreased to limit activity loss by heat-damage, but as a 
consequence, preparation time would be increased. Alternatively, instead of the 
spraying of the Bsh enzyme onto cellets, where the Bsh enzyme remains in 
solution for a relatively long time, the Bsh enzyme could be incorparated into 
core particles prepared by an encapsulation method that involves reduction of 
the amount of water in the particles (such as extrusion). Subsequently, the 
encapsulate core containing the stabilized Bsh enzyme would be coated with a 
protective layer of activated whey protein and gum arabic. 
Furthermore, after one month of dry storage at 4 ºC, Bsh activity in the 
microencapsulates was fully retained (data not shown), illustrating the excellent 
shelf life properties of these encapsulates. 
 
Figure 3. (A). GC deconjugation by 0.5 g Bsh-encapsulate in time following treatment in SGF 
with or without pepsin at pH 2.  treatment with SGF, activity in SIF;  treatment with SGF 
with pepsin, activity in SIF; ▲treatment with SGF, activity in SIF with pancreatin. (B). GC 
deconjugation by 0.5 g Bsh-encapsulate in time following treatment in SGF with or without 
pepsin at pH 4.5.  treatment with SGF, activity in SIF;  treatment with SGF with pepsin, 
activity in SIF; ▲treatment with SGF, activity in SIF with pancreatin. (C). GC deconjugation 
by 0.5 g Bsh-encapsulate in time without prior treatment in SGF.  activity in SIF;  activity 
in SIF with pancreatin. 
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Influence of pancreatin on intestinal Bsh activity. The presence of 
pancreatin during intestinal incubation had a major effect on the physical 
appearance of the Bsh encapsulates, as determined by microscopical analysis 
(Figure 2A and 2B). The digestive action of pancreatin totally dissolved the 
Bsh-whey protein-gum arabic layer of the microencapsulates, whereas in 
absence of pancreatin, this layer remained intact. Thus, pancreatin may enhance 
release of enzymes from the microencapsulate layer.  
In contrast, in the presence of pancreatin during intestinal conditions, the Bsh 
activity from microencapsulates was found to decrease parabolically (Figure 3). 
The pancreatin-dependent decrease of Bsh activity in time of the 
microencapsulates probably indicated that the Bsh enzyme was degraded by 
proteolytic enzymes present in pancreatin. Thus, pancreatin may have a dual 
action in delivery of enzymes in the small intestine. Pancreatin may enhance 
release of enzymes from the microencapsulate layer, but it will also degrade the 
released enzyme. This is in agreement with the US Pharmacopeia (22), where 
the use of pancreatin was found to be of importance for in vitro oral drug release 
assays.  
Notably, the Bsh activity from the microencapsulates in presence of pancreatin 
did not exceed the activity in absence of pancreatin (Figure 3). Thus, in our 
experiments, total release of the Bsh-whey protein-gum arabic layer as observed 
during microscopical analysis (Figure 2B) appeared non-beneficial for obtaining 
higher Bsh activity during intestinal conditions in the presence of pancreatin. 
This is in agreement with the finding that Bsh activity is available immediately 
after transfer to intestinal conditions in absence of pancreatin and thus excluding 
physical release of the microencapsulate layer, as described above.  
Furthermore, the formation of a coacervate layer during gastric incubation may 
provide protection against the proteolytic activity of pancreatin while still 
allowing for Bsh activity upon entrance into intestinal conditions. This 
suggestion is supported by the fact that a slightly larger decrease in bile salt 
deconjugation was found in response to the presence of pancreatin during 
intestinal conditions with no gastric pre-incubation as compared to gastric pre-
incubation at pH 2 or pH 4.5 (Figure 3) (0.28 µmol, 0.42 µmol, and 0.39 µmol 
GC hydrolysed in 60 minutes, respectively). The protective effect of the 
formation of a whey protein-gum arabic coacervate layer on Bsh activity against 
pancreatin pressure was also found in a pancreatin resistance assay, where Bsh 
activity was monitored after various pancreatin incubation times with gastric 
pre-incubation at pH 2 or pH 4.5 in the presence of pepsin (Figure 4A). Here, 
gastric pre-incubation at pH 2 appeared to confer a slight advantage over pre-
incubation at pH 4.5. However, more investigation is needed to establish this 
effect further and eventually unravel the underlying mechanism. 
Gastro-intestinal incubation of free Bsh (Figure 4B) clearly shows that only a 
small amount of Bsh activity was left after gastric incubation in the presence of 
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pepsin (at assay starting time 0), with a more severe reduction of activity at 
gastric incubation at pH 2 compared to pH 4.5.  
 
 
 
Figure 4. GC deconjugation in response to pancreatin pressure during simulated intestinal 
conditions. Following treatment with SGF containing pepsin for 15 minutes, the GC 
deconjugation levels of (A) Bsh-encapsulate, (B) free Bsh enzyme, and (C) L. plantarum 
WCFS1, respectively, were determined in SIF containing pancreatin. To determine the effect 
of various pancreatin treatment times, the GC deconjugation assay was started at various time 
points after transfer to simulated SIF containing pancreatin. GC deconjugation levels are 
shown relative to the GC deconjugation in SIF without prior SGF-treatment, which was taken 
as a reference condition (that is, 20 nmol/g/min for encapsulate, 1 nmol/ml/min for L. 
plantarum culture at an OD600 of 3, and 40 nmol/g/min for free Bsh, respectively). White bars 
represent pre-treatment with SGF pH 2; black bars represent pre-treatment with SGF pH 4.5.  
 
Clearly, the enzyme is broken down further by pancreatin activity. As expected, 
the use of free enzyme is not recommended for delivery of Bsh activity in the 
proximal small intestine. 
However, an alternative to encapsulation of enzyme is the use of viable bacteria 
for delivery of enzymes in the small intestine (10). In order to evaluate this 
alternative, the bacterial strain L. plantarum WCFS1 that natively produces the 
Bsh-enzyme intracellularly (16) and that is capable of surviving the gastro-
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intestinal tract (23) was used as a model. Notably, the native amount of Bsh 
activity produced per ml of L. plantarum WCFS1 culture at an OD600 of 3 was 
20 times lower as compared to activity per gram of encapsulate. Importantly, L. 
plantarum WCFS1 appeared to be highly pancreatin-resistant in time (Figure 
4C). This characteristic may provide a particular advantage over encapsulate 
delivery. For L. plantarum, gastric incubation at pH 2 initially appeared to 
provide a minor negative effect on Bsh-activity as compared to pH 4.5, with 
gastric incubation decreasing Bsh-activity by approximately 50 %. However, 
after 60 minutes of incubation, L. plantarum appeared to have recuperated from 
gastric conditions, showing no difference in Bsh-activity for both gastric 
incubation treatments (Figure 4C).  Thus, although bacterial delivery may be 
limited quantitatively, it appears to be a more stable means of delivery under the 
conditions of the small intestine as compared to delivery using encapsulates. 
 
CONCLUSION 
 
Whey protein-gum arabic encapsulation is an excellent tool to protect 
enzymes during transit through gastric conditions and release enzyme activity in 
the proximal small intestine. However, following transfer to intestinal 
conditions, the enzyme is released by and exposed to the activity of pancreatin, 
and other proteolytic activities in vivo. Since L. plantarum WCFS1 is capable of 
surviving gastric conditions and is able to withstand pancreatin pressure, it may 
be a good alternative for intestinal delivery of enzymes.  
However, several issues need to be considered. For example, the ease of 
handling of encapsulates in terms of storage and shelf life may be preferred as 
compared to viable bacteria. Furthermore, the exact site of delivery using live 
bacteria is less well predictable compared to microencapsulates. In addition, the 
expression level of enzymes is limited by the contraints on protein production in 
live bacteria. In microencapsulates, the amount of enzyme that can be 
incorporated is virtually unlimited due to the usually high activity-to-weight 
ratio of enzymes. However, especially in industrial systems, the cost of purified 
enzymes to be used in microencapsulates may be an important issue; use of 
crude enzyme extracts could in many cases provide cost reduction. 
Furthermore, the use of genetically modified organisms (GMOs) for both 
production and delivery of enzymes in the intestinal tract could offer several 
advantages. The expression level of enzymes could be improved using over-
expression systems such as the food-grade NICE system (18), in combination 
with an appropriate food-grade selection marker (19), when desired. In addition, 
enzyme sequences could be optimized by strategies such as site-directed 
mutagenesis to improve stability during microencapsulation procedures, 
protease resistance, or activity level under intestinal conditions. GMO strategies 
may also be preferred for the delivery of human enzymes. Furthermore, the 
perception of oral intake of viable bacteria may be perceived differently as 
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compared to encapsulates for use in the food industry. However, application of 
GMO derived products in food, even when genetic modifications are performed 
using food-grade cloning strategies, are still subject to debate. Moreover, 
expression of some enzymes may only be achievable using genes obtained from 
non-food-grade hosts.   
Thus, the system to be used for intestinal delivery of enzymes largely depends of 
the enzyme to be delivered.  
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6. In vivo modulation of host response by intestinal delivery of bile 
salt hydrolase activity 
 
In the liver of mammals, bile salts are synthesised from cholesterol and 
conjugated to either taurine or glycine. Following release into the intestine, 
conjugated bile salts can be deconjugated by members of the endogenous 
microbiota that produce an enzyme called bile salt hydrolase. 
Bile salt deconjugation has been suggested to play an important role in the 
physiology of the intestine. Furthermore, a commonly used criterion for the 
selection of candidate probiotic strains is their capability to hydrolyse bile salts. 
However, the administration of large amounts of bile salt-hydrolysing bacteria 
could potentially result in a shift in intestinal bile salt composition that might be 
associated with an undesirable impact on intestinal physiology. To investigate 
the influence of small intestinal delivery of bile salt hydrolase on the host, the 
lactic acid bacterium Lactobacillus plantarum WCFS1 was used as a model for 
the administration of bile salt-hydrolysing probiotic strains. In addition, Bsh 
enzyme was delivered to the small intestine using protein-gum arabic 
encapsulates. The influence of delivery of Bsh enzyme to the small intestinal 
tract on the host was investigated by determination of the in vivo bile salt 
composition and mucin excretion levels. However, no effect of delivery of Bsh 
on the intestinal bile salt composition or mucin excretion was detected. These 
results indicate that the physiological relevance and magnitude of bile salt 
hydrolase activity of probiotics in the small intestine is limited. 
 
INTRODUCTION 
 
Primary bile salts are synthesised from cholesterol in the liver of 
mammals, where they are conjugated to either taurine or glycine. The type of 
amino acid conjugated to the steroid nucleus can be influenced by dietary 
components, such as pectin and cholesterol (13-15), and the availability of 
taurine or glycine in the diet (11). Since taurine is rare in plants but widely 
available in meat and seafood, the bile salts of herbivores are mostly conjugated 
to glycine, whereas the bile salts of carnivores are mostly conjugated to taurine 
(1). Analogously, in omnivores, bile salts are conjugated to both glycine and 
taurine. Furthermore, under normal physiological conditions, one or more 
hydroxyl groups can be added to the steroid nucleus of bile salts, rendering the 
molecule less hydrophobic (1). Thus, conjugated bile salts are amphiphatic 
molecules that, following secretion into the duodenum, play an important role in 
the adsorption and digestion of lipids and lipid-soluble vitamins. The majority of 
the bile salts recirculate to the liver by the portal blood by mostly active 
transport in the terminal ileum. 
Intestinal delivery of bile salt hydrolase activity 
In the intestine, conjugated bile salts can be deconjugated by members of the 
endogenous microbiota that produce an enzyme called bile salt hydrolase (Bsh; 
EC3.5.1.24; for review, see (3)), releasing the glycine or taurine moiety from the 
bile salt. Previously, especially lactobacilli were reported to be responsible for 
the majority of bile salt hydrolase activity in the small intestine (8, 29, 30); e.g., 
in lactobacillus-free mice, the Bsh activity in the ileal contents was found to be 
reduced by almost 90 % when compared to lactobacillus-reconstituted mice 
(29).  
Bile salt deconjugation plays an important role in the physiology of the intestine, 
since it is the first step in further bile salt transformations by intestinal bacteria, 
such as dehydroxylation reactions, leading to secondary bile salts that are 
associated with various intestinal diseases such as the formation of gallstones 
and colon cancer (19, 25). In addition, in vitro and ex vivo studies have 
suggested that bile salt deconjugation plays a role in stimulation of mucin 
production and excretion into the intestinal lumen (20), which could influence 
intestinal transit (26). Mucin consists of a network of glycoproteins that acts as a 
protective layer for the epithelial surfaces. Therefore, an increase in mucin 
production by epithelial cells may be considered as a host response to irritation 
caused by the formation of deconjugated bile salts by bacterial bile salt 
hydrolases.  
Bile salt hydrolases have been found in a wide variety of mainly Gram-
positive species that usually are inhabitants of the intestinal tract. The ability to 
hydrolyse bile salts has been suggested to be of importance to the survival and 
persistence of bacterial strains in the gastro-intestinal tract (for review, see (3)). 
Consequently, a commonly used criterion for the selection of candidate 
probiotic strains is their capability to hydrolyse bile salts. However, the 
administration of large amounts of bile salt-hydrolysing bacteria could 
potentially result in a shift in intestinal bile salt composition. This might be 
associated with an undesirable impact on intestinal physiology. Therefore, the 
influence of the delivery of bile salt hydrolase activity to the intestine on host 
response deserves attention.  
In order to deliver bile salt hydrolase activity in vivo, several delivery 
vehicles can be considered, such as viable bacteria (12) and/or various 
encapsulation methods (5, 10, 23, 33). Here we investigated the influence of the 
delivery of bile salt hydrolase activity to the small intestine of rats by either 
viable bacteria or encapsulates. To approximate the human situation as much as 
possible, the diet fed to the rats had a low calcium and high fat content, 
simulating the composition of a Western human diet (31). As a model for the 
administration of bile salt-hydrolysing probiotic strains, the lactic acid bacterium 
Lactobacillus plantarum WCFS1 (18) was used, which is a natural bile salt 
hydrolase producer (21). Notably, L. plantarum WCFS1 has been shown to 
survive in the gastro-intestinal tract for up to ten days (22, 32). For delivery of 
Bsh enzyme using microencapsulates, Bsh-containing whey protein-gum arabic 
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microencapsulates were used, of which the characteristics were previously found 
to be excellent for protection against stomach conditions and effective delivery 
in the small intestine (Chapter 5). The influence of delivery of Bsh enzyme to 
the small intestinal tract on the host was investigated by determination of the in 
vivo bile salt composition and mucin excretion levels. 
 
MATERIALS AND METHODS 
 
Animals and diets. The experimental protocols for two separate animal 
studies (i.e., L. plantarum and Bsh encapsulate intake, respectively) were 
approved by the animal welfare commission of Wageningen University, 
Wageningen, The Netherlands, and were conducted according to Dutch 
regulations and law. Two groups of n = 9 (for L. plantarum intake) or n = 11 
(for Bsh encapsulate intake) per group male Fischer F344 rats (Charles River, 
Maastricht, The Netherlands) were housed individually in grid cages with 
controlled temperature (22 to 24 ºC), a relative humidity of 50 to 60 %, and a 
light/dark cycle with lights on from 6:00 to 18:00h. All rats were fed a Western 
style humanized purified diet of 200 g/kg acid casein, 278 g/kg corn starch, 172 
g/kg glucose, 155 g/kg palm oil containing vitamin A, D, E, and K according to 
AIN 93 (24), 5 g/kg cholesterol, 40 g/kg corn oil, 10 g/kg vitamin mix and 35 
g/kg mineral mix according to AIN 93 (24), 50 g/kg citrus pectin, 50 g/kg 
cellulose, and 5.16 g/kg CaHPO4. The animals had free access to demineralised 
drinking water. Food intake was recorded daily and body weight was recorded 
every two days. 
Oral intake of L. plantarum WCFS1. After acclimatisation to the 
housing and dietary conditions for seven days, the two groups of rats were fed 
approximately 5 * 1010 colony forming units of either heat-killed or freshly 
cultured and viable L. plantarum WCFS1 (18) (previously adapted to be 
resistant to 50 µg/ml rifampicin) for eight days (day 1 to 8). For this purpose, an 
overnight culture of rifampicin-adapted L. plantarum WCFS1 grown in MRS 
broth (Difco, West Molesey, United Kingdom) supplemented with 50 µg/ml 
rifampicin at 37 °C without aeration was inoculated in fresh MRS broth and 
grown to an optical density at 600 nm (OD600) of 3. When appropriate, cells 
were killed by heating at 80 ºC for 13 minutes, and absence of growth was 
confirmed by plating of cells on MRS agar (Difco, West Molesey, United 
Kingdom). Lack of Bsh activity from the heat-killed cells was confirmed by 
HPLC analysis (see below). Heat-killed and viable cells were harvested by 
centrifugation for 10 minutes at 4000 rpm at room temperature (Megafuge 1.0R, 
Heraeus, Hanau, Germany), concentrated ten times in fresh MRS broth to an 
OD600 of 30, and mixed with 2 volumes of UHT-treated custard (Stabilac, 
Campina, The Netherlands).  
Rats were fed 3 g of the freshly prepared custard mixture per day. During the 
last 24 hours before dissection of the animals, faeces was collected from the 
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bottom of the grid cages of the animals and frozen at -20 °C for bile salt and 
mucin analyses (see below). Prior to dissection, fresh faecal samples were 
collected directly from the anus of the animals and analyzed for viable L. 
plantarum WCFS1 by plating of dilutions of the faeces in saline on MRS agar 
with and without 50 µg/ml rifampicin and incubation for two days at 37 °C. Five 
animals belonging to the group of animals fed heat-killed L. plantarum WCFS1 
rifR were excluded from analyses due to L. plantarum WCFS1 rifR found in 
fresh faeces, as determined by plate counting and RAPD analyses (data not 
shown).  
Furthermore, 3 animals of each group (fed viable or heat-killed L. plantarum 
WCFS1 rifR, respectively) were sedated using isoflurane and bile was collected 
for 30 minutes by canulation of the bile duct. Bile was stored at 4 °C. 
Subsequently, all animals were killed by carbon dioxide inhalation. The entire 
small intestine was removed and dissected into three parts equal in length. The 
contents of the small intestinal fragments were collected for bile salt and mucin 
analyses (see below) and kept at -80 °C. 
Oral intake of Bsh encapsulates. Stomach-resistant encapsulates 
designed for delivery into the small intestine were prepared as described earlier 
(Chapter 5) using the fluidized bed coating technique. Briefly, layers of whey 
protein with or without (for placebo) Bsh enzyme (Sigma, Zwijndrecht, the 
Netherlands) and gum arabic (pH 7) (Colloïdes Naturels International, Rouen, 
France) were sprayed onto a core of inert 350 to 500 µm microcrystalline 
cellulose spheres (Cellets® 350, Syntapharm, Mülheim an der Ruhr, Germany).  
After acclimatization to the housing and dietary conditions for thirteen days, the 
two groups of rats were fed 11 g of purified diet per day. Furthermore, rats were 
acclimatized to the feeding of 2.5 g of placebo encapsulate dispersed in 2.5 g of 
apple sauce for five days (day 1 to 5). Subsequently, rats were fed either 2.5 g of 
placebo or 2.5 g of Bsh encapsulate dispersed in 2.5 g of apple sauce for two 
days (day 6 and 7). On day 7, all animals were killed by carbon dioxide 
inhalation. The entire small intestine was removed and dissected into three parts 
equal in length. The contents of the small intestinal fragments were collected for 
bile salt and mucin analyses (see below) and kept at -80 °C.  
Mucin determination. Mucins were extracted from faeces and intestinal 
contents and quantified fluorimetrically, as described earlier (6). Briefly, faecal 
and intestinal extracts in phosphate buffered saline were filtrated (Ultrafree MC 
NMWL, cut off 30000 Da, Millipore, Bedford, USA) by centrifugation for 30 
minutes at 3000 g, followed by washing with 100 % methanol. After drying by 
air, the mucin retentate was solubilised in the original volume of phosphate 
buffered saline. Total mucin concentration was determined fluorimetrically 
using addition of 2-cyano-acetamide (7) to the mucin oligosaccharide chains 
liberated by alkaline β-elimination, with excitation at 336 nm and emission at 
383 nm. Recovery was determined by standard addition procedures. Standard 
solutions of N-acetylgalactosamine (Sigma, Zwijndrecht, The Netherlands) were 
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used to calculate the amount of oligosaccharide side chains liberated from total 
mucin. Therefore, the amount of mucin is expressed as oligosaccharide 
equivalents. 
HPLC determination of Bsh activity and bile salt composition. Bsh 
activity of L. plantarum WCFS1 rifR was determined essentially as described 
earlier for L. plantarum WCFS1 (21). Briefly, L. plantarum cells were 
concentrated to an OD600 of 50 in MRS. Subsequently, 1 mM of the bile salt 
glycocholic acid (GC; Sigma, Zwijndrecht, The Netherlands) was added or cells 
were mixed 9:1 with rat bile (v/v) or intestinal contents (w/v). Conversion of GC 
and the bile salt composition of faeces and intestinal contents was determined by 
HPLC as described previously (9). Prior to HPLC analysis, faecal and intestinal 
samples were cleared by dispersion in 70 % acetonitrile and repeated 
centrifugation at 13200 rpm for 5 minutes at room temperature (Eppendorf AG, 
Hamburg, Germany), followed by 3.5-fold dilution in water. Separations were 
carried out with a reversed-phase resin-based column (PLRP-S, 5 µm, 300 Å, 
250 x 4.6 mm I. D., Polymer laboratories, Shropshire, UK) and matching pre-
column, using an acetonitrile gradient. Bile salts were detected using a pulsed 
amperometric detector (EG&G Princeton applied research, Princeton, NJ), 
equipped with a gold working electrode and a reference electrode (Ag/AgCl). 
Chromatograms were analyzed and integrated using the Chromeleon program 
(Dionex, Sunnyvale, USA). 
 
RESULTS AND DISCUSSION 
 
In this work, the influence of bile salt hydrolase delivery in the small 
intestine of a rat model by L. plantarum WCFS1 and whey protein-gum arabic 
microencapsulates on bile salt composition and mucin excretion was 
determined. To approximate the human situation as much as possible, the diet 
fed to the rats had a low calcium and high fat content, simulating the 
composition of a Western human diet (31). Furthermore, rats naturally produce 
bile salts conjugated to glycine and taurine in a ratio ranging from 0.15 to 0.35 
(13-15), whereas this ratio is approximately 3 in humans (4, 9, 27). In addition, 
both L. plantarum WCFS1 and the encapsulated Bsh enzyme used here have a 
strong preference for glycine-conjugated over taurine-conjugated bile salts 
(Chapter 4 and Chapter 5), (2, 17). To mimic human conditions and to maximize 
the in vivo activity of the Bsh enzyme delivered in the intestine, cholesterol and 
pectin were added to the rat diet, shifting the synthesis of conjugated bile salts in 
the liver from predominantly taurine- to predominantly glycine-conjugated, 
resulting in a glycocholic/taurocholic acid ratio of 7±2 (Figure 1A, 
chromatogram A1), which is in agreement with earlier findings (13-15).   
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Figure 1. Schematic representation of exemplary HPLC chromatograms of rat bile, intestinal 
contents, and faeces. Panel A shows rat bile (A1), the contents of the distal part of the small 
intestine after in vivo administration of heat-killed (A2) or viable (A3) L. plantarum WCFS1, 
respectively, and faeces (A4) of control rats is shown. Panel B shows rat bile (B1), and the 
contents of the distal part of the small intestine after in vivo administration of placebo (B2) or 
Bsh (B3) encapsulates, respectively, and faeces (B4) of control rats is shown. Peak positions 
of bile salts used as a standard are shown. C, cholic acid; GC, glycocholic acid; TC, 
taurocholic acid; CDC, chenodeoxycholic acid; DC, deoxycholic acid; GCDC, 
glycochenodeoxycholic acid; GDC, glycodeoxycholic acid; TCDC, taurodeoxycholic acid; 
TDC, taurodeoxycholic acid. Total HPLC retention time was 40 minutes. 
 
 
In most animal models, the presence of a natural microbiota in the 
intestinal tract would be considered desirable. However, naturally residing 
lactobacilli have been reported to contribute greatly to the total bile salt 
hydrolase activity in the small intestine of mice (29, 30), possibly leading to 
undesirable background bile salt deconjugation levels. However, in our rat 
model, background bile salt deconjugation levels in the small intestine were very 
low, as apparent from comparative analysis of the bile salt composition of bile 
harvested directly from the bile duct and of the small intestinal contents of 
control rats (Figure 1, chromatogram A1 and A2; B1 and B2). Thereby, this 
model is highly suitable for the measurement of bile salt deconjugation in vivo 
in the presence of a conventional microbiota. Apparently, bile salt deconjugation 
by the natural microbiota occurred mostly in the colon, as exemplified by the 
high bile salt deconjugation levels found in faeces as compared with the small 
intestinal contents (Figure 2 and Figure 1, chromatogram A2 and A4; B2 and 
B4).  
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Figure 2. In vivo deconjugation of bile salts by L. plantarum WCFS1 (panel A), and Bsh 
encapsulates (panel B), respectively, represented by the ratio of the amount of deconjugated 
bile salt cholic acid (C) to the total cholic acid pool (cholic acid, and its conjugated forms 
glyco- and taurocholic acid [GC and TC]) present in the proximal, middle, and distal part of 
the small intestine (SI1, SI2, and SI3, respectively) and in faeces (F). Light grey bars 
represent the cholic acid deconjugation ratio in animals fed living L. plantarum WCFS1 or 
Bsh-encapsulate, respectively; dark grey bars represent the cholic acid deconjugation ratio in 
animals fed heat-killed L. plantarum WCFS1 or placebo encapsulate, respectively. Error bars 
represent the standard error of the mean (SEM) of n=9 or n=4 for viable and heat-killed L. 
plantarum, respectively, and n=11 for Bsh or placebo encapsulate. 
 
Most Bsh enzymes show a preference for glycine-conjugated bile salts 
(3), and this preference appeared to be reflected in the relative deconjugation of 
taurocholic and glycocholic acid by the microbiota present in the colon. For 
example, in the rats fed L. plantarum WCFS1, 70% of the conjugated cholic 
acid that was hydrolyzed in the colon consisted of glycocholic acid, and the 
remainder consisted of taurocholic acid. 
In animals that were administered 5 * 1010 of viable L. plantarum WCFS1 
rifR, this bacterium could be recovered from fresh faeces at an average of 1 * 
1010 cfu/g faeces. These findings illustrate the relatively high level of persistence 
and survival of L. plantarum WCFS1 in the intestinal tract, which has also been 
reported earlier (22, 32). Furthermore, L. plantarum WCFS1 is able to 
deconjugate bile salts in vitro even when the cells are in an energy-depleted state 
(Figure 3A), which might be a prerequisite for delivery of Bsh under the 
potentially nutrient-competitive environment in the intestinal tract. Although L. 
plantarum WCFS1 is capable of ex vivo deconjugation of bile salts present in rat 
bile and in rat intestinal contents (Figure 3B), the delivery of bile salt hydrolase 
to the small intestine using viable L. plantarum had only a minor effect on bile 
salt composition in situ, as exemplified by the amount of deconjugated cholic 
acid present in the total cholic acid pool (i.e., 3, 6, 1, and 16  % difference in the 
amount of deconjugated cholic acid present in the total cholic acid pool for SI1, 
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SI2, SI3, and faeces, respectively, with Student’s t-test p-values of 0.27, 0.16, 
0.78, and 0.11, respectively; Figure 2A and Figure 1A, chromatogram A2 and 
A3). Consequently, no effect on mucin excretion in the distal part of the small 
intestine by the delivery of Bsh by viable L. plantarum was found (Figure 4A).  
 
 
 
 
 
 
Figure 3. Schematic representation of exemplary HPLC chromatograms of a mixture of 
synthetic bile salts, rat bile, and intestinal contents. In panel A, a mixture of glycocholic acid 
(GC), glycochenodeoxycholic acid (GCDC), and glycodeoxycholic acid (GDC) before (A1) 
and after incubation with energized (A2) and de-energized (A3) L. plantarum WCFS1, 
respectively, is shown. Deconjugation of GC, GCDC, and GDC by these incubations can be 
readily detected by the appearance of cholic acid (C), chenodeoxycholic acid (CDC) and 
deoxycholic acid (DC) peaks, respectively. Panel B shows rat bile as it was isolated directly 
from the bile duct before (B1) and after (B2) ex vivo incubation with L. plantarum WCFS, 
and extracts from luminal contents of the distal small intestine before (B3) and after (B4) ex 
vivo incubation with L. plantarum WCFS1. Peak positions of bile salts used as a standard are 
shown. C, cholic acid; TC, taurocholic acid; CDC, chenodeoxycholic acid; DC, deoxycholic 
acid; TCDC, taurodeoxycholic acid; TDC, taurodeoxycholic acid. Total HPLC retention time 
was 40 minutes. 
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Figure 4. Mucin concentration in the contents of the proximal, middle and anterior part of the 
small intestine (SI1, SI2, and SI3, respectively) and in faeces (F), expressed in 
oligosaccharide equivalents released from the mucins during assaying. Panel A: Lp; mucin 
content in animals fed living (light-grey bars) or heat-killed (dark-grey bars) L. plantarum 
WCFS1. Panel B: Mucin content in pools of samples of animals fed Bsh (light-grey bars) or 
placebo (dark-grey bars) encapsulate. Error bars represent the SEM of n=9 or n=4 for viable 
and heat-killed L. plantarum, respectively, and n=11 for Bsh or placebo encapsulate. 
 
However, enzyme delivery using viable, wild type bacteria is limited due to 
constraints in the enzyme expression level that can be reached. Recent studies 
predicted the activity of L. plantarum WCFS1 to be 0.5 nmol ml-1 min-1 in an in 
vitro assay simulating gastro-intestinal conditions with glycocholic acid as a 
substrate under small intestinal conditions at an OD600 of 3 (Chapter 5). In the 
present study, 1 ml of a L. plantarum culture at an OD600 of 30 was fed to the 
rats, giving rise to a predicted activity of 5 nmol ml-1 min-1 in the small intestine. 
Following adherence of L. plantarum to a particular area of the small intestine, 
the bacterial cells would be in contact with intestinal contents for a limited time. 
In a crude estimation, 30 minutes of contact between the L. plantarum cells and 
intestinal contents passing through is assumed. Thus, in 30 minutes, 150 nmol of 
bile salts could be deconjugated by L. plantarum. When total bile salt production 
is estimated to be 4 µmol in 30 minutes (16), which is excreted in a constant 
flow in a rat model, the dose of Bsh activity delivered by L. plantarum wild type 
cells is predicted to be 30 times too low for total deconjugation of the bile salts 
present in intestinal contents, based on the amount of Bsh activity delivered by 
L. plantarum in our recent in vitro intestinal delivery model (Chapter 5). Since 
the amount of bacteria that can be handled and fed to rats is limited, the level of 
enzyme delivered by viable bacteria into the intestine can not easily be 
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increased. When focussed specifically on the delivery of enzymes into the small 
intestine, genetically modified organisms (GMOs) may yield much higher 
production levels of enzyme than wild type organisms. However, the use of 
GMO-derived products is still controversial. 
In contrast, the amount of enzyme that can be delivered using microencapsulates 
is much higher as compared to viable wild type bacteria. However, the delivery 
of Bsh from microencapsulates is significantly more sensitive to the proteolytic 
action of digestive enzymes encountered in the small intestine than viable L. 
plantarum, as shown earlier (Chapter 5). Previously, the Bsh activity of the 2.5 g 
of whey protein-gum arabic microencapsulates, as used in the present study, was 
shown to be 2 µmol h-1 in an in vitro model simulating gastro-intestinal 
conditions, with activity diminishing strongly after an hour due to the activity of 
pancreatin. Again, in a crude estimation, assuming a passage time of the 
encapsulates past the bile duct of 30 minutes, 4 µmol of bile salts would be 
dispersed into the encapsulate bolus. Assuming a total bile salt deconjugation of 
2 µmol by the Bsh encapsulates, the activity delivered should have a significant 
impact on the bile salt composition in the small intestine (~ 50 % deconjugation 
at the end of the small intestine). However, the protective properties of 
microencapsulates can be easily destroyed by mastication. This process possibly 
caused the effect of the delivery of Bsh using microencapsulates on bile salt 
composition to be minor (i.e., for SI1, SI2, and SI3, 0.5, 0.4, and 0.5 % 
difference in the amount of cholic acid present in the total cholic acid pool was 
found, respectively, with Student’s t-test p-values of 0.23, 0.14, and 0.22, 
respectively; Figure 2B and Figure 1B, chromatogram B2 and B3). No effect of 
the delivery of Bsh by microencapsulates on mucin excretion in faeces or the 
proximal, middle, or distal part of the small intestine was found (Figure 4B). 
Furthermore, increasing the incubation time of intestinal contents of rats fed Bsh 
encapsulates ex vivo following dissection of the animals did not increase the bile 
salt deconjugation level (Figure 5), indicating that the Bsh enzyme likely had 
been inactivated by digestive enzymes during passage of the intestinal tract and 
that the limited deconjugation effectuated by the Bsh encapsulates was not due 
to an insufficient incubation time in vivo.  
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Figure 5. Schematic representation of exemplary HPLC chromatograms of the contents of the 
proximal small intestine of a rat that was administered Bsh encapsulate before (1) and after 
(2) additional ex vivo incubation, showing that the limited in vivo deconjugation conveyed by 
the Bsh encapsulates was not due to insufficient in vivo incubation time. Peak positions of bile 
salts used as a standard are shown C, cholic acid; GC, glycocholic acid; TC, taurocholic acid; 
CDC, chenodeoxycholic acid; DC, deoxycholic acid; GCDC, glycochenodeoxycholic acid; 
GDC, glycodeoxycholic acid; TCDC, taurodeoxycholic acid; TDC, taurodeoxycholic acid. 
Total HPLC retention time was 40 minutes.                                                               
 
Deconjugated bile salts can be transformed into secondary bile salts such 
as deoxycholic acid by the natural microbiota present in the intestinal tract, 
possibly leading to misinterpretation of the bile salt composition, which was 
based on the pool of the primary bile salt cholic acid present in the in vivo 
samples. Importantly, especially secondary bile salts have been reported to have 
adverse effects on the host in for example the formation of gallstones and colon 
cancer (19, 25). To monitor the formation of secondary bile salts following 
delivery of bile salt hydrolase by L. plantarum or microencapsulates, the level of 
deoxycholic acid and its glycine- and taurine-conjugated counterparts 
(synthesized in the liver following enterohepatic circulation) in small intestinal 
contents was determined (Figure 6). However, no significant effect of the 
delivery of Bsh on the formation of secondary bile salts was found (i.e., for SI1, 
SI2, and SI3 of rats fed L. plantarum, the difference in the ratio of the total 
deoxycholic acid pool relative to the total cholic acid pool was 0.019, 0.033, and 
0.025, respectively, with Student’s t-test p-values of 0.81, 0.66, and 0.70, 
respectively). 
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Figure 6. Total deoxycholic acid pool (consisting of deoxycholic acid and its conjugates to 
glycine and taurine) relative to the total cholic acid pool in the contents of the proximal, 
middle and anterior small intestine (SI1, SI2, and SI3, respectively) in animals fed L. 
plantarum WCFS1 (panel A; living L. plantarum: light-grey bars; heat-killed L. plantarum: 
dark-grey bars) or encapsulate (panel B; Bsh-encapsulate: light-grey bars; placebo 
encapsulate: dark-grey bars). Error bars represent the SEM of n=9 or n=4 for viable and heat-
killed L. plantarum, respectively, and n=11 for Bsh or placebo encapsulate. 
 
CONCLUSION 
 
Here we describe the influence of delivery of Bsh using viable L. 
plantarum WCFS1 or whey protein/gum arabic microencapsulates into the small 
intestine on bile salt composition and mucin concentration in intestinal contents 
and faeces. Although an appropriate rat model for determination of small 
intestinal bile salt transformations was implemented, no effect of delivery of Bsh 
on the intestinal bile salt composition or luminal mucin concentration was 
detected. These results may indicate that the physiological relevance and 
magnitude of bile salt hydrolase activity of probiotics introduced in the small 
intestine is limited, alleviating concerns on the bile salt hydrolase activity 
produced by probiotic strains, especially lactobacilli. However, other strains 
commonly used as probiotics include bifidobacterial strains, which have 
previously been shown to generally express Bsh activity at a higher level as 
compared to lactobacilli (28), and therefore might have a more pronounced 
effect on bile metabolism in vivo. The rat model and methodology described 
here could be used to effectively investigate the possible effects of the 
administration of bifidobacteria on the host. 
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7. General discussion and concluding remarks 
 
Bacterial bile salt hydrolase activity appears to play an important role in 
both bacterial survival and persistence in the intestinal tract and in host intestinal 
physiology. In this thesis, various aspects of bile salt hydrolase activity were 
investigated in both bacteria and host model systems. Focussing on bacteria, the 
functionality of conjugated bile acid hydrolase (CBAH) superfamily members in 
Gram-positive bacteria was investigated, with an emphasis on the organism 
Lactobacillus plantarum WCFS1 used as a model for lactobacilli. Focussing on 
the host, the delivery of bile salt hydrolase into the small intestine was 
investigated both in vitro and in vivo. Below, the tools and most important 
results obtained during this PhD project are placed in a general context, with 
specific attention for their impact and future research directions. 
 
Improved annotation of CBAH superfamily members. An advanced 
bioinformatics approach was developed and applied for improved annotation of 
CBAH superfamily members in Gram-positive bacteria (Chapter 2). For this 
purpose, various in silico analysis methods were combined, including both 
phylogenetic clustering and 3D-modeling techniques, in addition to the more 
conventional method of sequence alignment. These resulted in the development 
of novel and discriminative hidden Markov models (HMMs) that can be used to 
distinguish between the homologous Bsh and Pva-family members, which 
appeared not feasible using the available and commonly used conserved motif 
databases. Following this advanced analysis, we propose re-annotation of eight 
Lactobacillus genes that belong to the CBAH superfamily from bsh into pva, 
including three of the four genes annotated as redundant bsh genes in L. 
plantarum (i.e., bsh2, bsh3, and bsh4). 
The hypothesis that Bsh activity is important for survival or persistence of 
bacteria in the host was reinforced here by the fact that all strains that were 
represented only in the Bsh-cluster are typical gut-related micro-organisms (i.e. 
Bifidobacteria, Enterococcus faecalis and faecium, and Lactobacillus 
acidophilus species), while strains represented only in the Pva-cluster were not. 
This is in agreement with earlier findings, where a strong correlation was found 
between the habitat of a specific bacterial species or strain and Bsh activity (31). 
Furthermore, all experimentally verified Bsh and Pva enzymes were clustered 
correctly in their corresponding gene family (i.e., the Bsh- or Pva-family), 
supporting the phylogenetic clustering method used here.  
Another important finding was the observation that the members of the 
Pva- and Bsh-clusters were not only found to be phylogenetically, but also 
structurally different (Chapter 2). Homology modelling and sequence 
alignment showed clear differences in the 3D-structure of the substrate binding 
pockets of Bsh- and Pva-enzymes. The benefits of the determination and 
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implementation of 3D protein structures – both those obtained experimentally 
and via homology modelling – in elucidating the biochemical function of 
proteins is clearly shown in this thesis. Recognition of the value of protein 
structure determination has led to the initiation of large scale activities aiming at 
the complete structural characterization of conserved biochemical pathways and 
processes (6), involving high-throughput protein production, crystallisation, 
homology modelling and functional annotation. 
Importantly, the methodology used here does not need to be limited to the 
CBAH superfamily. The rapid expansion of genome sequence data calls for 
improved annotation methods, since many biologically important gene families 
show functional or genetic redundancy or are simply notoriously difficult to 
annotate. Annotation based only on sequence similarity usually does not lead to 
a reliable prediction of functionality, but to the classification of the putative 
protein into a specific protein superfamily with common activities. For example, 
the annotation of transporters is often difficult because of the existence of large 
and complex transporter gene superfamilies, such as the ATP-binding cassette 
(ABC) (8), ATPase (20) and major facilitator (MFS) (26) superfamilies, and the 
presence of multiple transporter gene paralogs in many organisms. Phylogenetic 
profiling provided an insight into the differences in membrane transport in 
prokaryotes and eukaryotes (18). However, the incorporation of data on 
experimentally verified enzymes could provide additional and highly valuable 
information by enabling the annotation of an experimentally verified 
functionality to the clusters found. Indeed, the use of experimental data in 
phylogenetic profiling is crucial for interpretation and validation of the 
phylogenetic clusters. Furthermore, for some transporters, the crystal structure is 
known, providing opportunities for gathering additional information on their 
functionality. For example, several putative proteins in L. plantarum that have 
been annotated as manganese transporters are not highly homologous in 
sequence, but are predicted to be functionally redundant. Phylogenetic profiling 
was used to refine the annotation of these sequences (C. Francke, unpublished 
results). Other examples of protein superfamilies where the methodology 
described here could be implemented include the NADH oxidase family 
(PeroxiBase; (21)), and the thioredoxin superfamily (2). More specific examples 
include the four genes annotated as pyruvate oxidase (pox) in L. plantarum, 
where only two genes were found to encode true pyruvate oxidases (11, 12), and 
the four genes annotated as lactate dehydrogenase (ldh) in Lactococcus lactis; 
for these proteins, the crystal structure is also known (19, 24, 36). 
Exploring the functionality of redundant genes. Clearly, even when 
using improved in silico annotation methods as described in this thesis, there 
appear to be many functionally redundant proteins. However, from an 
evolutionary perspective, conserved genes should have a certain functionality. 
Thus, many putative proteins predicted to be redundant may merely have a 
function unknown to us. Furthermore, in silico predictions will always need to 
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be validated by experimental evidence. The unravelling of the functionality of 
each of the separate redundant genes in a single organism requires the 
generation of multiple deletion strains. For this purpose, a Cre-lox-based toolbox 
for the construction of multiple deletions and selectable-marker removal in 
Gram-positive organisms was designed and implemented in L. plantarum 
WCFS1 (Chapter 3). The generated Cre-lox-based mutagenesis system 
appeared to be highly effective in multiple gene replacements and deletions in a 
single genetic background, as exemplified by successive mutagenesis of the 
genetically closely linked loci melA and lacS2 in L. plantarum WCFS1, where 
essentially all of the clones that were analysed had undergone correct Cre-lox 
resolution.  
Previously, the four CBAH family members bsh1, bsh2, bsh3, and bsh4 of 
L. plantarum WCFS1 were predicted to be redundant genes. However, bsh2, 
bsh3, and bsh4 were proposed to be re-annotated to penicillin acylase-related 
genes according to our in silico analyses. Therefore, it was interesting to 
investigate their true functionality. For this purpose, heterologous 
overexpression strains and multiple bsh-deletion strains were constructed, the 
latter using the Cre-lox toolbox (Chapter 4). In agreement with our in silico 
prediction, bsh1 was shown to be the major bile salt hydrolase in L. plantarum, 
and was involved in glycodeoxycholic acid tolerance.  
In addition, bsh2, bsh3, and bsh4 appeared to be conserved among L. 
plantarum strains, suggesting a biologically important function that, however, 
remains unclear. It is tempting to speculate that their function is related to 
acylase activity with penicillin-like chemicals as substrate. Since the in vivo role 
of penicillin acylase is unknown, Bsh2, Bsh3 and Bsh4 may play a role in 
acylation of compounds other than the substrates tested in this work, such as 
additional phenylacetic acid amide derivates, as suggested by the capability of 
penicillin acylases to cleave these substrates in addition to penicillins (37). 
Phenylacetic acid derivatives would be available to L. plantarum in vivo, since 
they are formed on fermenting plants. Lactic acid bacteria are commonly found 
on a wide range of fermenting plant material, such as silage, cabbage (sauerkraut 
and Korean kirachi), and various pickles (10, 29). Plants synthesise a large 
amount of phenols and phenolic acids, known for their antimicrobial activity, 
such as cinnamic and caffeic acids (for review, see (7)). Thus, acylation activity 
on plant phenylacetic acid derivatives by bacterial CBAH superfamily proteins 
could well serve as a detoxification mechanism. In addition, many types of 
plants synthesize a large range of isoprenoids via the mevalonate pathway (for 
example, see Figure 1A; (30)), which in their backbone show a significant 
structural resemblance with bile salts (Figure 1B – D). Isoprenoids are 
synthesised from oxosqualene ((S)-squalene-2,3-epoxide; Figure 1A), which is 
converted into lanosterol, leading to the pathway involved in synthesis of 
cholesterol, and cycloartenol, which leads to the synthesis of phytosterols. 
Interestingly, some oxosqualene, lanosterol, and cycloartenol derivatives called 
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saponins are bactericidal (7, 39, 40). In plants, a wide array of saponins has been 
found that is still expanding (39). Thus, putative amide-derivatives of plant 
isoprenoids may serve as an alternative substrate for Bsh-family members, 
possibly in the detoxification of saponins. 
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Figure 1. Panel A. Part of the isoprenoid synthesis pathway (derived from the KEGG database 
(15)), showing the vast amount of sterols synthesised in this pathway alone. Panel B, C, and D 
show the molecular structure of lanosterol, cycloartenol, and the bile salt glycocholic acid, 
respectively. 
 
The putative activity of CBAH superfamily members on secondary plant 
metabolites cannot easily be assessed due to limited commercial availability of 
the substrates and to the vast amount of different plant metabolites that exists. 
However, the availability of the defined set of Bsh mutants in L. plantarum will 
allow for furthers studies on their functionality even in the absence of purified 
substrates. 
Delivery of Bsh to the host intestine. It has been reported that intestinal 
lactobacilli are of importance for in vivo bile salt deconjugation in the small 
intestine (4, 32, 33). Currently, there is an increasing interest in the use of 
lactobacilli as a probiotic to positively influence health status. Because of the 
alleged role of Bsh in survival and persistence of bacterial strains in the 
intestinal tract, a commonly used criterion for the selection of candidate 
probiotic strains is their capability to hydrolyse bile salts. However, the 
administration of large amounts of bile salt-hydrolysing probiotic bacteria could 
potentially result in a shift in intestinal bile salt composition that might be 
associated with an undesirable impact on the host, such as the formation of 
gallstones or promotion of colon cancer. Therefore, the impact on host 
physiology of Bsh delivery into the small intestine deserves attention.  
To investigate the influence of small intestinal delivery of bile salt 
hydrolase on the host, the lactic acid bacterium L. plantarum WCFS1 was used 
as a model for the administration of bile salt-hydrolysing activity. In vitro 
experiments showed that L. plantarum WCFS1 was capable to withstand gastric 
conditions as well as pancreatin challenge (Chapter 5), making it an ideal 
vehicle for in vivo delivery of enzymes. In a placebo-controlled human 
intervention study, L. plantarum WCFS1 was capable of deconjugating bile salts 
in healthy volunteers. In this study, L. plantarum or placebo was perfused into 
the small intestine for one hour using a catheter that enabled injection of a fluid 
5 cm distal to the pylorus, and aspiration of luminal contents at 40 cm distal to 
the injection port. This catheter was inserted during a gastroduodenoscopy 
procedure, as described previously (35). Following placebo perfusion, the bile 
salts in the aspirated luminal contents consisted of the normal human conjugated 
bile salts glyco- and tauro-cholic acid, -chenodeoxycholic acid and -deoxycholic 
acid, as determined by HPLC analysis (Figure 2, chromatogram 1). In the same 
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volunteer, when perfused on a separate occasion with L. plantarum, small but 
significant HPLC peaks of the deconjugated forms of these bile acids appeared 
(i.e., free cholic, chenodeoxycholic, and deoxycholic acid), clearly showing the 
capability of L. plantarum WCFS1 to deconjugate bile salts in vivo (Figure 2). 
Comparative transcriptome analysis of mucosal biopsies taken after placebo or 
L. plantarum perfusion did not show a significant differential response related to 
Bsh activity as a consequence of the L. plantarum perfusion (Fred Troost, 
unpublished data). This could be due to the fact that these biopsies were 
obtained from the horizontal part of the duodenum, which is a position more 
proximal to the stomach than the locus where the luminal contents used for 
determination of the intestinal bile salt composition were aspirated. 
Consequently, the bile salt deconjugation level at the site where the biopsies 
were taken is likely to be much less exposed to deconjugated bile salts as 
compared to regions further down the small intestine, based on the shorter 
exposure of the native bile salts to the L. plantarum Bsh activity.  
 
 
 
 
 
Figure 2. Schematic representation of exemplary HPLC chromatograms of human small 
intestinal samples after perfusion with placebo (1) or with L. plantarum (2). Peak positions of 
bile salts used as a standard are shown C, cholic acid; GC, glycocholic acid; TC, taurocholic 
acid; CDC, chenodeoxycholic acid; DC, deoxycholic acid; GCDC, glycochenodeoxycholic 
acid; GDC, glycodeoxycholic acid; TCDC, taurodeoxycholic acid; TDC, taurodeoxycholic 
acid. 
 
To establish the impact of Bsh on the host, several studies were performed 
using animal models. In the rat model we used to determine the impact of 
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delivery of Bsh on host physiology (Chapter 6), the human situation was 
approximated as much as possible by a low calcium and high fat diet, simulating 
the composition of a Western human diet (38). Rats naturally produce bile salts 
mostly conjugated to taurine, whereas in humans, bile salts are mostly 
conjugated to glycine (see above, and Figure 2). In addition, most Bsh enzymes 
prefer glycine-conjugated over taurine-conjugated bile salts (3). Therefore, in 
the rat model implemented here, the conjugation of bile salts was shifted from 
predominantly taurine to glycine by inclusion of pectin and cholesterol in the 
diet. The developed animal model appeared to be an excellent tool to measure 
the impact of delivery of bile salt hydrolase in the small intestine in a 
conventional animal, since background bile salt deconjugation levels were very 
low. This circumvented the need to use germ-free animals, which is a system 
that is far from the normal situation. In the developed animal model, bile salt 
deconjugation appeared to occur mostly in the colon. Although L. plantarum 
WCFS1 is capable of ex vivo deconjugation of bile salts present in rat bile and in 
rat intestinal contents, the delivery of bile salt hydrolase to the small intestine 
using viable L. plantarum merely induced a trend effect on bile salt composition 
in vivo (Chapter 6). As described earlier, one of the possible mechanisms 
implemented by the host in response to generation of the more toxic 
deconjugated bile salts is upregulating the production of mucin. (16). However, 
the delivery of Bsh by L. plantarum had no effect on host mucin excretion.  
In an additional study, the effect of Bsh delivery by L. plantarum on the 
transcriptome profile of the distal small intestine was determined by co-
colonising germ-free mice fed a Western-style diet with the Bsh-negative 
Bacteroides thetaiotamicron and wild type L. plantarum or its four-fold bsh-
mutant derivative, that was constructed earlier (Chapter 4). Affymetrix 
genechip analysis of the distal SI of these mice revealed that the absence of Bsh 
production in the L. plantarum bsh-mutant strain changed the expression of 298 
genes (i.e., 172 genes downregulated, and 126 genes upregulated). Among those 
genes, a group of 22 genes related to host lipid metabolism was regulated 
moderately but significantly, of which 18 genes were downregulated, suggesting 
an effect of delivery of Bsh on host lipid metabolism. However, we found no 
effect of colonisation of wild-type L. plantarum on bile salt composition as 
compared to its bsh-mutant derivative (Figure 3). However, we can not rule out 
the possibility that a small amount of deconjugated bile salts formed by L. 
plantarum WCFS1 in the intestinal lumen escaped detection due to fast uptake 
by the intestinal epithelium into the enterohepatic cycle . Since the major bile 
salt hydrolase of L. plantarum WCFS1, Bsh1, showed a preference towards 
glycine- over taurine-conjugated substrates, the bile salt hydrolase activity in 
vivo on the mainly taurine-conjugated murine bile salts (Figure 3) may have 
been limited. Possibly, the effect of Bsh on host physiology with a Bsh that 
displays higher activity levels towards taurine-conjugated bile salts could have a 
larger impact on the bile salt composition in a conventional rat or mouse model. 
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However, most Bshs that have been described show a preference for glycine- 
over taurine-conjugated bile salts (3).  
 
 
 
Figure 3. Schematic representation of exemplary HPLC chromatograms of the contents of the 
proximal small intestine of a germ-free mouse that was administered placebo (1) or L. 
plantarum (2). Peak positions of bile salts used as a standard are shown C, cholic acid; GC, 
glycocholic acid; TC, taurocholic acid; CDC, chenodeoxycholic acid; DC, deoxycholic acid; 
GCDC, glycochenodeoxycholic acid; GDC, glycodeoxycholic acid; TCDC, taurodeoxycholic 
acid; TDC, taurodeoxycholic acid. 
 
Clearly (see above), the rat model we used in this thesis (Chapter 6) that 
produced mainly glycine-conjugated bile salts may be preferable for 
determination of the impact of bile salt hydrolase on host physiology. Although 
some animal models produce mainly glycine-conjugated bile salts (e.g., guinea 
pig), their applicability is restricted due to limited availability of suitable 
transcriptome analysis platforms. In addition, it would be interesting to use 
Lactobacillus-free mice that have been described earlier (32, 33), to determine 
the impact of L. plantarum WCFS1 on bile salt deconjugation in vivo. In this 
animal model, lactobacilli were previously shown to be responsible for most 
(i.e., 90 %) of the Bsh activity in the small intestine (32).   
Since enzyme delivery using viable, wild type bacteria is limited due to 
constraints in the enzyme expression level that can be reached, an alternative for 
bacterial delivery might be provided by use of enteric encapsulates, where the 
amount of enzyme that can be incorporated is virtually unlimited. Therefore, the 
properties of delivery using food-grade protein-gum arabic encapsulates were 
determined, using Bsh as a model enzyme. In vitro experiments showed that the 
microencapsulates gave rise to highly effective protection of the enzyme under 
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gastric conditions (Chapter 5 – see above). Moreover, enzyme release under 
intestinal conditions appeared to be very efficient, although in contrast to 
delivery by L. plantarum, the Bsh activity decreased in time due to proteolytic 
degradation in presence of pancreatin (Chapter 5). However, when used in our 
rat model, no effect of the delivery of Bsh by microencapsulates on bile salt 
composition or mucin excretion was detected. 
The results obtained for intestinal delivery of Bsh may indicate that the 
physiological relevance and magnitude of bile salt hydrolase activity of the 
natural microbiota and probiotics in the small intestine is not very high, 
alleviating concerns on the bile salt hydrolase activity produced in vivo by 
probiotic strains, especially lactobacilli. However, other strains commonly used 
as probiotics include bifidobacterial strains, which have previously been shown 
to generally express Bsh activity at a higher level as compared to lactobacilli 
(31), and therefore might have a more pronounced effect on bile metabolism in 
vivo. The rat model and methodology described here could be used to effectively 
investigate the possible effects of the administration of bifidobacteria on the 
host. 
 Delivery of enzymes using genetically modified organisms. When 
comparing intestinal delivery by viable bacteria and microencapsulates, delivery 
of therapeutics using bacteria in treating or preventing disease may be preferable 
due to their natural adjuvant activity and low immunogenicity (22, 23) (Peter 
van Baarlen, unpublished results). In addition, the implementation of viable 
bacteria as a delivery vehicle is attractive because of their food-grade nature and 
existing association with health by the general public.  
As a solution for the limited expression levels that can be obtained in wild 
type bacteria, genetically modified organisms (GMOs) can be used. For 
example, the implementation of genetical engineering allows for the expression 
of exogenous gene products (for review, see (13)); e.g., several organisms such 
as Lactococcus lactis, L. plantarum, and Streptococcus gordonii have been used 
for delivery of therapeutics in vivo. In Lactococcus lactis, the cytokine IL-10, 
which is a powerful anti-inflammatory cytokine that plays a central role in 
downregulation of inflammatory cascades (1), was expressed for use in 
treatment in inflammatory bowel disease. In mice with dextran sulphate sodium 
(DSS)-induced enterocolitis, inflammation was reduced by IL-10 delivered by 
Lactococcus lactis (27, 28). Furthermore, the dose of IL-10 required could be 
decreased a 1000-fold when using localised delivery by viable bacteria when 
compared to standard non-localised systemic treatment (28). In addition, the 
intake of trefoil factor (TFF)-secreting Lactococcus lactis was shown to convey 
repair of inflammatory damage to the epithelium of DSS-induced colitis. TFFs 
are known to be important in the protection and repair of the intestinal 
epithelium (34). Other examples include the expression of a model antigen, 
consisting of an epitope derived from the HIV-virus, in L. plantarum (14), 
where high expression levels could be reached. Furthermore, lipid digestion 
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could be enhanced in pigs by the expression of a lipase in Lactococcus lactis (9). 
Another application of GMO technology was the reduction of caries by the 
production of anti-Streptococcus mutans antibodies by Lactobacillus zeae (17) 
in rats. In the field of vaccination, tetanus toxin fragment C (TTFC) has been 
expressed in both Lactococcus lactis and L. plantarum  (5, 25), yielding 
protection against tetanus following mucosal immunization regimes. Cell wall 
mutants of Lactococcus lactis and L. plantarum that contained an alanine 
racemase (alr) mutation were shown to be more effective in immunisation, 
possibly due to improved release of antigen from the bacterial cells. However, 
since alanine racemase is an essential gene in these organisms (14), the use of 
alr mutants could have a second, important application in containment of the 
bacterial strains when used outside the laboratory. To date, biological safety of 
GMOs is still subject to debate. Recently, the first clinical trial using live IL-10 
expressing Lactococcus lactis that is contained by the deletion of the essential 
gene thyA has been approved and carried out in The Netherlands (28), which is 
an important step forward in the introduction of GMOs in medical applications.  
Concluding remarks. The work presented in this thesis led to the 
improvement and refinement of the annotation of CBAH superfamily members 
in Gram-positive bacteria into bile salt hydrolases and penicillin acylase-related 
enzymes. However, several bacteria appeared to be redundant for bile salt 
hydrolase or penicillin acylase-related functionality, such as L. plantarum 
WCFS1, which contains four genes (bsh1 to bsh4) originally annotated as bile 
salt hydrolase. To enable investigation of genes predicted to be redundant, a 
Cre-lox toolbox for the construction of multiple deletions and selectable-marker 
removal in Gram-positive organism was designed and implemented in L. 
plantarum WCFS1. Analysis of the functionality of Bsh1, Bsh2, Bsh3, and Bsh4 
of L. plantarum WCSF1 revealed that Bsh1 is the major bile salt hydrolase in 
this strain, whereas Bsh2, Bsh3, and Bsh4 appear to be penicillin acylase-
related. The delivery of bile salt hydrolase activity to the small intestine using 
viable L. plantarum was compared to delivery using Bsh-whey protein/gum 
arabic microencapsulates in vitro. However, no effect of delivery of Bsh on the 
intestinal bile salt composition or mucin excretion in a rat model was found. In 
contrast, initial human experiments showed that L. plantarum WCFS1 has the 
capacity to deconjugate human bile salts in vivo. 
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 Nederlandse samenvatting. 
In de lever van zoogdieren worden galzouten gesynthetiseerd vanuit 
cholesterol en geconjugeerd met taurine of glycine. Na uitscheiding in de darm 
kunnen geconjugeerde galzouten gedeconjugeerd worden door leden van de 
endogene microbiota die het enzym galzout hydrolase produceren. Galzout 
hydrolase lijkt een belangrijke rol te spelen in zowel de darmfysiologie van de 
gastheer als in bacteriële overleving en persistentie in de darm; met name voor 
lactobacillen wordt gesuggereerd dat zij van belang zijn voor in vivo galzout 
hydrolyse in de dunne darm. In dit proefschrift is een functionele analyse van 
galzout hydrolase in Gram-positieve bacteriën, en in bijzonder van het model 
organisme Lactobacillus plantarum WCFS1 uitgevoerd. Dieper onderzoek naar 
de annotatie van galzout hydrolase genen in Gram-positieve bacteriën, gebruik 
makend van een combinatie van in silico methoden, leidde tot de re-annotatie 
van acht galzout hydrolase superfamilieleden in verschillende lactobacillen. 
Verder leverden deze analyses een robuuste methodologie voor de accurate 
annotatie van deze enzym superfamilie. L. plantarum WCSF1 was eerder 
voorspeld vier galzout hydrolase genen te bevatten (bsh1, bsh2, bsh3 en bsh4), 
maar volgens onze in silico analyses zijn drie van deze genen mogelijk verwant 
aan penicilline acylases. Om de functionaliteit van elk van deze 
galzouthydrolase genen te onderzoeken was het nodig om meervoudige isogene 
galzouthydrolase-deletiestammen te maken. Voor de constructie van 
meervoudige selectiemarker-vrije deletiestammen is een Cre-lox-gebaseerde 
toolbox ontworpen en gebruikt in L. plantarum WCFS1. Gebruik makend van 
heterologe overexpressie en meervoudige galzouthydrolase-deletiestammen van 
L. plantarum WCFS1 werd aangetoond dat Bsh1 de belangrijkste galzout 
hydrolase is in deze stam. Bsh1 lijkt ook belangrijk te zijn voor de tolerantie van 
glycodeoxycholinezuur. Hoewel deze experimenten de voorspelling dat bsh2, 
bsh3 en bsh4 niet voor ware galzouthydrolases coderen valideerden, kon de in 
vivo functionaliteit van Bsh2, Bsh3 en Bsh3 niet volledig achterhaald worden. 
Bsh2, Bsh3 en Bsh4 lijken voor enzymen met acylase activiteit te coderen die 
mogelijk penicilline-achtige chemicaliën als voorkeurssubstraat gebruiken. 
Verder werd de invloed van galzouthydrolyserende probiotica op de fysiologie 
van de gastheer bestudeerd door gebruik te maken van twee manieren om 
galzouthydrolase af te leveren in de dunne darm; aflevering van galzout 
hydrolase activiteit door levende L. plantarum werd vergeleken met aflevering 
door galzout hydrolase/wei eiwit/arabische gom micro-encapsulaten in een in 
vitro model. De micro-encapsulaten gaven een uitstekende bescherming van het 
enzym onder maagcondities. Echter, onder pancreatinedruk tijdens 
darmcondities werd het Bsh enzym geproteolyseerd. L. plantarum bleek in staat 
om zowel maag- als darmcondities te weerstaan, maar het niveau van 
enzymaflevering is relatief laag vergeleken met de capaciteit van micro-
encapsulaten. Verder werd de invloed van aflevering van galzout hydrolase 
 activiteit door levende L. plantarum en wei eiwit/arabische gom micro-
encapsulaten op de gastheer in vivo in een rat model bestudeerd. Er werd echter 
geen effect van de aflevering van galzout hydrolase op de galzout compositie of 
mucine excretie in de darm gevonden. Deze resultaten zouden kunnen betekenen 
dat de fysiologische relevantie en grootte van galzout hydrolase activiteit van 
probiotica in de dunne darm beperkt is. 
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